|
TCMBANKIN000080 |
Deoxycholic Acid |
SCHEMBL11962424; deoxycholic acid; Deoxycholicacid; deoxycholicacid; AKOS015965182; AC-20221 |
C24H40O4 |
392.57 |
CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C |
|
TCMBANKIN000116 |
cneorin-NP36 |
|
C30H46O3 |
454.68 |
CC(C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)C5C(O5)C6C(O6)(C)C |
|
TCMBANKIN000127 |
oleanolic acid-3-O-β-D-glucuronopyranoside_qt |
3-O-β-D-glucuronopyranoside-6-O-butyl ester_qt; Oleanolic acid-28-O-beta-D-glucopyranoside_qt; 3-O-β-D-glucuronopyranoside-6-O-methyl ester_qt |
|
456.78 |
|
|
TCMBANKIN000130 |
(1S,4aR,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
C30H48O5 |
488.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1O)C)C(=O)O)C |
|
TCMBANKIN000186 |
Methyl ganoderate K |
|
C31H44O7 |
528.68 |
|
|
TCMBANKIN000237 |
rotungenic acid |
|
C30H48O5 |
488.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN000281 |
Myricadiol |
AC1NSYWT; isomyricadiol; myricadiol; (3S,14bR)-8a-(hydroxymethyl)-4,4,6a,6a,11,11,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol |
C30H50O2 |
442.72 |
CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)CO)C |
|
TCMBANKIN000331 |
ginsenoside R0_qt |
|
C48H76O19 |
957.11 |
|
|
TCMBANKIN000383 |
Euphol |
CHEMBL465181; (3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; ST24047202; AIDS-064689; ZINC4097719; FT-0698509; AIDS064689; CHEBI:4940; AKOS016010616; Euphol (6CI); AC1L9BGD; (3S,5R,10S,13S,14S)-17-((R)-1,5-Dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; SCHEMBL541497; BG01135940; (20R)-(+)-triucalla-8,24-diene-3beta-ol; AK120346; euphol; (3S,5R,10S,13S,14S,17S)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3beta,13alpha,14beta,17alpha)-Lanosta-8,24-dien-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.,13.alpha.,14.beta.,17.alpha.)-; Euphadienol; (+)-Euphol; (s)-euphol; (+)-alpha-Euphol; AJ-48007; alpha-Euphol; Eupha-8,24-dienol; C08624; 514-47-6; LMPR0106090002; KB-277032; 13alpha,14beta,17betaH-Lanosta-8,24-dien-3beta-ol (8CI); 7162AB |
C30H50O |
426.72 |
CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN000456 |
ganoderic acid M |
|
C30H42O8 |
530.65 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)O)C)C |
|
TCMBANKIN000486 |
acutumine |
SMR001397290; MLS002473201; NCGC00247495-01; CHEMBL1716763; HMS2196C12; Acutumine |
C19H24ClNO6 |
397.8 g/mol |
CN1CCC23C1(CC(C24C(C(=CC4=O)OC)O)Cl)C(=C(C(=O)C3)OC)OC |
|
TCMBANKIN000668 |
Hexyl b-D-glucopyranoside |
|
C12H24O6 |
264.31 g/mol |
CCCCCCOC1C(C(C(C(O1)CO)O)O)O |
|
TCMBANKIN000704 |
ilexoside A_qt |
|
C35H56O8 |
604.81 |
|
|
TCMBANKIN000734 |
Ginsenoside-Rh3_qt |
ginsenoside-Rh3_qt |
C36H60O7 |
604.86 |
|
|
TCMBANKIN000911 |
akebonoic acid |
3β-hydroxy-30-norolean-12,20(29)-dien-28-oicacid; akebonoic acid |
C29H44O3 |
440.66 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(=C)CC5)C(=O)O)C)C)C |
|
TCMBANKIN001013 |
fernenol |
C16958; CHEBI:80823; 4966-00-1; Fernenol |
C30H50O |
426.72 |
CC(C)C1CCC2C1(CCC3(C2(CC=C4C3CCC5C4(CCC(C5(C)C)O)C)C)C)C |
|
TCMBANKIN001029 |
Penconazol |
|
C13H15Cl2N3 |
284.18 |
|
|
TCMBANKIN001139 |
papyrioside L- IIa_qt |
|
C49H76O19 |
969.12 |
|
|
TCMBANKIN001176 |
ganolucidic acid E |
|
C30H44O5 |
484.67 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN001195 |
Dauricumine |
dauricumine |
C19H24ClNO6 |
397.85 |
CN1CCC23C1(CC(C24C(C(=CC4=O)OC)O)Cl)C(=C(C(=O)C3)OC)OC |
|
TCMBANKIN001296 |
Tuberostemoenone |
tuberostemoenone; AC1NT1AO; azane; butane; methane; methanol; molecular hydrogen; trihydrate |
|
387.52 |
[HH].[HH].[HH].C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.CCCC.CO.N.O.O.O |
|
TCMBANKIN001297 |
Abrusoside A_qt |
|
|
498.77 |
|
|
TCMBANKIN001345 |
mimengoside,e_qt |
|
|
472.78 |
|
|
TCMBANKIN001349 |
C09704 |
ZINC01531550; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (3S,6E)-; EINECS 214-276-7; (3S)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (S-(E))-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; (3S,6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; 1119-38-6; LMPR01030037 |
C15H26O |
222.37 |
CC(=CCCC(=CCCC(C)(C=C)O)C)C |
|
TCMBANKIN001370 |
(1S,2R,4aS,6aS,6aR,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,12a-pentamethyl-9-methylene-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |
(1S,2R,4aS,6aS,6aR,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,12a-pentamethyl-9-methylidene-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |
|
456.73 |
|
|
TCMBANKIN001388 |
Ginsenoside-Rh4_qt |
|
C36H60O8 |
620.86 |
|
|
TCMBANKIN001394 |
dimethyl platyconate A |
|
|
562.82 |
|
|
TCMBANKIN001500 |
Soyasaponin_qt |
|
|
458.8 |
|
|
TCMBANKIN001525 |
Cristatain_qt |
|
|
500.79 |
|
|
TCMBANKIN001558 |
Abrisapogenol E |
abrisapogenol e |
C30H50O4 |
474.7 g/mol |
CC12CCC(C(C1CCC3(C2CC=C4C3(CCC5(C4CC(CC5O)(C)CO)C)C)C)(C)CO)O |
|
TCMBANKIN001564 |
Pomolic acid acetate |
methyl (1R,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate; AIDS-010229; AIDS010229; (1R,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid methyl ester |
C36H58O8 |
618.84 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1(C)O)C)C(=O)OC |
|
TCMBANKIN001593 |
3β-acetoxy-30-norlupan-20-one |
|
|
470.81 |
|
|
TCMBANKIN001672 |
Ganoderic acid alpha |
ganodericacidα |
C32H46O9 |
574.7 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(C(C(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)OC(=O)C)C)C)O |
|
TCMBANKIN001715 |
Thladioside H1_qt |
|
|
470.76 |
|
|
TCMBANKIN001758 |
ginsenoside Rh8_qt |
|
|
460.77 |
|
|
TCMBANKIN001896 |
(4aS,6aR,6aS,6bR,8aR,9R,10S,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-methylol-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
(4aS,6aR,6aS,6bR,8aR,9R,10S,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
C30H48O5 |
488.7 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN001931 |
(E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid |
(E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid; (E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid |
C34H50O6 |
554.76 |
|
|
TCMBANKIN002037 |
(3S,4S,5R,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-((R)-6-methyl-5-methyleneheptan-2-yl)-2,3,4,5,6,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
|
|
424.78 |
|
|
TCMBANKIN002103 |
ergosta-7,22-dien-3β,5α,6β-triol |
|
|
430.74 |
|
|
TCMBANKIN002188 |
sanguisorbin B _qt |
|
|
456.78 |
|
|
TCMBANKIN002207 |
22-hydroxyhopan-3-one |
|
C30H50O2 |
442.72 |
|
|
TCMBANKIN002233 |
(8R)-3-oxo-8-hydroxy-polypoda -13E,17E,21-triene |
|
|
442.8 |
|
|
TCMBANKIN002312 |
(3Z,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5,8a-dimethyl-2-methylene-5-methylol-decalin-1-yl]ethylidene]-4-hydroxy-tetrahydrofuran-2-one |
(3Z,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-decalinyl]ethylidene]-4-hydroxy-2-tetrahydrofuranone; (3Z,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decalin-1-yl]ethylidene]-4-hydroxy-tetrahydrofuran-2-one; (3Z,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxy-oxolan-2-one; (3Z,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one |
C20H30O5 |
350.45 |
|
|
TCMBANKIN002388 |
ginsenoside Rh7_qt |
|
|
474.8 |
|
|
TCMBANKIN002424 |
fischeriana B_qt |
|
C26H36O9 |
492.56 |
|
|
TCMBANKIN002465 |
(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one |
BB_NC-1001; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromanone; ZINC00001785 |
C15H12O5 |
272.25 |
|
|
TCMBANKIN002485 |
[(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate |
(E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester; [(4R,4aR,5S,7R,8S,8aR)-5-hydroxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate |
C25H36O6 |
432.55 |
|
|
TCMBANKIN002487 |
18α-hydroxyglycyrrhetic acid |
18α-hydroxy glycyrrheticacid |
C30H46O5 |
486.68 |
CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4(CC(CC5)(C)C(=O)O)O)C)C)C)C |
|
TCMBANKIN002489 |
hederagenin-28-O-β-D-glucopyranosyl ester_qt |
|
|
472.78 |
|
|
TCMBANKIN002496 |
poriferasta-7,22E-dien-3beta-ol |
(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; LMST01040140; (3S,5S,9R,10S,13R,14R,17R)-17-[(E,1R,4R)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(E,1R,4R)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C29H48O |
412.69 |
CCC(C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN002539 |
pelargonidin |
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1lambda-chromen-1-ylium; Pelargonidin-3,5-diglucoside_qt; 7690-51-9; C05904; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromenylium; XVFMGWDSJLBXDZ-UHFFFAOYSA-O; 3,4',5,7-Tetrahydroxyflavylium; anthocyanidin; pelargonidin 3,5-di-O-glycoside_qt; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium; CHEBI:25863; 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol; 2-(4-hydroxyphenyl)-1-benzopyrylium-3,5,7-triol; LMPK12010003; CHEMBL591036; pelargonidin-3-O-glucoside_qt; pelargonidin-3,5-di-O-glucoside_qt; BDBM50121994; CHEMBL1197905; A806724; BDBM50326998; 1-Benzopyrylium, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-; SCHEMBL20592; 134-04-3 (chloride); ZINC391840; Pelargonidin; AC1L9A0P; ZB012073 |
C15H11O5+ |
271.24 g/mol |
C1=CC(=CC=C1C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O |
|
TCMBANKIN002631 |
(8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
(8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C29H50O |
414.71 |
|
|
TCMBANKIN002713 |
[(1S,2R,4S,4aR,5R,6S,8aR)-4-acetoxy-6-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate |
[(3S,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-3-hydroxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,6S,8aR)-4-acetoxy-6-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,6S,8aR)-4-acetoxy-6-hydroxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester |
C27H38O8 |
490.59 |
|
|
TCMBANKIN002807 |
sanguisorbic acid dilactone |
|
C21H10O13 |
470.3 g/mol |
C1=C(C=C(C(=C1O)O)OC2=C(C(=O)C3=C4C2=C(OC5=C4C(=C(O3)O)C=C(C5=O)O)O)O)C(=O)O |
|
TCMBANKIN002824 |
glaucogenin,a |
glaucoside C_qt |
C41H62O15 |
794.92 |
|
|
TCMBANKIN002899 |
isoarborinol |
|
C30H50O |
426.72 |
CC(C)C1CCC2C1(CCC3(C2(CC=C4C3CCC5C4(CCC(C5(C)C)O)C)C)C)C |
|
TCMBANKIN002903 |
delta 5-Pregnenetriol |
(3S,8R,9S,10R,13S,14S,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol; 903-67-3; 5-Pregnene-3beta,17alpha,20alpha-triol; Pregn-5-ene-3,17,20-triol, (3beta,20S)-; Pregn-5-ene-3beta,17alpha,20alpha-triol |
C21H34O3 |
334.49 |
CC(C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O)O |
|
TCMBANKIN002956 |
[(1S,3R)-1-[(2R)-3,3-dimethyloxiran-2-yl]-3-[(5R,8S,9S,10S,11S,14R)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] acetate |
acetic acid [(1S,3R)-1-[(2R)-3,3-dimethyl-2-oxiranyl]-3-[(5R,8S,9S,10S,11S,14R)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] ester; acetic acid [(1S,3R)-1-[(2R)-3,3-dimethyloxiran-2-yl]-3-[(5R,8S,9S,10S,11S,14R)-11-hydroxy-3-keto-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] ester; [(1S,3R)-1-[(2R)-3,3-dimethyloxiran-2-yl]-3-[(5R,8S,9S,10S,11S,14R)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] ethanoate |
C32H50O5 |
514.74 |
CC(CC(C1C(O1)(C)C)OC(=O)C)C2=C3CC(C4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)O |
|
TCMBANKIN003024 |
16beta,17-dihydroxy-(-)-kauran-19-ate-beta-D-glucose ester_qt |
|
|
336.52 |
|
|
TCMBANKIN003114 |
18-(β-D-Oxy glucose)-28-Oxo-12-oleanolic acid-3β-3-O-(β-D-glucose)-β-D-glucuronic acid methylester_qt |
|
|
456.78 |
|
|
TCMBANKIN003175 |
ardisianoside H_qt |
|
C70H114O37 |
1547.63 |
|
|
TCMBANKIN003184 |
ilexsideii_qt |
zigu一glucoside II_qt |
C35H56O8 |
604.81 |
|
|
TCMBANKIN003288 |
ganodermic acid T- O |
lanosta-7,9(11),24-trien-3α-acetoxy-15α,22β-dihydroxy-26-oic acid |
|
512.8 |
|
|
TCMBANKIN003298 |
ganodermic acid T- Q |
ganodermic acid T- N |
C32H46O5 |
510.7 g/mol |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)OC(=O)C |
|
TCMBANKIN003333 |
cyclamin_qt |
ardisiacrispin B_qt; primulanin_qt |
C58H94O27 |
1223.35 |
|
|
TCMBANKIN003434 |
Gypenoside LV_qt |
Gypenoside LXXIX_qt; Gypenoside LXIII_qt; Gypenoside XXXVIII_qt |
C42H72O14 |
801.01 |
|
|
TCMBANKIN003495 |
2,3-isopropylidene isocyasterone |
|
|
560.8 |
|
|
TCMBANKIN003513 |
Smilagenin-3-O[beta-D-glucopyranosyl-(1-2)]-beta-D-mannopyranoside_qt |
|
C39H64O13 |
740.92 |
|
|
TCMBANKIN003630 |
ginsenoside-Rg2_qt |
ginsenoside- Rg2_qt; ginsenoside Rg2_qt; chikusetsusaponin I_qt; chikusetsusaponinⅠ_qt |
C42H72O13 |
785.01 |
|
|
TCMBANKIN003665 |
evoden |
|
|
|
C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O |
|
TCMBANKIN003703 |
paryriogenin I |
|
|
422.71 |
|
|
TCMBANKIN003722 |
mukurozisaponin X_qt |
Mukurozi-saponin X_qt; Mukurozi-saponin E1_qt; mukurozisaponin Y2_qt; Mukurozi-saponin Y2_qt; Mukurozi-saponin Y1_qt; mukurozisaponin Y1_qt |
C58H94O26 |
1207.35 |
|
|
TCMBANKIN003766 |
methyl 3-O-β-D-glucopyranosyl polygalacate _qt |
|
|
518.81 |
|
|
TCMBANKIN003803 |
ginsenoside Rb3_qt |
gensenoside- Rb3_qt; ginsenoside- Rb3_qt; gensenoside Rb3_qt |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN003804 |
Adiantone |
adiantone |
C29H48O |
412.7 g/mol |
CC(=O)C1CCC2(C1CCC3(C2CCC4C3(CCC5C4(CCCC5(C)C)C)C)C)C |
|
TCMBANKIN003809 |
siraitic acid E_qt |
|
|
472.78 |
|
|
TCMBANKIN003861 |
propapyriogeninA2 |
DTXSID20331681; Propapyriogenin A2; C08971; AC1L9BZ8; 72933-74-5; propapyriogenin a2; CHEBI:8484; (4aR,6aR,6aS,6bR,8aR,12aS,13R,14bS)-13-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,10-dioxo-1,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydropicene-4a-carboxylic acid; propapyriogenin A2 |
C30H44O5 |
484.67 |
CC1(CC2C3=CC(C4C5(CCC(=O)C(C5CCC4(C3(CCC2(CC1=O)C(=O)O)C)C)(C)C)C)O)C |
|
TCMBANKIN004097 |
STOCK1N-66370 |
|
|
414.69 |
|
|
TCMBANKIN004243 |
Secowithamerclin |
|
|
468.69 |
|
|
TCMBANKIN004312 |
esculentagenin |
|
C31H46O8 |
546.69 |
CC1(CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)O)C(=O)OC |
|
TCMBANKIN004363 |
22-Stigmasten-3-one |
|
C29H48O |
412.7 g/mol |
CCC(C=CC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(=O)C4)C)C)C(C)C |
|
TCMBANKIN004388 |
macrostemonoside d_qt |
macrostemonoside a_qt |
|
400.71 |
|
|
TCMBANKIN004416 |
Jujubasaponin VI_qt |
|
C42H68O14 |
796.98 |
|
|
TCMBANKIN004430 |
cynapanoside B_qt |
|
|
390.47 |
|
|
TCMBANKIN004445 |
Δ7,22,25-triene-3-ol |
Δ7,16,25,26-stigmastatrienol-3-O-glucoside_qt |
|
410.75 |
|
|
TCMBANKIN004454 |
Gypenoside LXV_qt |
Gypenoside LXXII_qt; Gypenoside LIV_qt; Gypenoside LXII_qt; Gypenoside LXXVI_qt; Gypenoside LXIV_qt; Gypenoside LXXIV_qt |
C41H70O13 |
770.99 |
|
|
TCMBANKIN004484 |
vittadinoside_qt |
|
|
412.77 |
|
|
TCMBANKIN004533 |
22β-acetoxy-3α,15α-dihydroxylanosta-7,9(11),24-trien-26-oic acid |
|
|
528.9 |
|
|
TCMBANKIN004638 |
polygalacic acid |
SMR001215693; CHEMBL1722733; polygalacicacid; NCGC00247514-01; Polygalacic acid; MLS000575020; HMS2268O05 |
C30H48O6 |
504.7 g/mol |
CC1(CCC2(C(C1)C3=CCC4C(C3(CC2O)C)(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C(=O)O)C |
|
TCMBANKIN004645 |
Abrisapogenol B |
abrisapogenol b |
C30H50O4 |
474.7 g/mol |
CC12CCC(C(C1CCC3(C2CC=C4C3(CCC5(C4CC(CC5O)(C)CO)C)C)C)(C)CO)O |
|
TCMBANKIN004652 |
2-[(1R)-2,2,3-trimethyl-1-cyclopent-3-enyl]ethanal |
ZINC01063075; 2-[(1R)-2,2,3-trimethyl-1-cyclopent-3-enyl]acetaldehyde |
C10H16O |
152.23 |
|
|
TCMBANKIN004812 |
(4aS,6aR,6aS,6bR,8aS,10R,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
C47H74O18 |
927.08 |
|
|
TCMBANKIN004908 |
7-oxomogroside Ⅴ_qt |
|
|
490.8 |
|
|
TCMBANKIN004943 |
Epibetulinic acid |
AIDS-107572; 3-Hydroxylup-20(29)-en-28-oic acid,(3.alpha.); AIDS107572 |
C30H48O3 |
456.7 |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)O |
|
TCMBANKIN005009 |
esculentoside M_qt |
|
|
546.77 |
|
|
TCMBANKIN005142 |
cimilactone a_qt |
|
|
458.7 |
|
|
TCMBANKIN005207 |
mimengoside B_qt |
|
|
488.83 |
|
|
TCMBANKIN005243 |
Shinjulactone A |
Picrasa-3,13(21)-dien-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-, (1.beta.,2.alpha.,11.beta.,12.alpha.); Picrasa-3,13(21)-dien-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-, (1beta,2alpha,11beta,12alpha); AIDS026411; 89353-91-3; AIDS-026411 |
C20H26O7 |
378.42 |
CC1=CC(C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O)O |
|
TCMBANKIN005294 |
ginsenoside rd_qt |
ginsenoside- F3_qt; ginsenoside F2_qt; notoginsenosider4_qt |
C42H72O13 |
785.01 |
|
|
TCMBANKIN005369 |
Kulactone |
kulactone |
C30H44O3 |
452.67 |
CC(=CCCC1C2C(CC3(C2(CCC4C3=CCC5C4(CCC(=O)C5(C)C)C)C)C)OC1=O)C |
|
TCMBANKIN005413 |
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,3E,5S)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,3E,5S)-5-ethyl-6-methyl-hepta-3,6-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(1R,2E,4S)-4-ethyl-1,5-dimethyl-hexa-2,5-dienyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(1R,2E,4S)-4-ethyl-1,5-dimethylhexa-2,5-dienyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C29H46O |
410.67 |
|
|
TCMBANKIN005420 |
periplocin_qt |
|
|
390.57 |
|
|
TCMBANKIN005452 |
(20S)-24-ene-3β,20-diol-3-acetate |
|
C32H54O3 |
486.77 |
|
|
TCMBANKIN005465 |
1-[(5R,8R,9S,10S,12R,13S,14S,17S)-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone |
|
|
318.55 |
|
|
TCMBANKIN005486 |
α-amyrenonol |
|
|
424.78 |
|
|
TCMBANKIN005702 |
(2S,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid |
(2S,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid; (2S,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-3,11,15-triketo-4,4,10,13,14-pentamethyl-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-4-keto-2-methyl-enanthic acid |
C30H42O7 |
514.65 |
|
|
TCMBANKIN005727 |
Ganoderenic acid G |
ganoderenic acid G |
C30H40O7 |
512.63 |
CC(CC(=O)C=C(C)C1CC(C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C)O)C(=O)O |
|
TCMBANKIN005774 |
dipterocarpol |
SCHEMBL14226155 |
C30H50O2 |
442.72 |
CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(=O)C4(C)C)C)C)C)O)C |
|
TCMBANKIN005818 |
Thujopsadiene |
thujopsadiene; AC1O575L; 2,4a,8,8-tetramethyl-1,1a,4,5-tetrahydrocyclopropa[j]naphthalene; HIRCZOSUMSSTDU-UHFFFAOYSA-N |
C15H22 |
202.33 g/mol |
CC1=CCC2(CC=CC(C23C1C3)(C)C)C |
|
TCMBANKIN005886 |
atratoglaucoside,b_qt |
|
|
374.47 |
|
|
TCMBANKIN005887 |
ganoderic acid J |
|
C30H42O7 |
514.65 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN005918 |
paryriogenin J |
|
|
452.74 |
|
|
TCMBANKIN006005 |
(20R)-3β-acetoxy-16β-dihydroxydammar-24-ene |
|
|
470.86 |
|
|
TCMBANKIN006029 |
polygosides E_qt |
polygosides C_qt; polygosides D_qt |
|
412.67 |
|
|
TCMBANKIN006040 |
Rubrosterone |
rubrosterone |
C19H26O5 |
334.41 |
CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2=O)O |
|
TCMBANKIN006050 |
parkeol |
|
C30H50O |
426.7 g/mol |
CC(CCC=C(C)C)C1CCC2(C1(CC=C3C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN006150 |
Euponin |
euponin; DTXSID70415122; 70469-59-9; CHEBI:4942; C09449 |
C20H24O6 |
360.4 |
CC=C(C)C(=O)OC1CC(=C2CC3C(C2C4C1C(=C)C(=O)O4)(O3)C)CO |
|
TCMBANKIN006152 |
aescigenin |
|
C30H48O5 |
488.7 |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC6C2(C(C1O6)O)CO)C)C)(C)CO)O)C)C |
|
TCMBANKIN006155 |
Cordylagenin |
cordylagenin |
|
432.71 |
|
|
TCMBANKIN006208 |
Ailantone |
C08747; 2H-1,11c-(Epoxymethano)phenanthro(10,1-bc)pyran-5,10(3H,6ah)-dione, 1,3a,4,7,7a,11,11a,11b-octahydro-8,11a-beta-dimethyl-3-methylene-1-alpha,2-beta,11-beta-trihydroxy-; AIDS-026407; Picrasa-3,13(21)-dien-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1.beta.,11.beta.,12.alpha.); Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1beta,11beta,12alpha)-; 981-15-7; Ailanthone; AIDS026407; Ailanthone (7CI); Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1-beta,11-beta,12-alpha)- |
C20H24O7 |
376.4 |
CC1=CC(=O)C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O |
|
TCMBANKIN006224 |
ergosta-4,7,22-trien-3,6-dione |
|
C28H40O2 |
408.62 |
|
|
TCMBANKIN006237 |
asterbatanoside K_qt |
3-o-beta-d-glucopyranosyl-(1-6)-beta-d-glucopyranosyl-medicagenic acid-28-o-beta-d-xylopyranosyl-(1-4)-[alpha-l-arabinopyranosyl-(1-3)-]-alpha-l-rhamnopytanosyl-(1-2)-beta-d-fucopyranside_qt; 3-o-beta-d-glucopyranosyl-(1-6)-beta-d-glucopyranosyl-2beta,3beta-dihydroxy-olean-12-en-23alpha,28-dioic acid-28-o-alpha-l-arabinopyranosyl-(1-3)-alpha-l-rhamnopytanosyl-(1-2)-beta-d-fucopyranoside_qt; asterbatanoside J_qt |
|
502.76 |
|
|
TCMBANKIN006241 |
ginsenoside-F1_qt |
|
C36H62O9 |
638.87 |
|
|
TCMBANKIN006262 |
12-Oxoarundoin |
(5aR,9S,11aS,13bR)-9-methoxy-3a,5a,8,8,11a,13a-hexamethyl-3-propan-2-yl-2,3,4,5,5b,6,7,7a,9,10,11,13b-dodecahydro-1H-cyclopenta[a]chrysen-13-one; AC1NSZBP; 12-oxoarundoin |
C31H50O2 |
454.73 |
CC(C)C1CCC2C1(CCC3(C2(C(=O)C=C4C3CCC5C4(CCC(C5(C)C)OC)C)C)C)C |
|
TCMBANKIN006312 |
10α-cucurbita-5,24-diene-3β-ol |
|
|
426.8 |
|
|
TCMBANKIN006389 |
dianoside A_qt |
|
C42H66O15 |
810.96 |
|
|
TCMBANKIN006636 |
zizyberanalic acid |
|
C30H46O4 |
470.7 g/mol |
CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(C(C(C5(C)C)O)C=O)C)C)C(=O)O |
|
TCMBANKIN006661 |
ginsenoside- Rg1_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN006665 |
melianotriol |
|
C30H50O5 |
490.71 |
CC1(C(CCC2(C1CC=C3C2CCC4(C3(CCC4C5CC(OC5O)C(C(C)(C)O)O)C)C)C)O)C |
|
TCMBANKIN006774 |
Sapindoside B_qt |
siraitic acid D_qt; siraitic acid C_qt; siraitic acid B_qt |
C46H74O16 |
883.07 |
|
|
TCMBANKIN006865 |
lanost-8-en-3beta-ol |
24,25-Dihydrolanosterol; C05109; LMST01010087; CHEBI:28113; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhexyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
C30H52O |
428.73 |
CC(C)CCCC(C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN006907 |
Timosaponin A-III_qt |
Timosaponin A III_qt |
C39H64O13 |
740.92 |
|
|
TCMBANKIN006913 |
esculentoside G_qt |
esculentoside B_qt |
|
532.79 |
|
|
TCMBANKIN007012 |
ginsenoside-Rh1_qt |
20(R)-Ginsenoside-Rh1_qt; ginsenoside- Rh1_qt; 20(R)-ginsenoside Rh1_qt |
C36H62O9 |
638.87 |
|
|
TCMBANKIN007023 |
stigmast-7-enol |
|
C29H46O |
410.67 |
CCC(CCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN007052 |
(3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-4,4,6a,6b,8a,11,14b-heptamethyl-11-methylol-1,2,3,4a,7,8,9,10,12,12a,13,14-dodecahydropicen-3-ol |
(3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,7,8,9,10,12,12a,13,14-dodecahydropicen-3-ol |
C30H48O2 |
440.7 |
|
|
TCMBANKIN007072 |
80-57-9 |
Bicyclo(3.1.1)hept-3-en-2-one, 4,6,6-trimethyl-; (1R,5R)-2,7,7-trimethylbicyclo[3.1.1]hept-2-en-4-one; (1R,5R)-2,7,7-trimethyl-4-bicyclo[3.1.1]hept-2-enone; EINECS 201-292-4; EPA Pesticide Chemical Code 128986; 4,6,6-Trimethylbicyclo(3.1.1)hept-3-en-2-one; NCGC00142604-01; ZINC00967600; AI3-23127 |
C10H14O |
150.22 |
CC1=CC(=O)C2CC1C2(C)C |
|
TCMBANKIN007135 |
subprogenin A |
|
C30H48O4 |
472.7 |
CC12CCC(C(C1CCC3(C2CC=C4C3(CCC5(C4CC(CC5=O)(C)CO)C)C)C)(C)CO)O |
|
TCMBANKIN007145 |
14-acetoxy-7beta-senecioyloxy-notonipetranone |
|
|
406.57 |
|
|
TCMBANKIN007152 |
ELTANOLONE |
Eltanolonum [INN-Latin]; Pregnanolone; 3.alpha.,5.beta.-Epimeric pregnanolone; Pregnanolone II; CHEBI:1712; 3.alpha.-Hydroxy-5.beta.-tetrahydroprogesterone; Eltanolone [INN]; 5.beta.-Pregnan-20-one, 3.alpha.-hydroxy-; WLN: L E5 B666TJ A1 E1 FV1 OQ; 3alpha-Hydroxy-5beta-tetrahydroprogesterone; 5beta-Pregnan-20-one, 3alpha-hydroxy- (8CI); NSC 82867; BRN 4785659; SKF 6455; (3alpha,5beta)-3-hydroxypregnan-20-one; 3alpha-Hydroxy-5beta-pregnan-20-one; 5beta-Pregnan-3alpha-ol-20-one; 3alpha,5beta-Epimeric pregnanolone; 3-alpha-Hydroxy-5-beta-pregnan-20-one; Pregnan-20-one, 3-hydroxy-, (3alpha,5beta)-; NSC82867; 128-20-1; 1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 3.alpha.-Hydroxy-5.beta.-pregnan-20-one; Pregnan-3alpha-ol-20-one; Eltanolona [INN-Spanish]; 5-beta-Pregnan-20-one, 3-alpha-hydroxy- |
C21H34O2 |
318.49 |
CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN007162 |
ocotillol |
ocotillone |
C30H52O3 |
460.73 |
CC1(C2CCC3(C(C2(CCC1O)C)CCC4C3(CCC4C5(CCC(O5)C(C)(C)O)C)C)C)C |
|
TCMBANKIN007235 |
20-(R)-ginsenoside Rh2_qt |
|
C36H62O8 |
622.87 |
|
|
TCMBANKIN007258 |
Yamogenin |
WQLVFSAGQJTQCK-CAKNJAFZSA-N; (25S)-spirost-5-en-3beta-ol; NSC 226132; LMST01080045; AC1L9BVW; AC-8895; S00020; (2R,5'S)-5'-tetramethylspiro[[?]-2,2'-tetrahydropyran]ol; Jamogenin; Neodiosgenin; AKOS025402417; CHEBI:10086; Spirost-5-en-3-ol, (3beta,25S)-; SCHEMBL6040875; CHEMBL400807; C08918; yamogenin; ZINC8234229; 512-06-1; 25-epi-Diosgenin |
C27H42O3 |
414.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN007311 |
19a-hydroxyasiatic acid |
|
|
504.78 |
|
|
TCMBANKIN007364 |
Gypnoside V_qt |
Ginsenoside-Ra2_qt; Gypenoside XI_qt; Ginsenoside-Rb3_qt; Gypenoside VII_qt; Gypenoside XII_qt; Ginsenoside-Ra0_qt; Dammarane Sapogenin; Gypenoside XVII_qt; Gypenoside IX_qt; Gypenoside LXXV_qt; Gypenoside LXIX_qt; Gypenoside XIX_qt; Gypenoside XV_qt; Gypenoside XIII_qt; Gypinoside III_qt; ginsenoside Rd2_qt; Notoginseoside Fe_qt; Gypenoside IV_qt; Ginsenoside-Rs2_qt; Ginsenoside-Rs1_qt; Gypenoside XVI_qt; Gypinoside VII_qt; Ginsenoside-Ra3_qt; Gypenoside II_qt; Ginsenoside-Ra1_qt; Gypenoside VI_qt |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN007567 |
cynanoside,g_qt |
|
|
392.49 |
|
|
TCMBANKIN007616 |
celosin E_qt |
|
|
502.76 |
|
|
TCMBANKIN007637 |
(1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane |
(1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane |
C10H16 |
136.23 g/mol |
CC(C)C12CCC(=C)C1C2 |
|
TCMBANKIN007646 |
Pulchinenoside C_qt |
|
|
470.81 |
|
|
TCMBANKIN007682 |
ardisiamamilloside H_qt |
|
C47H74O17 |
911.08 |
|
|
TCMBANKIN007694 |
p-mentha-1(7)-dien-8-ol |
|
|
152.26 |
|
|
TCMBANKIN007732 |
ganoderic acid V |
|
C32H48O6 |
528.72 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CCC3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)OC(=O)C |
|
TCMBANKIN007735 |
songbeisine |
Songbaisine |
C27H41NO3 |
427.62 |
CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5C(=O)C4=C3C)C)O)C)NC1 |
|
TCMBANKIN007740 |
ergosta-7,22-dien-2β,3α,9α-triol |
|
|
430.74 |
|
|
TCMBANKIN007792 |
3β-hydroxy-oleana-11,13(18)-dien-28-oic acid? |
|
|
454.76 |
|
|
TCMBANKIN007884 |
Gypenoside XXXV_qt |
Gypenoside XXXIII_qt; Gypenoside XXVI_qt; Gypenoside XXXIV_qt |
C42H70O14 |
799 |
|
|
TCMBANKIN007931 |
Regelindiol A |
methyl (1R,4aR,6bR,10S,12aR)-4,10-dihydroxy-1,4a,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-2-carboxylate; AC1NT002; regelindiol a |
C31H50O4 |
486.73 |
CC1C(CC(C2(C1C3=CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C)O)C(=O)OC |
|
TCMBANKIN007977 |
Amarolide |
AIDS-026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2.alpha.,11.alpha.)-; (2alpha,11alpha)-2,11-Dihydroxypicrasane-1,12,16-trione; 29913-86-8; amarolide; AIDS026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2alpha,11alpha)-; (2.alpha.,11.alpha.)-2,11-Dihydroxypicrasane-1,12,16-trione |
C20H28O6 |
364.43 |
CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)O)C)C)O |
|
TCMBANKIN007988 |
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methylhept-6-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
(3S,5S,9R,10S,13R,14R,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethyl-hex-5-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methyl-hept-6-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethylhex-5-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
|
412.77 |
|
|
TCMBANKIN008024 |
21-Hydroxy-30-norhopan-22-one |
21-hydroxy-30-norhopan-22-one; 1-[(3R,3aR,5bR,11aS,13aR)-3-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-2,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-tetradecahydro-1H-cyclopenta[a]chrysen-3-yl]ethanone; AC1NSWNO |
C29H48O2 |
428.77 |
CC(=O)C1(CCC2(C1CCC3(C2CCC4C3(CCC5C4(CCCC5(C)C)C)C)C)C)O |
|
TCMBANKIN008033 |
macrostemonoside f_qt |
|
|
416.71 |
|
|
TCMBANKIN008145 |
siamenoide I_qt |
grosmomosideⅠ_qt |
C54H92O24 |
1125.29 |
|
|
TCMBANKIN008150 |
Withametelin C |
|
C28H42O6 |
474.6 g/mol |
CC1=C(C(=O)OC(C1)C(CO)C2CCC3C2(CCC4C3CC(C5(C4(C(=O)CCC5)C)O)O)C)C |
|
TCMBANKIN008262 |
(4aR,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-10-hydroxy-2,2,4a,6a,6b,9,12a-heptamethyl-9-methylol-3,5,6,6a,7,8,8a,10,11,12,13,14b-dodecahydro-1H-picen-4-one |
(4aR,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-10-hydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-3,5,6,6a,7,8,8a,10,11,12,13,14b-dodecahydro-1H-picen-4-one |
C48H76O18 |
941.11 |
|
|
TCMBANKIN008283 |
Anemarsaponin G_qt |
|
|
430.69 |
|
|
TCMBANKIN008292 |
mimengoside,f_qt |
|
|
472.78 |
|
|
TCMBANKIN008322 |
Periplocoside M_qt |
|
|
474.7 |
|
|
TCMBANKIN008366 |
2- methyl-5-(5 ' -hydroxy-1 ' ,5 ' -dimethyl-3 ' -hexenyl)phenol |
|
|
232.4 |
|
|
TCMBANKIN008368 |
20-hydroxy-11-oxomogroside I A1_qt |
|
|
504.83 |
|
|
TCMBANKIN008398 |
cimilactone b_qt |
|
|
456.68 |
|
|
TCMBANKIN008575 |
ganoderic acid Mi |
|
C33H52O6 |
544.76 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CCC3=C2C(CC4C3(CCC(C4(C)C)OC(=O)C)C)OC)C)C)O |
|
TCMBANKIN008636 |
acetylcholine |
Vagusstoff; AC1NSTAT; Acetylcholine Hydroxide; 2-acetyloxyethyl(trimethyl)azanium hydroxide; SCHEMBL3904052; 56-13-3 |
C7H16NO2+ |
146.21 g/mol |
CC(=O)OCC[N+](C)(C)C |
|
TCMBANKIN008645 |
angeloylcumambrin B |
|
C20H26O5 |
346.42 |
|
|
TCMBANKIN008667 |
21-O-Methyl-5,14-pregndiene-3β,14β,17β,21-tetrol-20-one |
|
|
362.56 |
|
|
TCMBANKIN008688 |
przewalskin a |
|
C23H30O6 |
402.5 g/mol |
CC(C)C1=CC2=C(C(=O)C(=C1O)C(=O)C)C34CCCC(C3C(C2OC4O)O)(C)C |
|
TCMBANKIN008788 |
Aspidin |
AIDS-048751; AIDS048751; aspidin; 2,5-Cyclohexadien-1-one, 2-((2,6-dihydroxy-4-methoxy-3-methyl-5-(1-oxobutyl)phenyl)methyl)-3,5-dihydroxy-4,4-dimethyl-6-(1-oxobutyl)-; 4-[[2,6-dihydroxy-4-methoxy-3-methyl-5-(1-oxobutyl)phenyl]methyl]-3,5-dihydroxy-6,6-dimethyl-2-(1-oxobutyl)-1-cyclohexa-2,4-dienone; 2-butanoyl-4-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methyl-phenyl)methyl]-3,5-dihydroxy-6,6-dimethyl-cyclohexa-2,4-dien-1-one; 4-08-00-03749 (Beilstein Handbook Reference); BRN 2068604; 2-butyryl-4-(3-butyryl-2,6-dihydroxy-4-methoxy-5-methyl-benzyl)-3,5-dihydroxy-6,6-dimethyl-cyclohexa-2,4-dien-1-one; Aspidin VV; 584-28-1; C10672; 2-butanoyl-4-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methylphenyl)methyl]-3,5-dihydroxy-6,6-dimethylcyclohexa-2,4-dien-1-one; Aspidin BB; 2-Butyryl-6-(3-butyryl-2,6-dihydroxy-4-methoxy-5-methylbenzyl)-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one |
C25H32O8 |
460.52 |
CCCC(=O)C1=C(C(=C(C(C1=O)(C)C)O)CC2=C(C(=C(C(=C2O)C)OC)C(=O)CCC)O)O |
|
TCMBANKIN008791 |
Elatericin A |
C08796; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(1R)-1,5-dihydroxy-1,5-dimethyl-2-oxo-hex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(E,1R)-1,5-dihydroxy-1,5-dimethyl-2-oxohex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(E,1R)-1,5-dihydroxy-1,5-dimethyl-2-oxo-hex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; 3877-86-9; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; NCI60_002636; NSC521776; Cucurbitacin D; NSC 521776; NSC308606; LMST01010106; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(1R)-1,5-dihydroxy-1,5-dimethyl-2-oxohex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxo-hept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; 19-Norlanosta-5,23-diene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-; NSC 308606; Elatericine A; Cucurbitacine (D); (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(E,1R)-1,5-dihydroxy-2-keto-1,5-dimethyl-hex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-quinone; 19-Nor-9-beta,10-alpha-lanosta-5,23-diene-3,11,22-trione, 9-methyl-2-beta,16-alpha,20,25-tetrahydroxy-; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(2R)-2,6-dihydroxy-6-methyl-3-oxo-hept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; (2S,8S,9R,10R,13R,14S,16R,17R)-17-[(1R)-1,5-dihydroxy-2-keto-1,5-dimethyl-hex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-quinone; 19-nor-9.beta.,10.alpha.-Lanosta-5,23-diene-3,11,22-trione, 9-methyl-2.beta.,16.alpha.,20,25-tetrahydroxy-; 19-Norlanosta-5,23-diene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (2beta,9beta,10alpha,16alpha,23E)- (9CI) |
C30H44O7 |
516.67 |
CC1(C2=CCC3C4(CC(C(C4(CC(=O)C3(C2CC(C1=O)O)C)C)C(C)(C(=O)C=CC(C)(C)O)O)O)C)C |
|
TCMBANKIN008822 |
ilekudinoside G_qt |
|
|
470.76 |
|
|
TCMBANKIN008871 |
abricin |
|
C27H44O2 |
400.64 |
|
|
TCMBANKIN008878 |
Anemarsaponin B_qt |
|
C45H74O18 |
903.06 |
|
|
TCMBANKIN008989 |
notoginsenosider3_qt |
|
|
460.82 |
|
|
TCMBANKIN009034 |
ganoderic acid K |
|
C32H46O9 |
574.7 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)OC(=O)C)C)C |
|
TCMBANKIN009054 |
triterpenoid glycoside 1_qt |
cyclamiretin A 3-O-alpha-L-rhamnopyranosyl(1-4)-beta-D-glucopyranosyl(1-2)-[beta-D-glucopyranosyl(1-4)]-alpha-L-arabinopyranoside_qt |
|
472.78 |
|
|
TCMBANKIN009220 |
epimansumbinol |
|
|
316.58 |
|
|
TCMBANKIN009222 |
Ganoderic aldehyde A |
|
C30H46O3 |
454.68 |
CC(CCC=C(C)C=O)C1CCC2(C1(CC(=O)C3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN009244 |
13657-68-6 |
Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))-; (3S,6E,10S)-3-isopropyl-6,10-dimethyl-cyclodec-6-ene-1,4-dione; (3S,6E,10S)-6,10-dimethyl-3-propan-2-ylcyclodec-6-ene-1,4-dione; (3S,6E,10S)-3-isopropyl-6,10-dimethylcyclodec-6-ene-1,4-dione; 6-Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))- (9CI); Germacr-1(10)-ene-5,8-dione; (3S,6E,10S)-6,10-dimethyl-3-propan-2-yl-cyclodec-6-ene-1,4-dione; (3S,6E,10S)-3-isopropyl-6,10-dimethyl-cyclodec-6-ene-1,4-quinone |
C15H24O2 |
236.35 |
CC1CCC=C(CC(=O)C(CC1=O)C(C)C)C |
|
TCMBANKIN009284 |
desgalactotigonin_qt |
|
|
416.71 |
|
|
TCMBANKIN009309 |
Daturameteloside I_qt |
|
|
474.7 |
|
|
TCMBANKIN009441 |
4α,14α-dimethyl-5α-ergosta-7,9(11),24(28)-trien-3β-ol |
|
|
424.78 |
|
|
TCMBANKIN009488 |
pinocarvone |
|
C10H14O |
150.22 |
CC1(C2CC1C(=C)C(=O)C2)C |
|
TCMBANKIN009508 |
[(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate |
(E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; [(4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-acetoxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester |
C27H38O7 |
474.59 |
|
|
TCMBANKIN009567 |
(3S,4S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-3-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid |
|
C48H76O20 |
973.1 |
|
|
TCMBANKIN009575 |
Dammaradienyl acetate |
dammaradienyl acetate |
C32H52O2 |
468.75 |
CC(=CCCC(=C)C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)C |
|
TCMBANKIN009640 |
Germanicol |
germanicol; (3S,6aR,6bR,8aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,6a,7,8,9,10,13,14,14a-tetradecahydropicen-3-ol |
C30H50O |
426.72 |
CC1(CCC2(CCC3(C(C2=C1)CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C)C)C |
|
TCMBANKIN009679 |
acutuminine |
|
C19H24ClNO5 |
381.85 |
CN1CCC23C1(CC(C24CC(=CC4=O)OC)Cl)C(=C(C(=O)C3)OC)OC |
|
TCMBANKIN009752 |
ZINC04081604 |
(8S,9S,10R,13S,14R,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-ethanoyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C21H30O2 |
314.46 |
|
|
TCMBANKIN009823 |
la-7beta-di(4-methulsenecioyloxy) oplopa-3(14)Z,8(10)-dien-2-one |
|
|
442.65 |
|
|
TCMBANKIN009826 |
sarcostin |
18607-76-6; C17770; (3S,9R,10R,12R,13S,14R,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta(a)phenanthrene-3,8,12,14,17-pentol; CHEBI:81323; Pregn-5-ene-3,8,12,14,17,20-hexol, (3beta,12beta,14beta,17alpha,20S)-; Sarcostin |
C21H34O6 |
382.49 |
CC(C1(CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)O)C)O)O)O |
|
TCMBANKIN009867 |
subprogenin C |
|
C30H46O4 |
470.68 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5=O)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN009883 |
Gypenoside I_qt |
ginsenoside-F2_qt; ginsenoside-Ra0_qt; gypenoside XI_qt; ginsenoside- Rc_qt; ginsenoside- F2_qt; gypenosideXVII_qt; Gypenoside XVII_qt; ginsenoside- Rb2_qt |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN009895 |
Z-6,8',7,3'-diligustilide |
|
|
380.52 |
|
|
TCMBANKIN009926 |
ergosta-7,22-dien-3-one |
(22E,24R)-ergosta-7,22-dien-3 β-one; Ergosta-7,22-dien-3-one |
C28H44O |
396.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(=O)C4)C)C |
|
TCMBANKIN010133 |
20(R)-Ginsenoside-Rh1_qt |
|
C36H62O9 |
638.87 |
|
|
TCMBANKIN010316 |
16-hydroperoxymansumbin-13(17)-en-3β-ol |
|
|
348.58 |
|
|
TCMBANKIN010335 |
ginsenoside Rh5_qt |
|
|
474.8 |
|
|
TCMBANKIN010351 |
Glycoside K_qt |
Glycoside H1_qt |
|
318.55 |
|
|
TCMBANKIN010411 |
methyl (4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester; (4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetoxy-3,7,11,15-tetraketo-4,4,10,13,14-pentamethyl-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid methyl ester; methyl (4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
|
528.7 |
|
|
TCMBANKIN010419 |
Gypenoside XXIX_qt |
Gypenoside XXIV_qt |
C41H68O12 |
752.97 |
|
|
TCMBANKIN010515 |
mogrol |
mogroside V_qt; mogroside Ⅲ_qt; 11-oxomogroside Ⅴ_qt |
C60H102O29 |
1287.43 |
CC(CCC(C(C)(C)O)O)C1CCC2(C1(CC(C3(C2CC=C4C3CCC(C4(C)C)O)C)O)C)C |
|
TCMBANKIN010574 |
Gitoxigenin |
CHEBI:38105; ST5308210; .delta.(20,22)-2,14,16,21-(Tetrahydroxy)norcholenic acid lactone; 5beta,20(22)-Cardenolide-3beta,14,16beta-triol; MEGxp0_001900; 16.beta.-Hydroxydigitoxigenin; gitoxigenin; ZINC03978407; 5.beta.-Card-20(22)-enolide, 3.beta.,14,16.beta.-trihydroxy-; .delta.20,(22)-2,14,16,21-(Tetrahydroxy)norcholenic acid lactone; NSC407807; 16.beta.-Hydroxydisitoxigenin; 3beta,14,16beta-Trihydroxy-5beta,20(22)-cardenolide; 3beta,14,16beta,21-Tetrahydroxy-20(22)-norcholenic acid lactone; 4-[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14,16-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 545-26-6; Card-20(22)-enolide, 3,14,16-trihydroxy-, (3.beta.,5.beta.,16.beta.)-; NCI60_003893; G4635_SIGMA |
C23H34O5 |
390.51 |
CC12CCC(CC1CCC3C2CCC4(C3(CC(C4C5=CC(=O)OC5)O)O)C)O |
|
TCMBANKIN010599 |
EINECS 213-897-0 |
(20R,25R)-Spirost-5-en-3beta-yl acetate |
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
|
TCMBANKIN010665 |
Inumakilactone E |
37886-71-8; inumakilactone e |
C19H24O7 |
364.39 |
CC(CO)C1=C2C(C3C4C(CCC(C4(C2=CC(=O)O1)C)O)(C(=O)O3)C)O |
|
TCMBANKIN010698 |
Gypenoside XXVIII_qt |
|
|
416.71 |
|
|
TCMBANKIN010764 |
methyl (4R)-4-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-3,11-diketo-4,4,10,13,14-pentamethyl-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid methyl ester; (4R)-4-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester |
C28H42O6 |
474.63 |
|
|
TCMBANKIN010795 |
Yibeissine |
3,11-dihydroxy-3',6',10,11b-tetramethylspiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-5-one; AC1NSSZ8; 22,26-imino-17,23-oxidojerv-12-en-6-oxo-3β,11α-diol; yibeissine |
C27H41NO4 |
443.62 |
CC1CC2C(C(C3(O2)CCC4C5CC(=O)C6CC(CCC6(C5C(C4=C3C)O)C)O)C)NC1 |
|
TCMBANKIN010855 |
4alpha,24-dimethylcholesta-7,24-dienol |
|
C29H48O |
412.7 g/mol |
CC1CCCC2(C1CC=C3C2CCC4(C3CCC4C(C)CCC(=C(C)CO)C)C)C |
|
TCMBANKIN010866 |
(+)-Ganoderic acid Mf |
|
C32H48O5 |
512.72 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)O |
|
TCMBANKIN010875 |
lanosta-7,9(11),24-trien-15α-acetoxy-3α-hy-droxy-23-oxo-26-oicacid |
lanosta-7,9(11),24-trien-15α-acetoxy-3α-hydroxy-23-oxo-26-oic acid |
C32H46O6 |
526.78 |
|
|
TCMBANKIN010884 |
Spirostan-3-ol, (3alpha,5alpha,25S)- |
75172-34-8 |
C27H44O3 |
416.64 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN010909 |
solasonine_qt |
solamargine_qt; α-solasonine_qt; solasodine-3-O-α-L-rhamnopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→4)]-β-D-glucopyranoside_qt; β1-solamargine_qt |
|
413.71 |
|
|
TCMBANKIN011043 |
mogroside ⅡE_qt |
bitter mogroside A_qt |
|
490.85 |
|
|
TCMBANKIN011072 |
Volon |
ZINC03882036; Triamcinolon; Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-; 11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione; Fluoxyprednisolone; BRN 2341955; STOCK1N-56723; 9alpha-Fluoro-16alpha-hydroxyprednisolone; EU-0101179; 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Tiamcinolonum [INN-Latin]; Triamcinolona [INN-Spanish]; 9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-dione; BSPBio_000140; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI); (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyethanoyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; Prestwick0_000120; 9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1, 4-pregnadiene-3,20-dione; Aristocort; 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Triamcinolone; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-; SK-Triamcinolone; Triamcinlon; EINECS 204-718-7; AIDS-124117; HSDB 3194; Rodinolone; WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ; NSC 13397; 9.Alpha.-Fluoro-11.beta.,16.alpha.,17, 21-tetrahydroxypregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; NCGC00021580-05; Kenacort (TN); NCI60_000750; NSC13397; Triamcinolonum [INN]; Prednisolone, 9-fluoro-16alpha-hydroxy-; 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone; Vetalog; Kenacort-A; 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-17-glycoloyl-11,16,17-trihydroxy-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; Lopac0_001179; Cinolone-T; Delphicort; Ledercort; BPBio1_000154; Prestwick2_000120; AIDS124117; 124-94-7; MLS000028542; 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Prednisolone, 9-fluoro-16.alpha.-hydroxy-; MLS001066543; SPBio_002079; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9-alpha-Fluoro-16-alpha-hydroxyprednisolone; Aristocort Tablets; Pregna-1,4-diene-3, 20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-; 83474-03-7; Triamcinolone (JP15/USP); Triamcinolone [USAN:BAN:INN:JAN]; 11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione; Triam-Tablinen; T6376_SIGMA; Celeste; Prestwick1_000120; 4-08-00-03629 (Beilstein Handbook Reference); 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione; Prestwick3_000120; Prestwick_438; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha); Adcortyl; 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; Omcilon; 287334_ALDRICH; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11-beta,16-alpha)-; Triamcet; Kenacort; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy-; D00385; Triamcinalone; SMR000058333; CL 19823; 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Kenacort-AG; Tricortale; nchembio.2007.53-comp7; SMP1_000300 |
C21H27FO6 |
394.43 |
CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O |
|
TCMBANKIN011181 |
Daturameteloside G_qt |
|
|
474.7 |
|
|
TCMBANKIN011203 |
Cymarin |
cymarin |
C30H44O9 |
548.66 |
CC1C(C(CC(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)OC)O |
|
TCMBANKIN011278 |
latifoloside D_qt |
|
C47H76O17 |
913.1 |
|
|
TCMBANKIN011369 |
Gypenoside XLVIII_qt |
|
C53H88O22 |
1077.25 |
|
|
TCMBANKIN011399 |
papyrioside L-Ⅱc_qt |
papyrioside L- IIc_qt |
C48H74O19 |
955.09 |
|
|
TCMBANKIN011543 |
brahmic acid |
Madecassic acid; AC1L5ZR7; 8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid; SCHEMBL14286199; NSC88135; CHEMBL1993179; Brahmic acid; NCI60_041951; 8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; brahmicacid; AC1Q5V62; AKOS032948362; 4CN-1172; 18449-41-7; 2,3,6,23-tetrahydroxyurs-12-en-28-oic acid; NSC-88135; madecassic acid |
C30H48O6 |
504.7 |
CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)O |
|
TCMBANKIN011588 |
(1S,3S,5R)-3,6,6-trimethylnorpinan-2-one |
(1S,3S,5R)-3,6,6-trimethyl-2-norpinanone; (1R,3S,5S)-3,7,7-trimethylbicyclo[3.1.1]heptan-4-one |
|
152.26 |
|
|
TCMBANKIN011623 |
Triptotriterpenoidel lactone A |
triptotriterpenoidel lactone a |
|
452.79 |
CC1(CCC23CC(CC2=O)C4(C(=CCC5C4(CCC6C5(CCC(C6(C)C)O)C)C)C3C1)C)C |
|
TCMBANKIN011625 |
ergosta-7,22-diene-3β-ol |
(22e,24r)-ergosta-7,22-dien-3beta-ol |
C28H46O |
398.7 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN011650 |
Siegesmethyletheric acid |
siegesmethylethericacid; siegesmethyletheric acid |
|
334.55 |
CC12CCCC(C1CCC34C2CCC(C3)C(C4)COC)(C)C(=O)O |
|
TCMBANKIN011755 |
Triptoriterpenic acid A |
triptoriterpenic acid a |
|
488.78 |
|
|
TCMBANKIN011764 |
11-dehydroxymogroside Ⅲ_qt |
|
|
460.82 |
|
|
TCMBANKIN011785 |
3-O-beta-D-Glucopyranosyl betulinic acid-28-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside_qt |
|
|
454.76 |
|
|
TCMBANKIN011818 |
kryptogenin |
|
C27H42O4 |
430.62 |
CC(CCC(=O)C(C)C1C(=O)CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO |
|
TCMBANKIN011917 |
neogitogenin |
Neogitogenin; C17003; 6811-13-8; CHEBI:80854 |
C27H44O4 |
432.6 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CC(C(C6)O)O)C)C)C)OC1 |
|
TCMBANKIN011950 |
1α,2α,3β,19α-tetrahydroxyurs-12-en-28-oic acid |
|
|
504.78 |
|
|
TCMBANKIN011967 |
Gypenoside XXVII_qt |
|
C42H72O13 |
785.01 |
|
|
TCMBANKIN011980 |
darutigenol B |
|
C20H34O3 |
322.48 |
|
|
TCMBANKIN011998 |
protostemotinine |
|
C23H29NO6 |
415.48 |
CC1CC(OC1=O)C2CCC34N2CCCCC3=C(C(=O)C45C(=C(C(=O)O5)C)OC)C |
|
TCMBANKIN012091 |
alpha-amyrin acetate |
α-amyrin acetate; alpha-Amyrin acetate |
C32H52O2 |
468.75 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C)C)C)C2C1C)C)C |
|
TCMBANKIN012104 |
14-deoxy-12-methoxyandrographolide |
|
C21H32O5 |
364.5 g/mol |
CC12CCC(C(C1CCC(=C)C2CC(C3=CCOC3=O)OC)(C)CO)O |
|
TCMBANKIN012178 |
glucose ,d-glucose |
|
C30H48O |
424.7 |
|
|
TCMBANKIN012478 |
alpha-Solamarine_qt |
|
C45H73NO16 |
884.06 |
|
|
TCMBANKIN012498 |
cyanin |
LMPK12010113; Cyanidin 3,5-diglucoside; cyanine; Cyanin |
C27H31O16+ |
611.5 g/mol |
C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O |
|
TCMBANKIN012501 |
Suaveolic acid |
(1R,4aS,7S)-8-hydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,5,6,7,8,9,10,10a-decahydrophenanthrene-1-carboxylic acid; suaveolic acid; suaveolicacid; AC1NT0M7 |
C20H32O3 |
320.47 |
CC(C)C1CCC2=C(C1O)CCC3C2(CCCC3(C)C(=O)O)C |
|
TCMBANKIN012579 |
esculentoside J_qt |
|
|
490.75 |
|
|
TCMBANKIN012679 |
3-O-beta-D-Xylopyranosyl-(1-6)-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranosyl oleanolic acid 28-O-beta-D-glucopyranosyl ester_qt |
|
|
456.78 |
|
|
TCMBANKIN012700 |
coumestrol |
NCIMech_000078; CCRIS 7311; A-Lactone; API0002121; Tox21_200032; MolPort-003-846-031; US8552057, 3; HMS3374A07; 3,9-Dihydroxy-6H-benzofuro[3,2-c]-[1]benzopyran-6-one; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,3,9-dihydroxy-; Cumostrol; CHEBI:3908; C-16836; VZ31590; LS-35394; S00280; 3,9-dihydroxy-[1]benzofuro[3,2-c]chromen-6-one; MFCD00016885; SMP2_000163; DSSTox_RID_76572; 27885_FLUKA; 6H-Benzofuro[3, 3,9-dihydroxy-; 5-19-06-00405 (Beilstein Handbook Reference); BRN 0266702; 479-13-0; NSC22842; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, delta-lactone; C10205; 3,9-dihydroxy-[1]benzoxolo[3,2-c]chromen-6-one; AC1NQYXV; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, delta-lactone (6CI); NCGC00018124-01; DSSTox_CID_2399; CTK8F8799; Coumestrol, >=95.0% (HPLC); NCI60_001863; 4CN-2508; ZZIALNLLNHEQPJ-UHFFFAOYSA-N; BIDD:ER0114; NCGC00018124-03; 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one #; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-; A1-00298; NSC 22842; 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one; CCG-35536; NCGC00018124-06; 3,9-bis(oxidanyl)-[1]benzofuro[3,2-c]chromen-6-one; ZINC1219; NCGC00257586-01; 3,9-Dihydroxy-benzo[4,5]furo[3,2-c]chromen-6-one; AIDS011954; SCHEMBL22012; UNII-V7NW98OB34; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, .delta.-lactone; 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-; MLS000069446; CCG-36200; LMPK12090018; 3-Benzofurancarboxylic acid,4-dihydroxyphenyl)-6-hydroxy-, .delta.-lactone; 7,12-Dihydroxycoumestan; CS-6343; D02DML; CHEMBL30707; 3,9-dihydroxy-6-benzofurano[3,2-c]chromenone; ZINC00001219; 5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one; Oprea1_222511; MLS000738006; EINECS 207-525-6; 3,9-Dihydroxycoumestan; Coumestrol, BioReagent, suitable for fluorescence, >=97.5% (HPLC); A827386; DTXSID6022399; CAS-479-13-0; FT-0603177; ST50320052; 2-(2,4-Dihydroxyphenyl)-6-hydroxy-3-benzofurancarboxylic Acid ; 3,9-dihydroxybenzofurano[3,2-c]chromen-6-one; 3,9-dihydroxybenzo[d]chromeno[4,3-b]furan-6-one; NCGC00023462-03; AIDS-011954; V0359; Cumoestrol; DSSTox_GSID_22399; Cumoesterol; NCGC00018124-05; Coumestrol; NCGC00018124-04; V7NW98OB34; ZB000278; 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one; ST5320052; AN-6463; Cumestrol; NCGC00023462-04; NCGC00018124-02; CC-25990; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihdyroxy-; NSC-22842; 3,9-dihydroxybenzofuro[3,2-c]chromen-6-one; AKOS028111776; HMS2235B05; Coumesterol; COUMESTROL; BDBM23451; SMR000059001; HY-N2335; 27883_FLUKA |
C15H8O5 |
268.22 |
C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=C3C=CC(=C4)O |
|
TCMBANKIN012715 |
rotundic acid |
Rutundic acid; MolPort-028-754-175; BDBM50391059; CHEBI:70684; Pedunculoside_qt; DTXSID80173963; rotundicacid; BG01176242; (3beta,4alpha)-3,19,23-Trihydroxyurs-12-en-28-oic acid; SCHEMBL1045049; Rotundic acid; Ilexolic acid (Rotundic acid); AKOS032949054; Y0176; (1R,2R,4AS,6AS,6BR,8AR,9R,10S,12AR,12BR,14BS)-1,10-DIHYDROXY-9-(HYDROXYMETHYL)-1,2,6A,6B,9,12A-HEXAMETHYL-2,3,4,5,6,7,8,8A,10,11,12,12B,13,14B-TETRADECAHYDROPICENE-4A-CARBOXYLIC ACID; CHEMBL1271052; Urs-12-en-28-oic acid, 3,19,23-trihydroxy-, (3beta,4alpha)-; 20137-37-5; ZINC64527839 |
C30H48O5 |
488.7 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN012742 |
sessilifoliamide F |
|
C22H31NO7 |
421.5 g/mol |
CCC1C2C(C(C(=O)O2)C)C3(CC(N(C3=O)CCCCC1=O)C4CC(C(=O)O4)C)O |
|
TCMBANKIN012782 |
Triptotriterpenic acid A |
AKOS032961770; 3,22-Dihydroxyolean-12-en-29-oic acid; 808769-54-2; triptotriterpenicacid a; MolPort-039-052-646; CHEMBL482586; 3alpha,22beta-Dihydroxyoleana-12-ene-29-oic acid; ZINC36435563; triptotriterpenic acid a |
C30H48O4 |
472.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN012883 |
ATRACTYLODES MACROCEPHALA |
|
|
462.68 |
|
|
TCMBANKIN013131 |
Anemoside B_qt |
|
C59H96O26 |
1221.38 |
|
|
TCMBANKIN013192 |
Meldenin |
[(10R)-17-(furan-3-yl)-7-hydroxy-4,4,10,13-tetramethyl-3-oxo-2,5,6,7,8,9,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate; AC1NSXXA; meldenin |
C28H38O5 |
454.6 g/mol |
CC(=O)OC1C2C(C(=O)CCC2(C3CCC4(C(CC=C4C3(C1O)C)C5=COC=C5)C)C)(C)C |
|
TCMBANKIN013208 |
(6S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethylhexyl]-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
(6S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (6S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methyl-heptan-2-yl]-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (6S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C29H48O2 |
428.69 |
|
|
TCMBANKIN013221 |
biatractylolide |
Biatractylolide |
C30H38O4 |
462.6 g/mol |
CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)C45CC6(CCCC(=C)C6CC4=C(C(=O)O5)C)C)C |
|
TCMBANKIN013252 |
Corchoroside A_qt |
|
|
404.55 |
|
|
TCMBANKIN013261 |
ceanothic acid |
NCGC00168838-03_C30H46O5_(1R,2S,5aR,5bR,7aS,10R,12bR)-2-Hydroxy-10-isopropenyl-3,3,5a,5b,12b-pentamethyloctadecahydrodicyclopenta[a,i]phenanthrene-1,7a(1H)-dicarboxylic acid; (1R,2R,5S,8R,14R,15R,16S)-16-HYDROXY-1,2,14,17,17-PENTAMETHYL-8-(PROP-1-EN-2-YL)PENTACYCLO[11.7.0.0(2),(1)?.0?,?.0(1)?,(1)?]ICOSANE-5,15-DICARBOXYLIC ACID; ACon0_000328; ACon1_000054; MolPort-001-741-019; ceanothicacid; NCGC00168838-01; NP-002508; MEGxp0_000866 |
C30H46O5 |
486.68 |
CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(C(C(C5(C)C)O)C(=O)O)C)C)C(=O)O |
|
TCMBANKIN013264 |
Soyasapogenol E |
soyasapogenol e |
C30H48O3 |
456.7 |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(=O)C1)C)C)C)(C)CO)O)C)C |
|
TCMBANKIN013287 |
eupatorin_qt |
|
|
318.5 |
|
|
TCMBANKIN013297 |
przewalskin b |
|
C20H26O4 |
330.4 g/mol |
CC(C)C1=CC23CCC4C(=CCCC4(C)C)C2OC(=O)C3(C1=O)O |
|
TCMBANKIN013326 |
ursendiol |
|
|
442.8 |
|
|
TCMBANKIN013374 |
pjs-1_qt |
3-Epi-oleanolic acid-28-O-alpha-L-rhamno-pyranosyl-(1-B58666)-beta-D-glucopyranoside |
C36H58O8 |
618.84 |
|
|
TCMBANKIN013379 |
Daturameteline M |
Datuarmeteline G |
|
504.68 |
|
|
TCMBANKIN013464 |
Daturameteline B |
|
|
490.7 |
|
|
TCMBANKIN013518 |
ardisianoside J_qt |
|
C53H84O23 |
1089.22 |
|
|
TCMBANKIN013519 |
Withafastuosin F |
Withafastuosin E |
C28H40O7 |
488.6 g/mol |
CC1=C(C(=O)OC(C1)C(CO)C2CCC3C2(CCC4C3CC(C5(C4(C(=O)C=CC5)C)O)O)C)CO |
|
TCMBANKIN013609 |
tomatidenol |
tomatide-nol |
C27H43NO2 |
413.64 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)NC1 |
|
TCMBANKIN013676 |
Phytolaccasaponin G_qt |
|
C36H56O11 |
664.82 |
|
|
TCMBANKIN013691 |
guggulsterol-VI |
|
C21H32O2 |
316.48 |
|
|
TCMBANKIN013711 |
Methyl dehydro-15-hydroxy-abietan-18-oate |
methyl dehydro-15-hydroxy-abietan-18-oate |
|
330.51 |
CC12CCCC(C1CCC3=C2C=CC(=C3)C(C)(C)O)(C)C(=O)OC |
|
TCMBANKIN013754 |
ganoderan B |
|
C30H46O3 |
454.68 |
|
|
TCMBANKIN013784 |
ganoderic acid W |
|
C34H52O7 |
572.77 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CCC3=C2C(CC4C3(CCC(C4(C)C)OC(=O)C)C)O)C)C)OC(=O)C |
|
TCMBANKIN013923 |
Gypenoside LI_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN013951 |
angeloylajadin |
|
|
330.41 |
|
|
TCMBANKIN014016 |
glycoside E_qt |
|
|
334.55 |
|
|
TCMBANKIN014085 |
Korsevinine |
AC1NSXCI; korsevinine; (3S,10R,13S)-3-hydroxy-10,13-dimethyl-17-[1-(5-methyl-7-oxa-3-azabicyclo[2.2.1]hept-2-en-2-yl)ethyl]-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one |
C27H41NO3 |
427.62 |
CC1CC2C(=NC1O2)C(C)C3CCC4C3(CCC5C4CC(=O)C6C5(CCC(C6)O)C)C |
|
TCMBANKIN014135 |
ailantinol A |
|
C21H26O8 |
406.43 |
CC1=CC(=O)C(C2(C1CC3C4(C2C(=O)OC4)C(CC(=O)O3)C(C)C(=O)OC)C)O |
|
TCMBANKIN014158 |
mogroside ⅡB_qt |
mogroside ⅠA1_qt; mogroside ⅠE1_qt |
|
490.85 |
|
|
TCMBANKIN014177 |
threo-austrobailignan-5 |
|
|
326.42 |
|
|
TCMBANKIN014291 |
capsicastrine_qt |
|
|
415.73 |
|
|
TCMBANKIN014300 |
3β-hydroxystigmast-5-en-7-one |
3β-Hydroxystigmast- 5-en- 7-one |
C29H48O2 |
428.69 |
|
|
TCMBANKIN014385 |
Jujuboside C_qt |
Jujuboside A1_qt |
C58H94O26 |
1207.35 |
|
|
TCMBANKIN014427 |
Gypenoside XV_qt |
|
C52H88O21 |
1049.24 |
|
|
TCMBANKIN014437 |
glaucoside H_qt |
|
C47H72O20 |
957.06 |
|
|
TCMBANKIN014444 |
Methyl ganoderate G |
|
C31H46O8 |
546.69 |
|
|
TCMBANKIN014484 |
laxogenin |
|
C27H42O4 |
430.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(=O)C6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN014488 |
beta-peltoboykinolic acid |
β-peltoboykinolicacid |
C30H48O3 |
456.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C(=O)O)C)C |
|
TCMBANKIN014496 |
disacoside B_qt |
pulsatilla saponin D_qt; macranthoidin A_qt |
C59H96O27 |
1237.38 |
|
|
TCMBANKIN014530 |
bauer-7-ene-3beta-16alpha-diol |
|
C30H50O2 |
442.72 |
|
|
TCMBANKIN014645 |
Ganoderic acid V1 |
|
C30H42O7 |
514.65 |
CC(=CCCC(C)(C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C)O)C(=O)O |
|
TCMBANKIN014671 |
miltionone Ⅰ |
|
312.39 |
49.684394 |
|
|
TCMBANKIN014754 |
3-[2-[(1R,4aS,5R,8aS)-5,8a-dimethyl-2-methylene-5-methylol-decalin-1-yl]ethyl]-5H-furan-2-one |
3-[2-[(1R,4aS,5R,8aS)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-5H-furan-2-one; 3-[2-[(1R,4aS,5R,8aS)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-decalinyl]ethyl]-5H-furan-2-one; 3-[2-[(1R,4aS,5R,8aS)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decalin-1-yl]ethyl]-5H-furan-2-one |
C26H40O8 |
480.59 |
|
|
TCMBANKIN014769 |
3-O-alpha-L-Arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid_qt |
|
|
472.78 |
|
|
TCMBANKIN014806 |
polygosides B_qt |
|
|
430.69 |
|
|
TCMBANKIN014884 |
ophipogonin D_qt |
prosapogenin A of dioscin_qt; lililancifoloside A_qt; Diosgenin-3-O-beta-D-glucopyranoside_qt; 25(R,S)spirost-5-en-3beta-ol-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylylpyranylosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galactopyranose_qt |
|
414.69 |
|
|
TCMBANKIN014922 |
(1R)-1-[(2S,4aR,4bS,7R,8aS)-7-hydroxy-2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-2-yl]ethane-1,2-diol |
1,2-Ethanediol, 1-(2,3,4,4a,4b,5,6,7,8,8a,9,10-dodecahydro-7-hydroxy-2,4b,8,8-tetramethyl-2-phenanthrenyl)-, (2S-(2alpha(S*),4abeta,4balpha,7alpha,8abeta))- |
C20H34O3 |
322.48 |
CC1(C2CCC3=CC(CCC3C2(CCC1O)C)(C)C(CO)O)C |
|
TCMBANKIN014925 |
ergosta-7,9(11),22-trien-3β,5α,6α-triol |
|
C28H44O3 |
428.65 |
|
|
TCMBANKIN014975 |
Kudinoside F_qt |
|
|
472.83 |
|
|
TCMBANKIN015046 |
Ganoderic acid P |
|
C34H50O7 |
570.76 |
|
|
TCMBANKIN015068 |
glaucoside,c_qt |
|
|
376.49 |
|
|
TCMBANKIN015084 |
stemonamide |
|
|
329.43 |
|
|
TCMBANKIN015219 |
polygosides A_qt |
3beta,14alpha-dihydroxy-(25S)-sipirost-5-ene; (3beta,14alpha)-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl(1-4)-beta-d-galacopyranosyl-14-hydroxy-(25S)-spirost-5-ene_qt |
|
430.69 |
|
|
TCMBANKIN015221 |
15alpha-Hydroxy-ent-kaur-16-en-19-oic acid |
CCRIS 1516; NSC 332872 |
C20H30O3 |
318.45 |
CC12CCCC(C1CCC34C2CCC(C3)C(=C)C4O)(C)C(=O)O |
|
TCMBANKIN015225 |
Gypenoside XXXVI_qt |
Gypenosdie XXXVII_qt; Gypenoside XXXVII_qt |
C53H88O21 |
1061.25 |
|
|
TCMBANKIN015239 |
Ecliptasaponin A_qt |
|
C36H58O9 |
634.84 |
|
|
TCMBANKIN015280 |
polyfuroside_qt |
|
C57H94O29 |
1243.34 |
|
|
TCMBANKIN015371 |
pseudolarifuroic |
|
C30H42O4 |
466.65 |
|
|
TCMBANKIN015442 |
ZINC03978781 |
(3S,8R,9R,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9R,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9R,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9R,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C35H58O6 |
574.83 |
|
|
TCMBANKIN015449 |
23-o-acetyl-12β-hydroxysolasodine |
23-O-acetyl-12β-hydroxysolasodine |
C29H45NO5 |
487.67 |
C29H45NO5 |
|
TCMBANKIN015452 |
Gypentonoside A_qt |
|
C54H88O21 |
1073.26 |
|
|
TCMBANKIN015460 |
(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
C47H74O18 |
927.08 |
|
|
TCMBANKIN015497 |
atratoglaucoside b_qt |
|
|
374.47 |
|
|
TCMBANKIN015611 |
Ecliptasaponin_qt |
|
C36H58O9 |
634.84 |
|
|
TCMBANKIN015617 |
solanine_qt |
|
C45H73NO15 |
868.06 |
|
|
TCMBANKIN015674 |
(1R,2R,4aS,6aR,6aS,6bR,8S,8aR,10S,12aR,14bS)-1,8,10-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
|
488.78 |
|
|
TCMBANKIN015742 |
pseudoprotodioscin_qt |
|
C51H82O21 |
1031.18 |
|
|
TCMBANKIN015768 |
bisacumol |
|
C15H22O |
218.33 |
CC1=CC=C(C=C1)C(C)CC(C=C(C)C)O |
|
TCMBANKIN015967 |
periplocymarin_qt |
|
|
390.57 |
|
|
TCMBANKIN015977 |
Chlorogenin |
(25R)-5alpha-spirostan-3beta,6alpha-diol; chlorogenin; LMST01080086 |
C27H44O4 |
432.64 |
CCC1C(CC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C)OC5(CCC(CO5)C)C |
|
TCMBANKIN016169 |
mogroside Ⅳ_qt |
neomogroside_qt |
C54H92O24 |
1125.29 |
|
|
TCMBANKIN016299 |
beta-Sitosterol-beta-D-glucopyranoside_qt |
|
|
398.69 |
|
|
TCMBANKIN016332 |
Carnosifloside I_qt |
|
|
456.78 |
|
|
TCMBANKIN016581 |
neokadsuranic acid C |
neokadsuranicacid c; neokadsuranic acid c; AC1NSZ1V; (Z)-6-[(11bS)-4,4,6b,11b-tetramethyl-10-methylidene-3-oxo-1,2,4a,5,6,7,8,9,10a,11-decahydrobenzo[a]fluoren-9-yl]-2-methylhept-2-enoic acid |
C30H46O4 |
470.68 |
CC(CCC=C(C)C(=O)O)C1CCC2(C(C1(C)O)CC3=C2CCC4C3(CCC(=O)C4(C)C)C)C |
|
TCMBANKIN016644 |
stigmasterol glucoside_qt |
|
C35H58O6 |
574.83 |
|
|
TCMBANKIN016747 |
florilenalin isobutyrate |
|
|
348.48 |
|
|
TCMBANKIN016767 |
salvilenone Ⅰ |
|
270.4 |
32.434709 |
|
|
TCMBANKIN016788 |
papyrioside L-Ⅱb_qt |
papyrioside L- IIb_qt |
C49H78O19 |
971.13 |
|
|
TCMBANKIN016922 |
7β,20,26-trihydroxy-20(s)-24E-dammaragonene-3-O-α-L-(4'-acetyl)-arabinopyranose-(l-2)-β-D-glucopyranoside_qt |
7β,20,26-trihydroxy-8-formyl-20(s)-24E-dammaragonene-3-O-α-L-(3'-acetyl)-arabinopyranose-(l-2)-β-D-glucopyranoside_qt |
|
488.83 |
|
|
TCMBANKIN016924 |
sumaresinolic acid |
sumaresinolicacid |
C30H48O4 |
472.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN016937 |
ergosta-7,22-dien-3β-ol |
24-methylcholesta-7,22-dien-3β-ol; Ergosta-7,22-dien-3β-ol |
|
398.74 |
CC(C)C(=C)CCC(C)C1CCC2C1(CCC3=C2CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN016967 |
Shinjulactone B |
|
C19H22O7 |
362.37 |
CC1C2CC(=O)OC3C2(C(=C(C1=O)O)C(C3)(C)C4C(=CC(=O)O4)C)CO |
|
TCMBANKIN016989 |
triterpenoidsaponin_qt |
|
|
442.75 |
|
|
TCMBANKIN017095 |
Anemarsaponin F_qt |
|
|
432.71 |
|
|
TCMBANKIN017129 |
Timosaponin A-1_qt |
|
|
416.71 |
|
|
TCMBANKIN017174 |
androstane-3,11,17-triol |
|
C19H32O3 |
308.5 g/mol |
CC12CCC(CC1CCC3C2C(CC4(C3CCC4O)C)O)O |
|
TCMBANKIN017190 |
amantadine |
|
C10H17N |
151.25 g/mol |
C1C2CC3CC1CC(C2)(C3)N |
|
TCMBANKIN017218 |
Periplogenin-3-O-alpha-L-rhamnopyranoside_qt |
|
|
390.57 |
|
|
TCMBANKIN017284 |
3-O-[β-D-glucopyranosyl(1→2)-β-D-glucuronopyranosyl]-azukisapogenol_qt |
|
C42H66O15 |
810.96 |
|
|
TCMBANKIN017303 |
dianoside E_qt |
|
|
502.76 |
|
|
TCMBANKIN017311 |
Gypinoside LXVII_qt |
|
|
476.82 |
|
|
TCMBANKIN017382 |
Cucurbitacin C |
CUCURBITACIN C; 19-Nor-9beta,10alpha-lanosta-5,23-diene-11,22-dione, 3beta,16alpha,20,25-tetrahydroxy-9-(hydroxymethyl)-, 25-acetate; cucurbitacin c; 19-nor-9.beta.,10.alpha.-Lanosta-5,23-diene-11,22-dione, 3.beta.,16.alpha.,20,25-tetrahydroxy-9-(hydroxymethyl)-, 25-acetate; 19-Norlanosta-5,23-diene-11,22-dione, 25-(acetyloxy)-3,16,20-trihydroxy-9-(hydroxymethyl)-, (3.beta.,9.beta.,10.alpha.,16.alpha.,23E)-; acetic acid [(E,5R)-5-[(3S,8S,9R,10R,13R,14S,16R,17R)-3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; Cucurbitacine (C); LS-97295; [(E,5R)-5-[(3S,8S,9R,10R,13R,14S,16R,17R)-3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; NSC94744; AC1O5G8S; [(E,6R)-6-[(3S,8S,9R,10R,13R,14S,16R,17R)-3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; 5988-76-1; HSDB 3477; [(E,6R)-6-[(3S,8S,9R,10R,13R,14S,16R,17R)-3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; 19-Norlanosta-5,23-diene-11,22-dione, 25-(acetyloxy)-3,16,20-trihydroxy-9-(hydroxymethyl)-, (3beta,9beta,10alpha,16alpha,23E)-; [(E)-6-[(3S,10R,16R)-3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; NSC 94744; LMST01010105; acetic acid [(E,5R)-5-[(3S,8S,9R,10R,13R,14S,16R,17R)-3,16-dihydroxy-11-keto-4,4,13,14-tetramethyl-9-methylol-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; C08795; 25-(Acetyloxy)-3,16,20-trihydroxy-9-(hydroxymethyl)-19-norlanosta-5,23-diene-11,22-dione; 19-Nor-9-beta,10-alpha-lanosta-5,23-diene-11,22-dione, 3-beta,16-alpha,20,25-tetrahydroxy-9-(hydroxymethyl)-, 25-acetate |
C32H48O8 |
560.72 |
CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CCC(C4(C)C)O)CO)C)C)O)O |
|
TCMBANKIN017486 |
Gypenoside LII_qt |
Gypenoside XLIX_qt |
C52H86O21 |
1047.23 |
|
|
TCMBANKIN017491 |
esculentoside N_qt |
esculentoside H_qt; esculentoside I_qt |
C54H86O26 |
1151.24 |
|
|
TCMBANKIN017657 |
4, 7-dimethoxy-5-methylcoumarin |
4,7-dimethoxy-5-methyl-coumarin; 4,7-dimethoxy-5-methyl-2-chromenone; 4,7-dimethoxy-5-methyl-chromen-2-one; 4,7-dimethoxy-5-methylchromen-2-one; 53377-54-1 |
C12H12O4 |
220.22 |
CC1=CC(=CC2=C1C(=CC(=O)O2)OC)OC |
|
TCMBANKIN017660 |
Abrisapogenol G |
abrisapogenol g; 4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-3,9-diol; AC1NSTBT |
C30H50O2 |
442.72 |
CC1(CC(C2(CCC3(C(=C2C1)CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C)C)O)C |
|
TCMBANKIN017711 |
dammar-20(22),24-diene-3β,6α,12β-triol |
|
|
458.8 |
|
|
TCMBANKIN017757 |
Oleanolic acid-28-O-beta-D-glucopyranoside |
oleanolicacid-28-o-β-d-glucopyranoside; oleanolic acid-28-o-beta-d-glucopyranoside |
C36H58O8 |
618.8 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C |
|
TCMBANKIN017852 |
azukisaponin_qt |
|
C42H68O13 |
780.98 |
|
|
TCMBANKIN017911 |
ganolucidic acid C |
|
C30H46O7 |
518.68 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2CCC4C3(CCC(C4(C)CO)O)C)C)C)O |
|
TCMBANKIN017990 |
Cinobufagin |
cinobufagin |
C26H34O6 |
442.54 |
CC(=O)OC1C(C2(CCC3C(C24C1O4)CCC5C3(CCC(C5)O)C)C)C6=COC(=O)C=C6 |
|
TCMBANKIN018043 |
19α-hydroxy-3-oxo-olean-12-en-28-oic acid |
|
|
470.76 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1O)C)C(=O)O)C |
|
TCMBANKIN018095 |
cycloartenone |
Cycloartenone; CYCLOARTENONE; CHEMBL226084; 511-63-7 |
C30H48O |
424.7 |
CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C |
|
TCMBANKIN018104 |
leonurinine_qt |
leonuridine_qt |
C15H24O9 |
348.35 |
|
|
TCMBANKIN018158 |
TES |
ZINC03814409; AA 2500; Geno-cristaux Gremy; Testogel; 17beta-Hydroxy-delta(sup4)-androsten-3-one; Testandrone; NSC 9700; Testosterone and its esters; Testoderm; 4-androstene-17beta-ol-3-one; Androgel (TN); Striant (TN); Andrusol; Cristerona T; CCRIS 574; 58-22-0; Perandren; Synandrol F; Androlin; HSDB 3398; BB_NC-0117; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Testim; Orquisteron; Androst-4-en-3-one, 17-beta-hydroxy-; Androst-4-en-3-one, 17-hydroxy-, (17-beta)-; Testopropon; CHEBI:17347; Androst-4-en-3-one, 17-hydroxy, (17.beta.)-; AIDS-070519; COL 1621; delta4-Androsten-17beta-ol-3-one; Halotensin; Testosterone [Androgenic steroids, anabolic]; Virosterone; Teslen; Primotest; delta4-androsten-17b-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; Testoject-50; Sustason 250; Androst-4-en-3-one, 17-hydroxy-, (17beta)-; CP 601B; Testosteroid; Malogen, aquaspension injection; Testro AQ; Andropatch; Testosterone (JAN/USP); 17b-hydroxy-4-androsten-3-one; Percutacrine androgenique; Oreton; EINECS 200-370-5; Relibra; 17beta-Hydroxyandrost-4-ene-3-one; Testolin; (17beta)-17-Hydroxyandrost-4-en-3-one; Striant; 4-androsten-17beta-ol-3-one; Virilon; 17-Hydroxy-(17-beta)-androst-4-en-3-one; Testosteronum [INN-Latin]; Testosterona [INN-Spanish]; CDB 111C; 46923_RIEDEL; Testostosterone; 17-Hydroxy-(17beta)-androst-4-en-3-one; Testosterone; LibiGel; 9-beta,10-alpha-ANDROST-4-EN-3-ONE, 17-beta-HYDROXY-; Androst-4-en-17beta-ol-3-one; NCGC00091018-01; D00075; delta(sup 4)-Androsten-17(beta)-ol-3-one; T1500_SIGMA; Testim (TN); Mertestate; trans-Testosterone; Testrone; Testosterone [BAN:INN]; S00309; C00535; Malestrone (amps); Testosterone hydrate; Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one; Androderm (TN); Testiculosterone; 17beta-Hydroxy-4-androsten-3-one; LMST02020002; Primoteston; Sustanone; Neo-testis; Androst-4-en-3-one, 17beta-hydroxy-; beta testosterone; Testoviron Schering; Andronaq; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; Oreton-F; DEA No. 4000; CMC_13449; Androderm; Cristerone T; c1014; 17beta-Hydroxy-3-oxo-4-androstene; AndroGel; 17beta-Hydroxyandrost-4-en-3-one; Testryl; T5411_SIGMA; Homosteron; Testosteron; Testobase; Andro 100; Virormone; Testosterone solution; Homosterone; Testoviron T; AIDS070519; Malerone |
C19H28O2 |
288.42 |
CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C |
|
TCMBANKIN018176 |
ClematosideA'_qt |
Chikusetsusaponin Ib_qt |
C47H74O18 |
927.08 |
|
|
TCMBANKIN018190 |
sophoraflavoside IV_qt |
|
C59H94O29 |
1267.36 |
|
|
TCMBANKIN018239 |
Olitoriside_qt |
|
|
404.55 |
|
|
TCMBANKIN018260 |
(2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid |
(2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-hept-5-enoic acid |
|
470.76 |
|
|
TCMBANKIN018324 |
(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol |
(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol |
C42H72O14 |
801.01 |
|
|
TCMBANKIN018335 |
(2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-isopropyl-hex-5-enoic acid |
(2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylidene-heptanoic acid; (2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid; (2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methyleneheptanoic acid; (2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylene-heptanoic acid |
C31H48O4 |
484.71 |
CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)O)C)C)C)O)C(=O)O |
|
TCMBANKIN018406 |
sitogenin |
|
|
432.71 |
|
|
TCMBANKIN018504 |
(R,E)-6-((3S,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid |
|
C34H52O6 |
556.77 |
|
|
TCMBANKIN018531 |
20(s)-protopanaxadiol |
(3S,8R,9R,10R,12R,13R,14S,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2R)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; AC1MIVF3; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1R)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; 7755/1/3; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1R)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
C30H52O3 |
460.73 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)O)C |
|
TCMBANKIN018562 |
dimethyl 3-O-β-D-glucopyranosylplatycogenate A |
|
|
546.82 |
|
|
TCMBANKIN018576 |
ganoderiol H |
|
C30H50O5 |
490.71 |
CC(CCC(C(C)(CO)O)O)C1CCC2(C1(CCC3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN018749 |
azukisaponinI |
kaikasaponinII; azukisaponin i |
C42H68O13 |
781 g/mol |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(C1)O)C)C)C)(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C |
|
TCMBANKIN018751 |
plantenolic acid |
|
|
470.76 |
|
|
TCMBANKIN018819 |
Akebiasaponin D_qt |
Mukurozisaponin E_qt; Akebia saponin D_qt; Mukurozi-saponin G_qt; Mukurozisaponin Y_qt; mukurozisaponin G_qt |
C50H78O18 |
967.14 |
|
|
TCMBANKIN018860 |
(1S,2R,4aS,6aR,6aS,6bR,8aR,10R,11S,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |
|
|
472.78 |
|
|
TCMBANKIN018881 |
Triptinin B |
triptinin b |
C20H26O3 |
314.4 g/mol |
CC1=C(CCC2(C1CCC3=C2C=CC(=C3O)C(C)C)C)C(=O)O |
|
TCMBANKIN019104 |
Abrisapogenol F |
10-hydroxy-2,2,4a,6a,6b,9,9,12a-octamethyl-3,5,6,6a,7,8,8a,10,11,12,13,14b-dodecahydro-1H-picen-4-one; AC1NST7F; abrisapogenol f |
C30H48O2 |
440.7 |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(=O)C1)C)C)C)(C)C)O)C)C |
|
TCMBANKIN019135 |
16-hydroperoxy-3,4-seco-mansumbin-3(28),13(17)- dien-3-oic acid |
|
C22H34O4 |
362.5 g/mol |
CC(=C)C1CCC2(C(C1(C)CCC(=O)O)CCC3=CC(CC32C)OO)C |
|
TCMBANKIN019172 |
3-beta-hydroxylup-20(29)-en-30-al |
3β-hydroxy-lup-20(29)-en-30-al |
|
440.78 |
|
|
TCMBANKIN019176 |
methyl maslinate |
SCHEMBL17124294 |
C31H50O4 |
486.73 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)OC)C |
|
TCMBANKIN019205 |
Cryptogenin |
Cryptogenine; 3-beta,26-Dihydroxycholest-5-ene-12,22-dione; cryptogenin; Cholest-5-ene-16,22-dione, 3beta,26-dihydroxy-, (20S,25R)- (8CI); Cryptogenine [French]; 3-beta,26-Dihydroxycholest-5-ene-12,22-dione [French]; BXC9X8B37J; 3beta,26-Dihydroxycholest-5-ene-16,22-dione; UNII-BXC9X8B37J; NSC 93751; Cholest-5-ene-16,22-dione, 3-beta,26-dihydroxy-, (20S,25R)- (8CI); Cholest-5-ene-16,22-dione, 3,26-dihydroxy-, (3-beta,25R)-; (3-beta,25R)-3,26-Dihydroxycholest-5-ene-16,22-dione |
C27H42O4 |
430.62 |
[H+].CC(CCC(=O)C(C)C1C(=O)CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO |
|
TCMBANKIN019276 |
zingibroside r1_qt |
|
C42H66O14 |
794.97 |
|
|
TCMBANKIN019313 |
pseudo-ginsenosideRT5_qt |
pseudoginsenoside F11_qt; pseudoginsenoside RT5_qt |
C36H62O10 |
654.87 |
|
|
TCMBANKIN019362 |
sarmentolin |
|
C30H48O3 |
456.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2(C1)OO)C)C)C |
|
TCMBANKIN019426 |
Adlantone |
|
|
412.77 |
|
|
TCMBANKIN019578 |
7beta-(3-ethyl-cis-crotonoyloxy)-14-hydroxy-notonipetranone |
|
|
378.56 |
|
|
TCMBANKIN019629 |
Ilekudinoside F_qt |
|
|
470.76 |
|
|
TCMBANKIN019631 |
glaucoside,d_qt |
cynanoside,j_qt; cynanoside,i_qt |
|
376.49 |
|
|
TCMBANKIN019700 |
(3S,4R,6S)-6-[(3S,5R,9R,10R,13S,14S,17S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptane-2,3,4-triol |
(3S,4R,6S)-6-[(3S,5R,9R,10R,13S,14S,17S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-heptane-2,3,4-triol |
|
476.82 |
|
|
TCMBANKIN019788 |
α-Spinasterol-β-D-glucoside_qt |
|
|
412.77 |
|
|
TCMBANKIN019792 |
omolic acid-28-O-β-D-glucopyranoside_qt |
|
|
470.81 |
|
|
TCMBANKIN019874 |
(1S,4aS,4bR,7R,10aS)-1,4a,7-trimethyl-7-vinyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid |
(1S,4aS,4bR,7R,10aS)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid |
|
302.5 |
|
|
TCMBANKIN019908 |
Kudinoside C_qt |
Kudinoside B_qt; Kudinoside A_qt |
|
486.76 |
|
|
TCMBANKIN020049 |
Ganoderic acid U |
|
C30H48O4 |
472.7 g/mol |
CC(CCC=C(C)C(=O)O)C1CCC2(C1(CCC3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C |
|
TCMBANKIN020082 |
4a-formyl-7alpha-hydroxy-1-methyl-8-methylidene-4aalpha,4bbeta-gibbane-1alpha,10beta-dicarboxylic acid |
(1S,2S,3S,4R,8R,9R,12S)-8-formyl-12-hydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.0(1,9).0(3,8)]pentadecane-2,4-dicarboxylic acid; GA19; CHEBI:28731 |
C20H26O6 |
362.42 |
CC1(CCCC2(C1C(C34C2CCC(C3)(C(=C)C4)O)C(=O)O)C=O)C(=O)O |
|
TCMBANKIN020193 |
Gypenoside XLI_qt |
|
C42H72O13 |
785.01 |
|
|
TCMBANKIN020246 |
(3S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,9-diol |
|
C30H50O2 |
442.72 |
|
|
TCMBANKIN020299 |
gensenoside- Rb1_qt |
|
C54H92O23 |
1109.29 |
|
|
TCMBANKIN020345 |
Aspafilioside A_qt |
|
C38H62O12 |
710.89 |
|
|
TCMBANKIN020363 |
(3R,4S,4aR,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-2,2,4a,6a,6b,9,12a-heptamethyl-9-methylol-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,4,10-triol |
(3R,4S,4aR,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,4,10-triol |
C30H50O4 |
474.72 |
|
|
TCMBANKIN020392 |
sarsasapogeni |
AKOS025402319; (1'R,2R,2'S,4'R,7'S,8'R,9'S,12'S,13'S)-5,7',9',13'-TETRAMETHYL-5'-OXASPIRO[OXANE-2,6'-PENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSAN]-16'-OL; AC-8053; BG01705212; Q-201700 |
C27H44O3 |
416.64 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN020438 |
Ecliptasaponin B_qt |
|
|
472.78 |
|
|
TCMBANKIN020546 |
Abrisapogenol D |
abrisapogenol d |
C30H50O3 |
458.72 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)CO)C)C)C)C |
|
TCMBANKIN020654 |
asiaticoside,c_qt |
|
|
502.81 |
|
|
TCMBANKIN020717 |
7-oxoroyleanone2 |
|
|
330.46 |
|
|
TCMBANKIN020721 |
fernenone |
|
C30H48O |
424.7 g/mol |
CC(C)C1CCC2C1(CCC3(C2(CC=C4C3CCC5C4(CCC(=O)C5(C)C)C)C)C)C |
|
TCMBANKIN020732 |
sibiricoside A_qt |
|
C57H94O28 |
1227.34 |
|
|
TCMBANKIN020746 |
7β,18,20,26-Tetrahydroxy-20(s)-24E-dammaragonene-3-O-α-L-(4'-acetyl)-arabinopyranose-(l-2)-β-D-glucopyranoside_qt |
7β,18,20,26-Tetrahydroxy-20(s)-24E-dammaragonene-3-O-α-L-(3'-acetyl)-arabinopyranose-(l-2)-β-D-glucopyranoside_qt |
|
490.85 |
|
|
TCMBANKIN020751 |
(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN020773 |
Macranthoidin A_qt |
|
C65H106O32 |
1399.52 |
|
|
TCMBANKIN020844 |
aster saponin G_qt |
|
C57H92O26 |
1193.32 |
|
|
TCMBANKIN020847 |
subprogenin B |
|
C30H48O5 |
488.7 |
CC12CCC(C(C1CCC3(C2CC=C4C3(CCC5(C4CC(CC5=O)(CO)CO)C)C)C)(C)CO)O |
|
TCMBANKIN020874 |
sibiricoside B_qt |
|
C50H80O24 |
1065.16 |
|
|
TCMBANKIN020942 |
mudanpinoic,acid,a |
|
|
454.76 |
|
|
TCMBANKIN020983 |
methyl (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-3,11,15-triketo-4,4,10,13,14-pentamethyl-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]valeric acid methyl ester; (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester |
|
472.68 |
|
|
TCMBANKIN021025 |
ergosta-4,24(28)-dien-3-one |
|
C28H44O |
396.6 g/mol |
CC(C)C(=C)CCC(C)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
|
TCMBANKIN021027 |
ardisicrenoside G_qt |
|
C53H86O23 |
1091.24 |
|
|
TCMBANKIN021028 |
Ecliptasaponin D_qt |
|
C36H58O9 |
634.84 |
|
|
TCMBANKIN021105 |
majoroside F2_qt |
ginsenoside Rg7_qt |
C42H72O14 |
801.01 |
|
|
TCMBANKIN021113 |
Zingiberoside A3_qt |
|
C45H72O17 |
885.04 |
|
|
TCMBANKIN021215 |
jujuboside B_qt |
|
C52H84O21 |
1045.21 |
|
|
TCMBANKIN021242 |
cynanoside,f_qt |
cynanoside,e_qt |
|
392.49 |
|
|
TCMBANKIN021266 |
ganoderic acid Q |
|
C34H50O7 |
570.76 |
|
|
TCMBANKIN021462 |
Abrisapogenol C |
abrisapogenol c; butane; ethane; methane; tetrahydrate; AC1NT0I6 |
C30H50O4 |
474.72 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(C(C5O)O)(C)CO)C)C)C)C |
|
TCMBANKIN021494 |
Ajugalactone |
42975-12-2; ajugalactone; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[1-(4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl)-1-hydroxyethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-dione; AC1NSUZW; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[(1R)-1-[(2R)-4-ethyl-6-keto-5-methyl-2,3-dihydropyran-2-yl]-1-hydroxy-ethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-quinone; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[(1R)-1-[(2R)-4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxy-ethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-dione; C08810; (2S,3R,5R,9R,10R,13R,14R,17S)-17-[(1R)-1-[(2R)-4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-2,3,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,9,11,15,16,17-decahydrocyclopenta[a]phenanthrene-6,12-dione |
C29H40O8 |
516.62 |
CCC1=C(C(=O)OC(C1)C(C)(C2CCC3(C2(C(=O)CC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)O)C |
|
TCMBANKIN021503 |
brassicasterol |
Brassicasterol; ergosta-5,22-dienol; ergosta-5,22-dien-3 beta-ol; ergosta-5,22E-dien-3beta-ol; 474-67-9; (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; C08813; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; LMST01030098 |
C28H46O |
398.66 |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN021515 |
3beta-O-(alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranosyl-(1-4)-alpha-L-arabinopynanosyl)cyclamiretin A_qt |
|
|
484.79 |
|
|
TCMBANKIN021528 |
soyasapogenol b |
Soyasapogenol B; (3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,9-diol; SMR001397335; C08980; 595-15-3; Olean-12-ene-3,22,23-triol, (3beta,4beta,22beta)-; NCGC00247505-01; HMS2267D19; MLS002473248; (3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-4,6a,6b,8a,11,11,14b-heptamethyl-4-methylol-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,9-diol; CHEMBL153969 |
C30H50O3 |
458.72 |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(C1)O)C)C)C)(C)CO)O)C)C |
|
TCMBANKIN021640 |
ginsenoside Ro_qt |
chikusetsusaponin Ⅳ_qt; chikusetsusaponinⅤ_qt; ginsenoside- Ro_qt; (3b)-3-hydroxy-Olean-12-en-28-oic acid, monosodium salt; Ginsenoside-R0_qt |
C47H74O18 |
927.08 |
|
|
TCMBANKIN021690 |
cynapanoside C_qt |
cynapanoside A_qt |
|
376.49 |
|
|
TCMBANKIN021743 |
3,3-Dimethylcyclohexanol |
3,3-dimethyl-cyclohexanol |
C8H16O |
128.21 |
CC1(CCCC(C1)O)C |
|
TCMBANKIN021764 |
Ganoderic acid T |
ganoderic acid t; (E,5S,6S)-5-acetoxy-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (E,5S,6S)-5-acetoxy-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid; (E,5S,6S)-5-acetyloxy-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid; (E,5S,6S)-5-acetyloxy-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid |
C36H52O8 |
612.79 |
CC(C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)OC(=O)C)C(CC=C(C)C(=O)O)OC(=O)C |
|
TCMBANKIN021774 |
3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S)-spirost-5(6)-en-3beta-ol_qt |
|
|
414.69 |
|
|
TCMBANKIN021781 |
Gypenoside XL_qt |
Gypenoside LIII_qt |
C41H68O13 |
768.97 |
|
|
TCMBANKIN021806 |
Tetrapanoside B_qt |
|
|
428.77 |
|
|
TCMBANKIN021823 |
ergosta-7-ene-3β,5α,6β-triol |
|
|
432.76 |
|
|
TCMBANKIN021903 |
semiaquilegoside A_qt |
|
|
332.48 |
|
|
TCMBANKIN021904 |
celosin G_qt |
|
|
516.79 |
|
|
TCMBANKIN021971 |
acutumidine |
Acutumidine; DTXSID90331971; CHEMBL237548; CHEBI:2452; C10565; AC1L9DHT; 18145-26-1 |
C18H22ClNO6 |
383.8 g/mol |
COC1=CC(=O)C2(C1O)C(CC34C2(CCN3)CC(=O)C(=C4OC)OC)Cl |
|
TCMBANKIN021972 |
darutoside_qt |
|
C26H44O8 |
484.62 |
|
|
TCMBANKIN022067 |
3-oxo-22α-hydroxyurs-12-en-27,28-dioc acid |
|
|
501.75 |
|
|
TCMBANKIN022084 |
Dihydrofukinolide |
dihydrofukinolide |
C22H32O6 |
392.49 |
CCC(C)C(=O)OC1CCC(C2(C1C(C3(C2)C(=C)COC3=O)OC(=O)C)C)C |
|
TCMBANKIN022095 |
mimengoside,d_qt |
mimengoside,c_qt |
|
472.78 |
|
|
TCMBANKIN022216 |
(3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
(3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
C54H92O23 |
1109.29 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)O)C |
|
TCMBANKIN022282 |
Datumetelin |
datumetelin |
|
468.69 |
CC12CCC3C(C1CCC2C4COC5(CC4OC(=O)C5COC)C)CC=C6C3(C(=O)C=CC6)C |
|
TCMBANKIN022306 |
stachysterone D |
|
C27H42O6 |
462.62 |
CC1(CCC(O1)C(C)(C2CCC3(C2(CCC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)O)C |
|
TCMBANKIN022336 |
3-[2-[(1S,4aR,5S,8aR)-5,8a-dimethyl-2-methylene-5-methylol-decalin-1-yl]ethyl]-5H-furan-2-one |
3-[2-[(1S,4aR,5S,8aR)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-decalinyl]ethyl]-5H-furan-2-one; 3-[2-[(1S,4aR,5S,8aR)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-5H-furan-2-one; 3-[2-[(1S,4aR,5S,8aR)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decalin-1-yl]ethyl]-5H-furan-2-one |
|
318.5 |
|
|
TCMBANKIN022364 |
Methyl desoxycholate |
|
C25H42O4 |
406.6 |
CC(CCC(=O)OC)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C |
|
TCMBANKIN022378 |
3-O-β-D-glucopyranosyl oleanolic acid_qt |
28-O-β-D-glucopyranosiduronic acid-(1→4)-β-D-glucopyranosyl hederagenin_qt |
|
472.78 |
|
|
TCMBANKIN022395 |
mogroside ⅡA1_qt |
|
|
476.82 |
|
|
TCMBANKIN022410 |
isokurarinone |
LMPK12140464; Isokurarinone |
C26H30O6 |
438.51 |
CC(=CCC(CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C |
|
TCMBANKIN022565 |
(+)-Methyl ganoderate E |
|
C31H42O7 |
526.66 |
|
|
TCMBANKIN022606 |
21302-79-4 |
A(1)-Norlup-20(29)-en-28-oic acid, 2-carboxy-3-hydroxy-, (2alpha,3beta)- |
C30H46O5 |
486.68 |
CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(C(C(C5(C)C)O)C(=O)O)C)C)C(=O)O |
|
TCMBANKIN022624 |
(3S,4S,5R,10S,13R,14R,17R)-3-hydroxy-4,10,13,14-tetramethyl-17-((R)-6-methyl-5-methyleneheptan-2-yl)-3,4,5,6,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-7,11(2H,10H)-dione |
|
|
454.76 |
|
|
TCMBANKIN022626 |
7-oxomogroside ⅡE_qt |
|
|
504.83 |
|
|
TCMBANKIN022648 |
Timosaponin B III_qt |
|
C45H74O18 |
903.06 |
|
|
TCMBANKIN022694 |
Ziziphin_qt |
Jujuboside_qt; Colubrinoside_qt |
C52H84O21 |
1045.21 |
|
|
TCMBANKIN022702 |
jujubasaponin IV_qt |
|
C48H78O18 |
943.12 |
|
|
TCMBANKIN022765 |
propapyriogeninA1 |
propapyriogenin A1; propapyriogenin a1 |
C31H46O5 |
498.69 |
|
|
TCMBANKIN022800 |
paryriogenin C |
|
|
468.74 |
|
|
TCMBANKIN022809 |
Isoeruboside_B_qt |
Isoeruboside B_qt |
C51H84O24 |
1081.2 |
|
|
TCMBANKIN022853 |
subprogenin D |
|
C30H46O4 |
470.68 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5=O)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN022919 |
Paniculogenin |
paniculogenin; (25S)-5alpha-spirostan-3beta,6alpha,23S-triol; AC1LCU9T; LMST01080021; 16750-37-1 |
C27H44O5 |
448.64 |
CC1CC(C2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)O)C)O)C)C)OC1)O |
|
TCMBANKIN022930 |
methyl (4R)-4-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester; (4R)-4-[(5R,10S,13R,14R,17R)-3,7,11,15-tetraketo-4,4,10,13,14-pentamethyl-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid methyl ester |
C28H38O6 |
470.6 |
|
|
TCMBANKIN023001 |
(2'R,5'R,6aS,6bS,8aR,8bS,11aR,12aR,12bR)-5',6a,8a-trimethyl-1,3',4',5',6,6a,6b,6',7,8a,8b,9,11a,12,12a,12b-hexadecahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,8(2H,5H)-dione |
|
|
412.62 |
|
|
TCMBANKIN023122 |
phellamurin_qt |
dihydro avonol glucoside phellamurin_qt |
C26H30O11 |
518.51 |
|
|
TCMBANKIN023543 |
Lantadene A |
(4R,4aS,6aR,6aS,6bR,8aR,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-4-[(Z)-2-methylbut-2-enoyl]oxy-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid; LANTADENE A; lantadene a; Olean-12-en-28-oic acid, 22-((2-methyl-1-oxo-2-butenyl)oxy)-3-oxo-, (22beta(Z))-; CHEMBL510691; ZINC42835006; LS-98303; 22-((2-Methyl-1-oxo-2-butenyl)oxy)-3-oxo-olean-12-en-28-oic acid, (22beta); Olean-12-en-28-oic acid, 22-beta-hydroxy-3-oxo-, 2-methylcrotonate, (Z)-; HSDB 3503; MolPort-039-052-678; BG01189754; 22-beta-Angeloyloxyoleanolic acid; 9SK62WCU1W; 467-81-2; AC1O5M0E; (4R,4AS,6AS,6BR,8AR,12AR,12BR,14BS)-2,2,6A,6B,9,9,12A-HEPTAMETHYL-4-{[(2Z)-2-METHYLBUT-2-ENOYL]OXY}-10-OXO-3,4,5,6,7,8,8A,11,12,12B,13,14B-DODECAHYDRO-1H-PICENE-4A-CARBOXYLIC ACID; 22-((2-Methyl-1-oxo-2-butenyl)oxy)-3-oxo-olean-12-en-28-oic acid, 22-beta(Z)-; Olean-12-en-28-oic acid, 22beta-hydroxy-3-oxo-, 2-methylcrotonate, (Z)-; Rehmannic acid; UNII-9SK62WCU1W |
C35H52O5 |
552.78 |
CC=C(C)C(=O)OC1CC(CC2C1(CCC3(C2=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C)C(=O)O)(C)C |
|
TCMBANKIN023744 |
Gypenoside LVIII_qt |
|
C52H88O21 |
1049.24 |
|
|
TCMBANKIN023801 |
Notoginsenoside Fc_qt |
Notoginsenoside Fa_qt |
C59H100O27 |
1241.41 |
|
|
TCMBANKIN023845 |
Hederagenin-28-O-beta-D-glucuronopyranosyl-(1-4)-beta-D-glucopyranoside_qt |
|
|
472.78 |
|
|
TCMBANKIN023876 |
14-acetoxy-7beta-angeloyloxy-notonipetranone |
|
|
406.57 |
|
|
TCMBANKIN024038 |
Cynanuriculoside A_qt |
|
|
490.7 |
|
|
TCMBANKIN024105 |
Digitogenin |
511-34-2; CHEBI:28431; (25R)-5alpha-spirostan-2alpha,3beta,15beta-triol; C08896 |
C27H44O5 |
448.64 |
CC1CCC2(C(C3C(O2)C(C4C3(CCC5C4CCC6C5(CC(C(C6)O)O)C)C)O)C)OC1 |
|
TCMBANKIN024140 |
Quassin |
Picrasa-2,12-diene-1,11,16-trione, 2,12-dimethoxy-; 1405-17-0; LMPR01060018; quassin; (3AS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo(de,g)chromene-1,5,11-trione; C08778; 76-78-8; Quassine; 2,12-Dimethoxypicrasa-2,12-diene-1,11,16-trione; EINECS 200-985-9; AIDS026399; NSC 36342; AIDS-026399 |
C22H28O6 |
388.45 |
CC1C=C(C(=O)C2(C1CC3C4(C2C(=O)C(=C(C4CC(=O)O3)C)OC)C)C)OC |
|
TCMBANKIN024160 |
olean-3-one |
|
|
426.8 |
|
|
TCMBANKIN024248 |
(2S,4aR,4bS,7S)-7-isopropyl-1,1,4a-trimethyl-2,4b,5,6,7,8-hexahydrophenanthren-2-ol |
(2S,4aR,4bS,7S)-1,1,4a-trimethyl-7-propan-2-yl-2,4b,5,6,7,8-hexahydrophenanthren-2-ol |
|
286.5 |
|
|
TCMBANKIN024306 |
16β-methoxyalisol B monoacetate |
|
C33H52O6 |
544.76 |
|
|
TCMBANKIN024327 |
sessilistemonamine A |
|
|
391.56 |
|
|
TCMBANKIN024329 |
cynanchoside c2_qt |
|
|
474.7 |
|
|
TCMBANKIN024359 |
linalyl butyrate |
|
C14H24O2 |
224.34 |
CCCC(=O)OC(C)(CCC=C(C)C)C=C |
|
TCMBANKIN024413 |
Soyasaponin A6_qt |
Soyasaponin A4_qt; Soyasaponin A5_qt |
C58H94O28 |
1239.35 |
|
|
TCMBANKIN024472 |
3β-hydroxy-5α-pregn-16(17)en-20-one-3-O-β-D-xylopyranosyl(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-β-D-galactopyranoside_qt |
|
|
302.55 |
|
|
TCMBANKIN024627 |
(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,8a-diol |
|
|
428.77 |
|
|
TCMBANKIN024653 |
(+)-Methyl ganolucidate A |
|
C31H46O6 |
514.69 |
|
|
TCMBANKIN024722 |
Abrisapogenol A |
AC1NSSNX; abrisapogenolA; abrisapogenol a; 11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,9-diol |
C30H50O3 |
458.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)CO)C)C)C)C |
|
TCMBANKIN024726 |
pedunculoside_qt |
|
|
488.78 |
|
|
TCMBANKIN024758 |
asiaticoside,f_qt |
|
|
472.73 |
|
|
TCMBANKIN024804 |
Gypenoside XX_qt |
Gypenoside XIX2_qt; Gypenoside XXI_qt; Gypenoside LXX_qt |
C60H102O28 |
1271.44 |
|
|
TCMBANKIN024848 |
(3S,4S,5R,10S,13R,14R,17R)-3-hydroxy-4,10,13,14-tetramethyl-17-((R)-6-methyl-5-methyleneheptan-2-yl)-3,4,5,6,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-7(2H)-one |
|
|
440.78 |
|
|
TCMBANKIN024859 |
evobioside_qt |
|
C35H54O13 |
682.8 |
|
|
TCMBANKIN024860 |
ZINC04073977 |
(8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethylhexyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C29H48O |
412.69 |
|
|
TCMBANKIN024915 |
Gypenoside LX_qt |
Gypenoside LXXVIII_qt |
C41H70O14 |
786.99 |
|
|
TCMBANKIN024975 |
Daturameteloside E_qt |
Daturameteloside D_qt |
|
488.68 |
|
|
TCMBANKIN025000 |
Notoginsenoside R4_qt |
|
|
460.82 |
|
|
TCMBANKIN025102 |
gynsenoside Rd_qt |
|
|
460.82 |
|
|
TCMBANKIN025130 |
Daturametelin A_qt |
|
|
438.66 |
|
|
TCMBANKIN025222 |
14-acetoxy-7beta-(3-ethyl crotonoyloxy)notonlpetranone |
|
|
404.6 |
|
|
TCMBANKIN025276 |
(+)-Methyl ganolucidate B |
|
C31H48O6 |
516.71 |
|
|
TCMBANKIN025283 |
Daturameteline F |
|
|
518.71 |
|
|
TCMBANKIN025342 |
Gypenoside XIV_qt |
ginsenoside rb3_qt; Notoginsenoside Fe_qt |
C42H72O12 |
769.01 |
|
|
TCMBANKIN025369 |
ginsenoside-F3_qt |
|
C41H70O13 |
770.99 |
|
|
TCMBANKIN025451 |
(1R,4aR,4bR,10aS)-7-isopropyl-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid |
(1R,4aR,4bR,10aS)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid |
C20H30O2 |
302.45 |
|
|
TCMBANKIN025475 |
Gypenoside L_qt |
Gypenoside XLVII_qt; Gypenoside LXVI_qt; Gypenoside XLV_qt; Gypenoside XLIII_qt; Gypenoside XLVI_qt; Gypenoside XLIV_qt; Gypenoside LVI_qt; Gypenoside XLII_qt; Gypenoside LVII_qt; Gypenoside LXXVII_qt |
C54H92O24 |
1125.29 |
|
|
TCMBANKIN025538 |
colchine |
(R/S)-Colchicine; MLS001181527; HMS3267B14; NE55304; I06-0591; CCG-46868; MCULE-7902106432; DTXSID20274387; ST056390; IAKHMKGGTNLKSZ-UHFFFAOYSA-N; 064T868; SMR000567246; KSC621O9T; HMS2875H17; C22H25NO6; CC0177; AC1Q5ODH; TR-031757; (+/-)-Colchicine; FT-0665155; Benzo[a]heptalen-9(5H)-one,7-acetamido-6,7-dihydro-1,2,3,10-tetramethoxy-; NCGC00094629-04; NCGC00094629-05; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide #; Epitope ID:141498; Neuro_000002; AC-281; M205; BRD-A46684810-001-04-6; SCHEMBL675246; KB-295593; J-013744; BC216204; AB00830494-06; CHEBI:23359; Acetamide,N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-; MFCD00078484; Colchine; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0(2),]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide; CTK5C1799; NCGC00094629-03; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamide; 209810-38-8; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide; Z1431321925; AKOS016374434; N-{3,4,5,14-TETRAMETHOXY-13-OXOTRICYCLO[9.5.0.0(2),?]HEXADECA-1(16),2,4,6,11,14-HEXAEN-10-YL}ACETAMIDE; AKOS003381878; MolPort-001-785-612; N-((7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7-trihydrobenzo[d]heptalen-7-yl)acetam ide; DB01394; NCGC00094629-01; NCGC00094629-06; AS-14691; 16416P; N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0;{2,7}]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide; BBL010108; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0^{2,7}]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}acetamide; NCGC00094629-02; SBB079703; SR-01000636539-1; 54192-66-4; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0?,?]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide; (S)-Colchicine >95%; STK801462; 1,2,3,10-Tetramethoxy-7-(acetylamino)-5,6,7,9-tetrahydrobenzo[a]heptalene-9-one; AC1L1EKN; CHEMBL87; N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7-trihydrobenzo[d]heptalen-7-yl)acetamide; KB-86571 |
C22H25NO6 |
399.4 g/mol |
CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC |
|
TCMBANKIN025544 |
(E,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid |
(E,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (E,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-11,15-diketo-4,4,10,13,14-pentamethyl-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid |
C30H44O6 |
500.67 |
|
|
TCMBANKIN025611 |
Ilekudinoside H_qt |
|
|
486.76 |
|
|
TCMBANKIN025738 |
ganoderiol E |
|
C30H48O4 |
472.7 |
CC(CCC=C(CO)CO)C1CCC2(C1(CCC3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN025773 |
malonyl-ginsenoside Rd_qt |
|
C51H84O21 |
1033.2 |
|
|
TCMBANKIN025788 |
sapindoside E_qt |
Sapindoside C_qt; Sapindoside D_qt |
C80H130O42 |
1763.86 |
|
|
TCMBANKIN025810 |
deglucose chikusetsusaponin Iva_qt |
|
|
456.78 |
|
|
TCMBANKIN025871 |
capitasterone |
|
C29H44O7 |
504.66 |
CCC1CC(OC(=O)C1C)C(C)(C2CCC3(C2(CCC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)O |
|
TCMBANKIN025892 |
Gypenoside LXXIII_qt |
|
C48H82O17 |
931.15 |
|
|
TCMBANKIN025905 |
Proliferin |
proliferin |
C27H40O5 |
444.6 g/mol |
CC1=CCCC(=CCC2(C(CC=C(C(CC1)O)C)C(=C(C2=O)O)C(C)COC(=O)C)C)C |
|
TCMBANKIN025989 |
(4aR,5R,6aR,6aS,6bR,8aR,10R,11S,12aR,14bS)-5,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
|
488.78 |
|
|
TCMBANKIN025993 |
l-Verbenone |
1196-01-6; 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one; ZINC00967601; (1S,5S)-2,7,7-trimethylbicyclo[3.1.1]hept-2-en-4-one; bicyclo[3.1.1]hept-3-en-2-one, 4,6,6-trimethyl-; AI3-23128; (1S,5S)-2,7,7-trimethyl-4-bicyclo[3.1.1]hept-2-enone; Verbenone, (L)-; Pin-2-en-4-one; BB_NC-0220; Bicyclo(3.1.1)hept-3-en-2-one, 4,6,6-trimethyl-, (1S,5S)-; InChI=1/C10H14O/c1-6-4-9(11)8-5-7(6)10(8,2)3/h4,7-8H,5H2,1-3H; NSC 6831; EINECS 214-807-2 |
C10H14O |
150.22 |
CC1=CC(=O)C2CC1C2(C)C |
|
TCMBANKIN026066 |
Ariskanin A |
AC1NSZ0Y; ariskanin a; methyl 3,4-dimethoxy-10-nitrophenanthrene-1-carboxylate; 128397-31-9 |
C18H15NO6 |
341.31 |
COC1=C(C2=C(C(=C1)C(=O)OC)C(=CC3=CC=CC=C32)[N+](=O)[O-])OC |
|
TCMBANKIN026070 |
Shinjulactone K |
94451-22-6; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2.alpha.,11.alpha.,12.alpha.); AIDS-026415; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2alpha,11alpha,12alpha); shinjulactone k; AIDS026415 |
C22H32O7 |
408.49 |
CC1CC(C(=O)C2(C1CC3C4(C2C(C(C(C4CC(=O)O3)C)OC(=O)C)O)C)C)O |
|
TCMBANKIN026105 |
Dauricumidine |
|
C18H22ClNO6 |
383.82 |
COC1=CC(=O)C2(C1O)C(CC34C2(CCN3)CC(=O)C(=C4OC)OC)Cl |
|
TCMBANKIN026210 |
(1S,2R,4aS,6aR,6aS,6bR,8aR,12aR,14bS)-1,2,6a,6b,9,9,12a-heptamethyl-10-oxo-1,2,3,4,5,6,6a,7,8,8a,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
(1S,2R,4aS,6aR,6aS,6bR,8aR,12aR,14bS)-10-keto-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,5,6,6a,7,8,8a,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
C30H46O3 |
454.68 |
|
|
TCMBANKIN026219 |
Jolkinolide A |
1H-Oxireno(1,10a)phenanthro(3,2-b)furan-9(7aH)-one, 2,3,4,4a,5,6,11a,11b-octahydro-4,4,8,11b-tetramethyl-, (4aR-(4aalpha,6aS*,7abeta,11aalpha,11bbeta))-; NCI60_035894; 37905-07-0 |
C20H26O3 |
314.42 |
CC1=C2C3C4(O3)CCC5C(CCCC5(C4C=C2OC1=O)C)(C)C |
|
TCMBANKIN026312 |
madecassoside_qt |
|
|
504.78 |
|
|
TCMBANKIN026367 |
1β-hydroxyeuscaphic acid |
|
|
504.78 |
|
|
TCMBANKIN026390 |
[(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxo-spiro[decalin-4,2'-tetrahydropyran]-1-yl] acetate |
acetic acid [(1R,3R,4R,4aS,8aS)-6'-keto-3,4a,8,8-tetramethyl-spiro[decalin-4,2'-tetrahydropyran]-1-yl] ester; [(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxospiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxane]-1-yl] acetate; [(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxo-spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxane]-1-yl] ethanoate; acetic acid [(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxo-1-spiro[decalin-4,2'-tetrahydropyran]yl] ester |
|
336.52 |
|
|
TCMBANKIN026497 |
gynosaponin TN-1_qt |
|
C36H62O9 |
638.87 |
|
|
TCMBANKIN026544 |
Danshenol B |
CHEMBL2261307; Phenanthro(1,2-b)furan-11(2H)-one, 1,6,7,8,9,10-hexahydro-10-hydroxy-1,6,6-trimethyl-10-(2-oxopropyl)-, (1R-trans)-; danshenol b; DTXSID80172335; Phenanthro(1,2-b)furan-11(2H)-one, 1,6,7,8,9,10-hexahydro-10-hydroxy-1,6,6-trimethyl-10-(2-oxopropyl)-, (1R,10S)-; AC1MJ0RA; MolPort-039-339-186; ZINC13431690; (1R,10S)-10-hydroxy-1,6,6-trimethyl-10-(2-oxopropyl)-2,7,8,9-tetrahydro-1H-naphtho[8,7-g][1]benzoxol-11-one; (1R,10S)-10-acetonyl-10-hydroxy-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-11-one; (1R,10S)-10-hydroxy-1,6,6-trimethyl-10-(2-oxopropyl)-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-11-one; 189308-09-6 |
C22H26O4 |
354.44 |
CC1COC2=C1C(=O)C(C3=C2C=CC4=C3CCCC4(C)C)(CC(=O)C)O |
|
TCMBANKIN026582 |
papyrioside L-Ⅱd_qt |
papyrioside L- IId_qt |
C48H76O19 |
957.11 |
|
|
TCMBANKIN026590 |
Diosgenin acetate |
AC1Q5X0O; diosgenin acetate |
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
|
TCMBANKIN026725 |
20(S)-dammar-24-ene-3β,20-diol-3-acetate |
|
|
486.86 |
|
|
TCMBANKIN026813 |
chebupentol |
|
C30H50O5 |
490.71 |
|
|
TCMBANKIN026829 |
polyporusterone,g |
|
|
460.72 |
|
|
TCMBANKIN027017 |
11-oxomogroside ⅣA_qt |
|
|
488.83 |
|
|
TCMBANKIN027083 |
Isatidine |
isatidine |
C18H25NO6 |
351.39 |
CC=C1CC(C(C(=O)OCC2=CC[N+]3(C2C(CC3)OC1=O)[O-])(CO)O)C |
|
TCMBANKIN027148 |
smilagenin |
EINECS 204-775-8; CHEBI:28933; (25R)-Spirostane-3beta-ol; C08913; 5beta-Spirostan-3beta-ol, (25R)- (8CI); (25R)-Spirostan-3.beta.-ol; Isosarsasapogenin; Spirostan-3-ol, (3.beta.,5.beta.,25R)-; Spirostan-3-ol, (3beta,5beta,25R)- (9CI); NSC93747; NSC 93747; (25R)-5beta-Spirostan-3beta-ol; SMP1_000275; SCHEMBL180193; AI3-44895; Isosarsapogenin; (25R)-Spirostan-3beta-ol; 126-18-1; Smilagenin; 5.beta.-Spirostan-3.beta.-ol, (25R)- |
C27H44O3 |
416.6 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN027263 |
hispidol B |
|
C30H52O4 |
476.7 g/mol |
CC(CC(C(C(C)(C)O)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN027322 |
Scillaren A_qt |
|
C36H52O13 |
692.79 |
|
|
TCMBANKIN027406 |
ganoderenic acid c |
|
C30H44O7 |
516.67 |
CC(CC(=O)C=C(C)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O)C(=O)O |
|
TCMBANKIN027473 |
kulinone |
|
C30H48O2 |
440.7 |
CC(CCC=C(C)C)C1C(CC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN027519 |
glut-5-en-3β-yl acetate |
|
|
468.84 |
|
|
TCMBANKIN027559 |
p-mentha-1,5-dien-8-ol |
p-Mentha-1, 5-dien-8-ol |
C10H16O |
152.23 g/mol |
CC1=CCC(C=C1)C(C)(C)O |
|
TCMBANKIN027616 |
pingbeisaponin_qt |
|
C39H62O13 |
738.9 |
|
|
TCMBANKIN027626 |
celosin D1_qt |
celosin C1_qt |
|
516.74 |
|
|
TCMBANKIN027682 |
Gypenoside XXV_qt |
|
C47H78O18 |
931.11 |
|
|
TCMBANKIN027708 |
poriferasterol monoglucoside_qt |
Stigmasterol-3-O-βD-glucopyranoside_qt; stigmasterol-3-O-β-D-glucopyranoside_qt |
C35H58O6 |
574.83 |
|
|
TCMBANKIN027739 |
(1R,2R,5R,6S)-2-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one |
(1R,2R,5R,6S)-2-[(8S,9S,10R,13S,14S,17R)-1-keto-10,13-dimethyl-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one |
|
468.69 |
|
|
TCMBANKIN027779 |
withanolide D |
withanolide d |
C28H38O6 |
470.6 |
CC1=C(C(=O)OC(C1)C(C)(C2CCC3C2(CCC4C3CC5C6(C4(C(=O)C=CC6O)C)O5)C)O)C |
|
TCMBANKIN027802 |
sendanolactone |
|
C30H42O4 |
466.65 |
CC(=CCCC1C2C(CC3(C2(CCC4C3=CC(=O)C5C4(CCC(=O)C5(C)C)C)C)C)OC1=O)C |
|
TCMBANKIN027819 |
paryriogenin B |
|
|
438.66 |
|
|
TCMBANKIN027995 |
cornutaside c_qt |
|
|
472.78 |
|
|
TCMBANKIN028079 |
ganoderal B |
|
C30H46O3 |
454.68 |
CC(CCC=C(C)C=O)C1CCC2(C1(CCC3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C |
|
TCMBANKIN028092 |
Korseverinine |
korseverinine |
C27H43NO2 |
413.64 |
CC1CCC2C(C3CCC4C(C3CN2C1)CC5=C4CC(C6C5(CCC(C6)O)C)O)C |
|
TCMBANKIN028106 |
(16S, 20R)-dihydroxydammar-24-en-3-one |
|
|
472.83 |
|
|
TCMBANKIN028166 |
tirucallane |
|
C30H54 |
414.7 g/mol |
CC(C)CCCC(C)C1CCC2(C1(CCC3C2CCC4C3(CCCC4(C)C)C)C)C |
|
TCMBANKIN028219 |
TNP00001 |
(1Z,6Z)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; NCGC00017159-01; (1Z,6Z)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione |
C21H20O6 |
368.38 |
COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O |
|
TCMBANKIN028493 |
stigmasterol-3-o-β-d-glucoside_qt |
|
|
398.74 |
|
|
TCMBANKIN028518 |
esculentoside L_qt |
esculentoside K_qt |
|
516.79 |
|
|
TCMBANKIN028617 |
Imperialine-β-N-oxide |
|
|
445.71 |
|
|
TCMBANKIN028634 |
arjunetin_qt |
2α,3β,19α-trihydroxyolean-12-en-28-oic acid |
|
488.78 |
|
|
TCMBANKIN028804 |
3beta-Hydroxy-24-methylene-8-lanostene-21-oic acid |
NSC 41969; (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methyleneheptanoic acid; (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylene-heptanoic acid; (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid; (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-isopropyl-hex-5-enoic acid; (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylidene-heptanoic acid |
C31H50O3 |
470.7 g/mol |
CC(C)C(=C)CCC(C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C)C(=O)O |
|
TCMBANKIN028878 |
Dioscoreside C_qt |
|
|
444.72 |
|
|
TCMBANKIN028887 |
Jujubogenin |
jujubogenin |
C30H48O4 |
472.7 |
CC(=CC1CC(C2C3CCC4C5(CCC(C(C5CCC4(C36CC2(O1)OC6)C)(C)C)O)C)(C)O)C |
|
TCMBANKIN028904 |
D-Friedoolean-14-en-3-one |
(4aR,6aR,6aS,8aR,12aR,14aR,14bR)-4,4,6a,6a,8a,11,11,14b-octamethyl-2,4a,5,6,8,9,10,12,12a,13,14,14a-dodecahydro-1H-picen-3-one; ZINC04104836 |
C30H48O |
424.7 |
CC1(CCC2(CC=C3C4(CCC5C(C(=O)CCC5(C4CCC3(C2C1)C)C)(C)C)C)C)C |
|
TCMBANKIN028933 |
celosin B_qt |
|
|
502.76 |
|
|
TCMBANKIN028948 |
3-o-beta-d-glucopyranosyl2alpha,3beta,12beta,20(S)-3hydroxy-dammarane24-ene20-o-beta-d-glucopyranoside_qt |
|
|
476.82 |
|
|
TCMBANKIN029045 |
Telocinobufagin |
telocinobufagin |
C24H34O5 |
402.5 g/mol |
CC12CCC(CC1(CCC3C2CCC4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O |
|
TCMBANKIN029101 |
cordiline |
Cevane-3,11-diol,8,9-didehydro-,(3R,5R,11 ,- 25R)- |
C27H43NO2 |
413.64 |
|
|
TCMBANKIN029162 |
18beta-glycyrrhetinic acid |
AJ-72559; Rhetinic Acid; C02283; GLYCYRRHETINIC ACID; 18-beta-Glycyrrhetinic acid; 1449-05-4; Glycyrrhetic acid; Hidermart; CHEMBL230006; SMR000058239; SR-01000721867-5; NCGC00142473-03; 18beta-Glycyrrhetinic acid, purum, >=97.0% (T); UNII-P540XA09DR; Enoxolone (Glycyrrhetin); 107420-91-7; Enoxolone, Glycyrrhetinic acid; CCRIS 3962; LMPR0106150014; 18beta-Glycyrrhetic acid; 4-10-00-03775 (Beilstein Handbook Reference); BB_NC-0599; HMS2233P23; LS-7417; (3?)-3-Hydroxy-11-oxoolean-12-en-30-oic acid; Opera_ID_1048; D0U8IF; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; NSC-35350; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo- (8CI); AC-1925; Glycyrrhetinic acid; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxidanyl-13-oxidanylidene-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; HY-N0180; Arthrodont; Hidermart (TN); DTXSID9020669; SR-01000721867-3; MLS002207101; Enoxolona; Glycyrrhetinic acid (JAN); A-Hydroxy-11-oxoolean-12-en-30-olic acid; SR-01000721867-6; Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-; (3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid; subglycyrrhelinic acid; SCHEMBL18540; 471-53-4; Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-; BG01168029; FT-0082445; BX-1; Glycyrrhetin; D00156; NCGC00017244-03; 202522-39-2; 18-beta-Glycyrrhetic acid; SR-01000721867-4; Enoxolonum [INN-Latin]; SBB006496; GM-1658; Q-201057; NSC-35347; NSC 35347; (5S,8S,15S,18S,1R,2R,10R,14R,20R)-18-hydroxy-1,2,5,8,15,19,19-heptamethyl-13-o xopentacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-8-carboxylic acid; alpha-Glycyrrhetinic acid; Tox21_112726; 130100-EP2295411A1; ZINC19203131; Biosone; D08LGJ; Bio-0549; Enoxolone; 18beta-Glycyrrhetinic acid; 3?-Hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid; Enoxolone (Glycyrrhetinic acid); 50510_FLUKA; BDBM50233538; Uralenic acid; NCGC00017244-04; P540XA09DR; 18beta-glycyrrhetic acid; C30H46O4; Jintan; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo-; CAS-471-53-4; Tox21_200799; SR-01000721867; Enoxolone (INN); MLS001146949; MLS000028748; [(125)I] RB129; G10105_ALDRICH; (3beta,20beta)-3-Hydroxy-11-oxo-olean-12-en-29-oic acid; s2296; CCG-208506; 8055-71-8; EINECS 207-444-6; (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid; Enoxolona [INN-Spanish]; GlycyrrhetinicAcid; 18b-Glycyrrhetic acid; AC1L1UIT; 130100-EP2269977A2; KS-1262; Glycyrrhetinate; Glycyrrhetinic acid [JAN]; (3alpha,5xi,8alpha,9xi,17alpha,18xi)-3-hydroxy-11-oxoolean-12-en-29-oic acid; BC201656; Enoloxone; Enoxolone [INN:BAN:DCF]; 18 beta-glycyrrhetinic acid; 3beta-Hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid; enoxolone; DSSTox_RID_75722; 18 beta-Glycyrrhetintic Acid; DSSTox_CID_669; 3-Glycyrrhetinic acid; 3beta-hydroxy-11-oxoolean-12-en-29-oic acid; NCGC00181115-01; Enoxolone; STX-352; AKOS016036757; 15301-63-0; G0149; MFCD00003706; ST24038257; Enoxolone, European Pharmacopoeia (EP) Reference Standard; ST056310; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-13-keto-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; AKOS015960428; 471G534; NCGC00258353-01; DB13089; Tox21_110804; CBW; DSSTox_GSID_20669; D0F6IV; MolPort-002-507-130; A827163; (3beta,5beta,14beta)-3-Hydroxy-11-Oxoolean-12-En-29-Oic Acid; 18beta-Glycyrrhetinic acid, 97%; CHEBI:30853; AC-8906; AN-14462; API0002854; BRN 2229654; Glyciram; 18beta-Glycyrrhetinic acid; MCULE-4676598997; 3beta-Hydroxy-11-oxoolean-12-en-30-oic acid; 3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid; BG00824432; Enoxolone [BAN:DCF:INN]; CS-W020624; S00284; Enoxolonum; 299198-00-8 |
C30H46O4 |
470.68 |
CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN029173 |
3β-hydroxy-11-oxo-olean-12-en-28-oic acid |
|
|
470.76 |
|
|
TCMBANKIN029220 |
(1R)-1-[(2S,4aR,4bS,6S,8R,8aS)-6-hydroxy-2,4b,8-trimethyl-8-methylol-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-2-yl]ethane-1,2-diol |
(1R)-1-[(2S,4aR,4bS,6S,8R,8aS)-6-hydroxy-8-(hydroxymethyl)-2,4b,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-2-yl]ethane-1,2-diol |
C20H34O4 |
338.48 |
|
|
TCMBANKIN029221 |
asiaticoside_qt |
|
|
488.78 |
|
|
TCMBANKIN029300 |
campesterol-3-O-β-D-glucopyranoside |
|
C34H58O6 |
562.82 |
|
|
TCMBANKIN029360 |
alisol A(B,C)monoacetate |
|
|
532.84 |
|
|
TCMBANKIN029445 |
(2S,2aS,2'R,4S,5'R,6aR,6bS,8aS,8bS,9S,11aR,12aS,12bR)-5',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-2,4-diol |
|
|
432.71 |
|
|
TCMBANKIN029592 |
ganoderic acid Ma |
Ganoderenic Acid A; ganoderic acid ma; BDBM50359036; FT-0082743; 907G622; CHEMBL1922171 |
C34H52O7 |
572.77 |
CC(CC(=O)C=C(C)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O |
|
TCMBANKIN029622 |
20-(R)-Ginsenoside-Rg2_qt |
|
C42H72O13 |
785.01 |
|
|
TCMBANKIN029659 |
Poststerone |
(2S,3R,5R,9R,10R,13R,14S,17S)-17-ethanoyl-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; poststerone; ZINC04081397; 10162-99-9; C08837; (2S,3R,5R,9R,10R,13R,14S,17S)-17-acetyl-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one |
C21H30O5 |
362.46 |
CC(=O)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O |
|
TCMBANKIN029678 |
Δ7,16,25,26-stigmastatrienol |
Δ7,22,25-triene-3-β-D-glucoside_qt |
|
410.75 |
|
|
TCMBANKIN029725 |
(1R,3S)-1-isopropyl-4-methylcyclohex-4-ene-1,3-diol |
(1R,3S)-4-methyl-1-propan-2-ylcyclohex-4-ene-1,3-diol; (1R,3S)-4-methyl-1-propan-2-yl-cyclohex-4-ene-1,3-diol; (1R,3S)-1-isopropyl-4-methyl-cyclohex-4-ene-1,3-diol |
|
170.28 |
|
|
TCMBANKIN029736 |
lanosta-8,24-dien-3-ol,3-acetate |
|
C32H52O2 |
468.75 |
|
|
TCMBANKIN029876 |
(4aS,6aR,6aS,6bR,8aR,10R,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
C30H48O3 |
456.7 |
|
|
TCMBANKIN029898 |
(1R,2S,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
|
472.78 |
|
|
TCMBANKIN029917 |
alisol,f |
|
|
528.85 |
|
|
TCMBANKIN029969 |
7beta-[3-ethyl-cis-crotonoyloxy]-5,6-dehydro-3,14-dehydro-Z-notonipetralactone |
|
|
370.58 |
|
|
TCMBANKIN029984 |
spirostanol |
|
|
400.71 |
|
|
TCMBANKIN029998 |
7beta-senecioyloxyoplopa-3(14)Z,8(10)-dien-2-one |
|
|
428.62 |
|
|
TCMBANKIN030082 |
(3R,20S)-3-acetoxy-20-hydroxydammar-24- ene |
|
|
486.86 |
|
|
TCMBANKIN030112 |
Triptonoterpene |
AC1NT19C; triptonoterpene; 8-hydroxy-1,1,4a-trimethyl-7-propan-2-yl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one |
C20H28O2 |
300.4 g/mol |
CC(C)C1=C(C2=C(C=C1)C3(CCC(=O)C(C3CC2)(C)C)C)O |
|
TCMBANKIN030252 |
3-O-[β-D-glucopyranosyl(1→2)-β-D-glucuronopyranosyl]-soyasapogenol B_qt |
3-O[β-D-glucopyranosyl(1→2)-β-D-glucuronopyranosyl]soyasapogenol B_qt |
C42H68O14 |
796.98 |
|
|
TCMBANKIN030253 |
epoxyganoderiol A |
|
C30H48O4 |
472.7 |
CC(CCC1C(O1)(C)CO)C2CCC3(C2(CCC4=C3C(CC5C4(CCC(=O)C5(C)C)C)O)C)C |
|
TCMBANKIN030336 |
Jujubasaponin V_qt |
|
|
472.78 |
|
|
TCMBANKIN030343 |
cucurbita-5,24-dienol |
|
|
440.83 |
|
|
TCMBANKIN030443 |
paryriogenin D |
|
|
468.74 |
|
|
TCMBANKIN030461 |
ncariasideA_qt |
|
|
456.73 |
|
|
TCMBANKIN030487 |
atratoglaucoside,a_qt |
|
|
360.49 |
|
|
TCMBANKIN030666 |
1,2-epoxyfurano-10(15)-germacren-6-one |
|
|
246.33 |
|
|
TCMBANKIN030726 |
abrisapogenol H |
|
C30H48O3 |
456.7 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5=O)(C)CO)C)C)C)C |
|
TCMBANKIN030871 |
12β,27-dihydroxysolasodine |
12β, 27-dihydroxy solasodine |
|
445.71 |
CC1C2C(CC3C2(C(CC4C3CC=C5C4(CCC(C5)O)C)O)C)OC16CCC(CN6)CO |
|
TCMBANKIN030873 |
12-oxomogroside IE1_qt |
11-oxomogroside IA1_qt; 11-oxomogroside ⅡA1_qt |
|
488.83 |
|
|
TCMBANKIN030896 |
Siraitic acid A |
siraiticacid a; siraitic acid a |
C29H44O5 |
472.66 |
CC1C(CCC2C13CCC4C2(CO3)C(=O)CC5(C4(CCC5C(C)CCC=C(C)C(=O)O)C)C)O |
|
TCMBANKIN030942 |
sophoraflavosideⅢ_qt |
sophoraflavoside II_qt |
C48H76O20 |
973.1 |
|
|
TCMBANKIN030998 |
esculentic acid |
AC1L4LQN; Olean-12-ene-28,29-dioic acid, 3,23-dihydroxy-, (3beta,4alpha,20beta)-; esculentoside O_qt; (2R,4aR,6aR,6aS,6bR,9R,10S,12aR,14bR)-10-hydroxy-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-2,4a-dicarboxylic acid; Esculentic acid (Phytolacca); 56283-68-2 |
C30H46O6 |
502.7 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1)C)C(=O)O)C(=O)O |
|
TCMBANKIN031036 |
cynanversicoside g_qt 2 |
|
|
344.49 |
|
|
TCMBANKIN031049 |
Alisol B monoacetate |
alisol b monoacetate; alisol B monoacetate |
C32H50O5 |
514.74 |
CC(CC(C1C(O1)(C)C)OC(=O)C)C2=C3CC(C4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)O |
|
TCMBANKIN031104 |
Lokundjoside_qt |
|
C29H44O10 |
552.65 |
|
|
TCMBANKIN031109 |
soyasapogenol A |
soyasapogenol a |
C30H50O4 |
474.72 |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(C1O)O)C)C)C)(C)CO)O)C)C |
|
TCMBANKIN031194 |
Ruvoside_qt |
|
C30H46O9 |
550.68 |
|
|
TCMBANKIN031196 |
Anemarrhenasaponin-I_qt |
|
|
434.73 |
|
|
TCMBANKIN031204 |
deacylbrownioside_qt |
|
|
430.69 |
|
|
TCMBANKIN031343 |
ardisiamamilloside C_qt |
|
C53H88O22 |
1077.25 |
|
|
TCMBANKIN031366 |
macrostemonoside e_qt |
|
|
416.71 |
|
|
TCMBANKIN031414 |
Peiminoside_qt |
|
|
431.73 |
|
|
TCMBANKIN031439 |
STOCK1N-70051 |
(3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carboxaldehyde; (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-17-(5-keto-2H-furan-3-yl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde; (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde |
C29H42O9 |
534.64 |
|
|
TCMBANKIN031532 |
(E,4S,6R)-4-hydroxy-2-methyl-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-2-enoic acid |
(E,4S,6R)-4-hydroxy-2-methyl-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-11,15-diketo-4,4,10,13,14-pentamethyl-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-2-enoic acid |
C30H44O8 |
532.67 |
|
|
TCMBANKIN031547 |
Anemoside B4_qt |
Anemoside A3_qt |
|
472.78 |
|
|
TCMBANKIN031569 |
NSC710352 |
(3S,8S,9R,10R,13R,14S,17R)-17-[(1R,4R)-4,5-dihydroxy-1,5-dimethyl-hexyl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one; NCI60_038830; (3S,8S,9R,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one; (3S,8S,9R,10R,13R,14S,17R)-17-[(1R,4R)-4,5-dihydroxy-1,5-dimethylhexyl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one; (24R)-11-Oxocucurbit-5-ene-3.beta.,24,25-triol; (3S,8S,9R,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methyl-heptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one |
C30H50O4 |
474.7 g/mol |
CC(CCC(C(C)(C)O)O)C1CCC2(C1(CC(=O)C3(C2CC=C4C3CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN031741 |
(4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetoxy-13-hydroxy-2,2,6b,9,12a,14a-hexamethyl-9-methylol-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid |
(4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetyloxy-13-hydroxy-9-(hydroxymethyl)-2,2,6b,9,12a,14a-hexamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid; (4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetoxy-13-hydroxy-9-(hydroxymethyl)-2,2,6b,9,12a,14a-hexamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid |
C32H48O8 |
560.72 |
|
|
TCMBANKIN031746 |
Daturameteloside F_qt |
|
|
504.68 |
|
|
TCMBANKIN031758 |
Gypenoside III_qt |
|
C54H92O23 |
1109.29 |
|
|
TCMBANKIN031836 |
Esculentoside L1_qt |
|
C48H76O20 |
973.1 |
|
|
TCMBANKIN031889 |
16β-hydroxyalisol B monoacetate |
|
C32H50O6 |
530.74 |
|
|
TCMBANKIN031908 |
Demissine_qt |
|
C50H83NO20 |
1018.19 |
|
|
TCMBANKIN031939 |
7,9(11)-dehydropachymic acid |
|
C33H50O5 |
526.75 |
|
|
TCMBANKIN031995 |
andrographolide-19-β-D-glucoside_qt |
|
|
350.5 |
|
|
TCMBANKIN032018 |
isofouquierone |
|
C30H50O3 |
458.72 |
CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(CCC4C(C)(CC=CC(C)(C)O)O)C)C)C |
|
TCMBANKIN032021 |
sessilifoliamide I |
|
C22H31NO6 |
405.5 g/mol |
CCC1C2C(C(C(=O)O2)C)C3(C14CCCCN(C4=O)C(C3)C5CC(C(=O)O5)C)O |
|
TCMBANKIN032043 |
stigmastenol |
|
C29H50O |
414.7 g/mol |
CC(C)C(CCC(C)C1CCC2C1(CCC3C2CCC4C3(CCCC4)C)C)C=CO |
|
TCMBANKIN032159 |
myrrhanones B |
|
|
472.78 |
|
|
TCMBANKIN032287 |
notoginsenoside R2_qt |
Notoginsenoside R6_qt |
C41H70O13 |
770.99 |
|
|
TCMBANKIN032288 |
2,3-isopropylidene cyasterone |
|
|
560.8 |
|
|
TCMBANKIN032314 |
jujuboside A_qt |
|
C58H94O26 |
1207.35 |
|
|
TCMBANKIN032316 |
acetic acid [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]-1-decalinyl] ester |
[(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]decalin-1-yl] acetate; acetic acid [(1R,3R,4R,4aS,8aS)-4-hydroxy-4-[2-(2-keto-5H-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-decalin-1-yl] ester; [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]-2,3,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] acetate; [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]-2,3,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] ethanoate |
|
378.56 |
|
|
TCMBANKIN032356 |
3β-hydroxy-12-oxo-13Hα-olean-28,19β-olide |
|
|
470.76 |
|
|
TCMBANKIN032573 |
melialactone |
|
|
474.8 |
CC(C)CC1CC(C(=O)O1)C2CCC3C2(CCC4C3(C(CC5C4(CCC(C5(C)C)O)C)O)C)C |
|
TCMBANKIN032584 |
(3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylenehexyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
(3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13R,14R,17R)-17-[(1R)-4-isopropyl-1-methyl-pent-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
C31H52O |
440.74 |
|
|
TCMBANKIN032662 |
(3S,8S,9S,10R,13R,14S,17R)-17-[(E,1R,4R)-1,4-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(E,2R,5R)-5-methylhept-3-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C29H48O |
412.69 |
|
|
TCMBANKIN032992 |
Methyl trametenolate |
methyl trametenolate |
C31H50O3 |
470.7 g/mol |
CC(=CCCC(C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C)C(=O)OC)C |
|
TCMBANKIN033049 |
hosenkosides C_qt |
|
|
492.82 |
|
|
TCMBANKIN033089 |
butyrospermol |
|
C30H50O |
426.72 |
CC(CCC=C(C)C)C1CCC2(C1(CCC3C2=CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN033135 |
ginsenoside- Re_qt |
gensenoside- Rd_qt |
C48H82O18 |
947.15 |
|
|
TCMBANKIN033177 |
ganoderic acid Mk |
|
C33H52O6 |
544.76 |
CC(C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)O)C(CC=C(C)C(=O)O)OC(=O)C |
|
TCMBANKIN033200 |
Lichesterol |
(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; C08823; 50657-31-3; Ergosta-5,8,22-trien-3-ol, (3beta,22E)- |
C28H44O |
396.65 |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3=C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN033216 |
mimengoside,g_qt |
|
|
472.78 |
|
|
TCMBANKIN033299 |
Ginsenoside-Rg3_qt |
20(R)-Ginsenoside Rg3_qt; ginsenoside- Rg3_qt; ginsenoside-Rg3_qt; Chikusetsusaponin Ia_qt; ginsenoside Rg3_qt; Ginsenoside Rg3_qt |
C42H72O13 |
785.01 |
|
|
TCMBANKIN033347 |
Tetrapanoside A_qt |
|
|
426.75 |
|
|
TCMBANKIN033377 |
stigmastadienone |
|
C29H46O |
410.67 |
|
|
TCMBANKIN033403 |
(3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-prop-1-en-2-yloxan-2-one |
(3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-prop-1-en-2-yl-oxan-2-one; (3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-isopropenyl-2-tetrahydropyranone; (3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-isopropenyl-tetrahydropyran-2-one; (3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-3-keto-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-isopropenyl-tetrahydropyran-2-one |
|
468.74 |
|
|
TCMBANKIN033466 |
zizyphus saponin I_qt |
Zizyphus saponin III_qt; Zizyphus saponin II_qt |
|
472.78 |
|
|
TCMBANKIN033483 |
Datuarmeteline C |
|
|
520.73 |
|
|
TCMBANKIN033707 |
methyl 6- O-digalloyl-β-glucopyranoside |
|
|
498.43 |
|
|
TCMBANKIN033709 |
ilexoside ii_qt |
|
|
472.78 |
|
|
TCMBANKIN033716 |
Datuarmeteline E |
Datuarmeteline D |
|
490.7 |
|
|
TCMBANKIN033723 |
Deoxyandrographolide |
4-[2-[(4aS,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl]-2H-furan-5-one; BG01310040; AC-20219; DTXSID60616868; 79233-15-1; ANDROGRAPHOLIDE, DEOXY-; deoxyandrographolide; ZINC21992845; 9342AF; MolPort-005-938-522; AKOS015965180; 3-{2-[(4aS,5R,6R,8aR)-6-Hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5H)-one; 3-{2-[(4AS,5R,6R,8AR)-6-HYDROXY-5-(HYDROXYMETHYL)-2,5,8A-TRIMETHYL-3,4,4A,6,7,8-HEXAHYDRONAPHTHALEN-1-YL]ETHYL}-5H-FURAN-2-ONE; AN-36619; CS-3655; AK546859; HY-N0857; 14-deoxyandrographolide(14-DAP) |
C20H30O4 |
334.45 |
CC1=C(C2(CCC(C(C2CC1)(C)CO)O)C)CCC3=CCOC3=O |
|
TCMBANKIN033730 |
(1R,2R,4aS,6aS,6aR,6bR,8aR,12aR,14bS)-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,6a,7,8,8a,13,14b-decahydro-2H-picene-4a-carboxylic acid |
(1R,2R,4aS,6aS,6aR,6bR,8aR,12aR,14bS)-1,11-dihydroxy-10-keto-1,2,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,13,14b-decahydro-2H-picene-4a-carboxylic acid |
|
484.74 |
|
|
TCMBANKIN033773 |
celosin A_qt |
|
|
486.76 |
|
|
TCMBANKIN033879 |
panaxatriol |
(3beta,6alpha,12beta,20R)-20,25-Epoxydammarane-3,6,12-triol; Panaxatriol; UPCMLD-DP046:002; SR-05000002178-2; 32791-84-7; (20S)-Panaxatriol; NSC 308880; SR-05000002178; NCGC00161615-01; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyltetrahydropyran-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; AIDS031251; MolPort-039-338-080; Dammarane-3,6,12-triol, 20,25-epoxy-, (3.beta.,6.beta.,12.beta.,20R)-; CCG-208596; AIDS-031251; UPCMLD-DP046:001; Ambotz32791-84-7; ZINC17654227; UPCMLD-DP046; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyl-2-tetrahydropyranyl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; CHEMBL1357750 |
C30H52O4 |
476.73 |
CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)O)C)C |
|
TCMBANKIN033882 |
(22S)-sipirost-5-ene-1beta,3beta,16beta,22-tetrol-1-o-alpha-l-rhamnopyranosyl-16-o-beta-d-glucopyranoside_qt |
|
|
434.73 |
|
|
TCMBANKIN033935 |
Malonylginsenoside Rd_qt |
Malonylginsenoside Rd_qt1 |
|
460.82 |
|
|
TCMBANKIN033957 |
saikosaponin c_qt |
|
C48H78O17 |
927.12 |
|
|
TCMBANKIN034030 |
paryriogenin G |
|
|
468.74 |
|
|
TCMBANKIN034087 |
quercetin-3-O-β-D-galactoside |
|
|
464.41 |
|
|
TCMBANKIN034097 |
20(S)-Ginsenoside-Rh1_qt |
20(R)-ginsenoside Rg2_qt; 20-(R)-Ginsenoside-Rg2_qt |
C42H72O13 |
785.01 |
|
|
TCMBANKIN034242 |
(E,5S,6S)-5-acetoxy-6-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid |
(E,5S,6S)-5-acetyloxy-6-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (E,5S,6S)-5-acetoxy-6-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (E,5S,6S)-5-acetyloxy-6-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid |
C30H44O3 |
452.67 |
|
|
TCMBANKIN034317 |
(3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-15,16-dione |
(3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-15,16-quinone |
C22H30O4 |
358.47 |
|
|
TCMBANKIN034320 |
sessilistemonamine C |
|
|
391.56 |
|
|
TCMBANKIN034334 |
clinopodiside A |
|
C48H78O19 |
959.12 |
CC1(CCC2(C(CC3(C(=C2C1)C=CC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)O)O)C)C)C)O)CO)C |
|
TCMBANKIN034338 |
Ineketone |
(4aS,4bS,5S,7S,10aR)-5,10a-dihydroxy-1,1,4b,7-tetramethyl-7-vinyl-3,4,4a,5,6,10-hexahydro-2H-phenanthren-9-one; CHEBI:5920; ineketone; (4aS,4bS,5S,7S,10aR)-7-ethenyl-5,10a-dihydroxy-1,1,4b,7-tetramethyl-3,4,4a,5,6,10-hexahydro-2H-phenanthren-9-one; 62574-18-9; AC1L4MU4; C09110 |
C20H30O3 |
318.45 |
CC1(CCCC2C1(CC(=O)C3=CC(CC(C23C)O)(C)C=C)O)C |
|
TCMBANKIN034420 |
ergosta-7,22-dien-3β,5α,6α-triol |
|
|
430.74 |
|
|
TCMBANKIN034427 |
asiaticoside-b_qt |
|
|
504.78 |
|
|
TCMBANKIN034428 |
ginsenoside-Rg4_qt |
|
C42H70O12 |
767 |
|
|
TCMBANKIN034437 |
dehydrouvaol |
|
|
440.78 |
|
|
TCMBANKIN034449 |
Markogenin-3-O-beta-D-glucopyranosyl-(1-2)-beta-D-galactopyranoside_qt |
|
|
432.71 |
|
|
TCMBANKIN034577 |
kaikasaponinI_qt |
|
|
442.8 |
|
|
TCMBANKIN034592 |
Gypenoside VIII_qt |
|
C48H82O18 |
947.15 |
|
|
TCMBANKIN034597 |
lanosta-7,9(11),24-trien-3α-acetoxy-15α-hy-droxy-23-oxo-26-oicacid |
lanosta-7,9(11),24-trien-3α-acetoxy-15α-hydroxy-23-oxo-26-oic acid |
C32H46O6 |
526.78 |
|
|
TCMBANKIN034606 |
ilekudinoside J_qt |
Ilekudinoside I_qt |
|
486.76 |
|
|
TCMBANKIN034639 |
Anemarsaponin C_qt |
|
|
416.71 |
|
|
TCMBANKIN034652 |
mansumbinoic acid |
|
C22H34O2 |
330.5 |
|
|
TCMBANKIN034662 |
Cauloside A_qt |
|
|
444.72 |
|
|
TCMBANKIN034702 |
Pseudo-ginsenoside F11_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN034719 |
Abrisaponin 1_qt |
|
|
486.76 |
|
|
TCMBANKIN034781 |
Daturameteloside H_qt |
|
|
490.7 |
|
|
TCMBANKIN034868 |
kaikasaponin III_qt |
kaikasaponinIII_qt |
C48H78O17 |
927.12 |
|
|
TCMBANKIN034976 |
Oleanic acid |
oleanolic acid; oleanoic,acid; oleanic acid |
C30H48O3 |
456.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN035031 |
majoroside F4_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN035064 |
olibanumol,c |
|
C10H18O2 |
170.25 |
|
|
TCMBANKIN035135 |
Arnicolide D |
|
C19H24O5 |
332.39 |
CC1CC2C(C(C(=O)O2)C)C(C3(C1C=CC3=O)C)OC(=O)C(=C)C |
|
TCMBANKIN035138 |
Senkyunolide-P |
|
C24H30O4 |
382.49 |
CCCCC1C23CCC(C=C2C(=O)O1)C4C3C5=C(CC4)C(=CCCC)OC5=O |
|
TCMBANKIN035158 |
esculentoside Q_qt |
|
|
518.76 |
|
|
TCMBANKIN035212 |
11-oxomogroside ⅡE_qt |
|
|
488.83 |
|
|
TCMBANKIN035229 |
C10822 |
126-17-0; BSPBio_000725; NSC178260; Prestwick3_000663; BPBio1_000799; STOCK1N-18148 |
C27H43NO2 |
413.64 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)NC1 |
|
TCMBANKIN035267 |
toosendanone A |
|
C30H48O4 |
472.7 g/mol |
CC1(C2CC=C3C(C2(CCC1=O)C)CCC4(C3(CC(C4C5CCC(C5O)C(C)(C)O)O)C)C)C |
|
TCMBANKIN035306 |
furostanol |
|
C27H46O2 |
402.7 g/mol |
CC1C(OC2C1C3(CCC4C(C3C2)CCC5C4(CCCC5)C)C)CCC(C)CO |
|
TCMBANKIN035514 |
achybidensaponin,ii_qt |
|
|
456.78 |
|
|
TCMBANKIN035535 |
(6R)-6-[(1R)-2-hydroxy-1-[(8S,9S,10R,13S,14S,17R)-1-keto-10,13-dimethyl-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]ethyl]-4-methyl-3-methylol-5,6-dihydropyran-2-one |
(6R)-6-[(1R)-1-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one; (6R)-6-[(1R)-1-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-hydroxy-ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one |
|
454.66 |
|
|
TCMBANKIN035624 |
lanost-8-enol |
|
|
428.82 |
|
|
TCMBANKIN035743 |
Gypenoside XXXII_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN035745 |
DOG |
3-beta,12,14-Trioxy-carden-(20:22)-olid [German]; Lanadigenin; delta-sup(20:22)-3-beta,12-beta,14,21-Tetrahydroxynorcholenic acid lactone; ZINC03982471; ST056392; HSDB 7108; 3-beta,12,14-Trioxy-digen-(20:22)-olid [German]; SPBio_002885; Prestwick2_000883; Prestwick1_000883; Prestwick3_000883; 5-beta-CARD-20(22)-ENOLIDE, 3-beta,12-beta,14-TRIHYDROXY-; 1672-46-4; BPBio1_000734; Cardogenen-(20:22)-triol-(3-beta,12,14) [German]; 5-18-04-00380 (Beilstein Handbook Reference); Prestwick0_000883; 3beta,12beta,14-trihydroxy-5beta-card-20(22)-enolide; 3-beta,12-beta,14-Trihydroxy-card-20(22)-enolide; BSPBio_000666; Card-20(22)-enolide, 3,12,14-trihydroxy-, (3-beta,5-beta,12-beta)- (9CI); Digoxigenine; (3beta,5beta,12beta)-3,12,14-Trihydroxycard-20(22)-enolide; BRN 0096479; EINECS 216-806-2; 4-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-(3,12,14-TRIHYDROXY-10,13-DIMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-17-YL)-5H-FURAN-2-ONE; CHEBI:42098 |
C23H34O5 |
390.51 |
CC12CCC(CC1CCC3C2CC(C4(C3(CCC4C5=CC(=O)OC5)O)C)O)O |
|
TCMBANKIN035921 |
Triptodihydroxy acid methyl ester |
methyl 10-hydroxy-2-(hydroxymethyl)-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-2-carboxylate; AC1NT191; triptodihydroxy acid methyl ester |
C31H50O4 |
486.81 |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5)(CO)C(=O)OC)C)C)C)C |
|
TCMBANKIN035983 |
3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S)-spirost-5(6)-en-3beta,14alpho-diol_qt |
|
|
430.69 |
|
|
TCMBANKIN036008 |
ardisianoside K_qt |
|
C53H86O22 |
1075.24 |
|
|
TCMBANKIN036054 |
siaresinolic acid |
siaresinolicacid |
C30H48O4 |
472.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1O)C)C(=O)O)C |
|
TCMBANKIN036135 |
alisol,b,23-acetate |
|
C32H50O5 |
514.74 |
|
|
TCMBANKIN036197 |
sessilistemonamine B |
|
|
391.56 |
|
|
TCMBANKIN036245 |
esculentoside C_qt |
esculentoside D2_qt |
|
532.79 |
|
|
TCMBANKIN036360 |
K-STROPHANTHOSIDE_qt |
|
C42H64O19 |
872.95 |
|
|
TCMBANKIN036458 |
ginsenoside Rh4_qt |
|
C36H60O8 |
620.86 |
|
|
TCMBANKIN036495 |
phellochin |
|
C31H52O4 |
488.74 |
CC(CC(C(C(C)(C)OC)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C |
|
TCMBANKIN036591 |
Withametelin G |
|
C28H38O7 |
486.6 |
|
|
TCMBANKIN036602 |
clerodendrin D |
|
C29H42O10 |
550.64 |
CCC(C)C(=O)OC1C(CC2C(C(CC(C2(C13CO3)COC(=O)C)OC(=O)C)C)(C)C4CC5C=COC5O4)O |
|
TCMBANKIN036622 |
(1S,4aS,10aR)-7-isopropyl-1,4a-dimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid |
(1S,4aS,10aR)-7-isopropyl-5,8-diketo-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid; (1S,4aS,10aR)-1,4a-dimethyl-5,8-dioxo-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid |
|
330.46 |
|
|
TCMBANKIN036640 |
α-amirone |
|
|
422.81 |
|
|
TCMBANKIN036682 |
ZINC01280365 |
(8S,9S,10R,13S,14R,17S)-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-glycoloyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-(2-hydroxyethanoyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C21H30O3 |
330.46 |
|
|
TCMBANKIN036696 |
Soyasaponin A3_qt |
Soyasaponin A2_qt |
C53H86O24 |
1107.24 |
|
|
TCMBANKIN036717 |
Kudinoside J_qt |
Kudinoside D_qt; Kudinoside E_qt |
|
454.81 |
|
|
TCMBANKIN036721 |
Kanziol |
|
|
440.83 |
|
|
TCMBANKIN036800 |
erythrodiol |
AKOS032948355; (3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol; Olean-12-ene-3beta,28-diol; erythro-diol; (3beta)-Olean-12-ene-3,28-diol; erythrodiol ; (4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol; A830234; 545-48-2; EINECS 208-890-4; Erythrodiol; (3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-methylol-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol; 09258_FLUKA |
C30H50O2 |
443 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])O[H])C([H])([H])C3([H])[H])[C@
@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H] |
|
TCMBANKIN036818 |
Asiatic acid |
NSC 166063; asiaticacid; Urs-12en-28-oic acid, 2,3,23-trihydroxy-, (2alpha, 3beta, 4alpha)-; Urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-; (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,12a-hexamethyl-9-methylol-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; 464-92-6; C08617; Asiatic acid; Ambotz464-92-6; (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |
|
488.7 |
|
|
TCMBANKIN036829 |
ursolic acid |
ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 |
C30H48O3 |
456.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
|
TCMBANKIN036867 |
glycyrrhetinic acid |
beta-Glycyrrhetic acid; glycyrrhetinicacid; 3-hydroxy-11-oxoolean-12-en-29-oate; (2S,4aS,6aS,6bR,10S,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; LT00233150; Glycyrrhetic acid; Glycyrrhetinic; 3b-hydroxy-11-oxo-Olean-12-en-30-oic acid; 3-hydroxy-11-oxoolean-12-en-29-oic acid (ACD/Name 4.0); 18b-Glycyrrhetic acid; Glycyrrhetin; Glycyrrhetinate; 3b-Hydroxy-11-oxoolean-12-en-30-oic acid; 18b-Glycyrrhtinic acid; Biosone; 3b-Hydroxy-11-oxoolean-12-en-30-oate; 3-Glycyrrhetinic acid; SCHEMBL13144257; 18b-Glycyrrhetinic acid; NCGC00186652-01; 3b-hydroxy-11-oxo-Olean-12-en-30-oate; b-glycyrrhetic acid; (2S,4AS,6AS,6BR,10S,12AS)-10-HYDROXY-2,4A,6A,6B,9,9,12A-HEPTAMETHYL-13-OXO-3,4,5,6,7,8,8A,10,11,12,12B,14B-DODECAHYDRO-1H-PICENE-2-CARBOXYLIC ACID; a-glycyrrhetinic acid |
C30H46O4 |
470.68 |
CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN036887 |
poricoic acid A |
AIDS113410; NSC715080; AIDS-113410; poricoicacid a; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-5-isopropyl-hex-5-enoic acid; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methyl-5-methylene-heptanoic acid; (R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-Carboxy-ethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-2,3,3a,4,6,7,8,9b-octahydro-1H-benz[e]inden-3-yl]-6-methyl-5-methylene-heptanoic acid; poricoic acid a; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methyl-5-methylidene-heptanoic acid; NCI60_039753; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid; 16.alpha.-Hydroxy-3,4-seco-24-methyllanosta-4(28),7,9(11),24(24(sup 1))-tetraene-3,21-dioic acid; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methyl-5-methyleneheptanoic acid |
C31H46O5 |
499 |
C(=C([H])[H])(C([H])([H])[H])[C@]1([H])C([H])([H])C([H])=C2C(=C([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C(O[H])=O)C([H])([H])C([H])([H])C(=C([H])[H])C([H])(C([H])([H])[H])C([H])([H])[
H])[C@]([H])(O[H])C3([H])[H])[C@]23C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C([H])([H])C(O[H])=O |
|
TCMBANKIN036898 |
cucurbitacin B |
Cucurbitacine (B); acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; LMST01010104; NSC144154; 19-nor-9.beta.,10.alpha.-Lanosta-5,23-diene-3,11,22-trione, 9-methyl-2.beta.,16.alpha.,20,25-tetrahydroxy-, 25-acetate; C08794; NSC49451; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; Datisca principle B; [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; Cucurbitacin B; Datiscn Principle B; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, [2.beta.,.gamma.,.beta.,10.alpha.,16.alpha.]-; NCI60_004184; 6199-67-3 |
C38H50O8 |
635 |
[C@@]1([H])(O[H])C([H])([H])[C@]2([H])C(=C([H])C([H])([H])[C@@]3([H])[C@@]2(C([H])([H])[H])C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@](O[H])(C(=O)\C([H])=C([H])\C(Oc4c([H])c([H])c([H])c([H])
c4C(C([H])([H])[H])=O)(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])[C@]([H])(O[H])C5([H])[H])[C@]35C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN036961 |
arnidiol |
AC1NSZ7F; arnidiol ; (3S,6aR,6aR,8aR,14bR)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-hexadecahydropicene-3,13-diol |
C30H50O2 |
442.72 |
CC1C2C3CCC4C5(CCC(C(C5CCC4(C3(CC(C2(CCC1=C)C)O)C)C)(C)C)O)C |
|
TCMBANKIN037067 |
β-Cedrene |
beta-cedrene; DYLPEFGBWGEFBB-OSFYFWSMSA-N; CTK8F1427; A-Cedrene; (+)-; (+)-?-CEDRENE; 6QL7ERD5Q1; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, (3R,3aS,7S,8aS)-; AKOS015896901; 546-28-1; KB-62482; (+)-beta-Funebrene; (+)-beta-Cedrene, >=95.0% (sum of enantiomers, GC); 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, [3R-(3.alpha.,3a.beta.,7.beta.,8a.alpha.)]-; UNII-6QL7ERD5Q1; (3R-(3alpha,3Abeta,7beta,8aalpha))-octahydro-3,8,8-trimethyl-6-methylene-1H-3a,7-methanoazulene; 1H-3a,7-Methanoazulene,octahydro-3,8,8-trimethyl-6-methylene-,(3R,3aS,7S,8aS)-; (+)-beta-Cedrene; ZINC59778864; (+)-.beta.-Cedrene; (3R,3aS,7S,8aS)-3,8,8-Trimethyl-6-methyleneoctahydro-1H-3a,7-methanoazulene; .beta.-Cedrene; EINECS 208-898-8; (1S,2R,5S)-8-Methylene-2,6,6-trimethyltricyclo[5.3.1.01.5]undecane; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, (3R-(3alpha,3abeta,7beta,8aalpha))-; beta-Cedrene |
|
204.35 |
|
|
TCMBANKIN037156 |
lilagenin |
|
C27H42O4 |
430.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CC(C(C6)O)O)C)C)C)OC1 |
|
TCMBANKIN037266 |
Karounidiol |
D:C-Friedo-oleana-7,9(11)-diene-3 alpha,29-diol]; (3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-4,4,6a,6b,8a,11,14b-heptamethyl-11-methylol-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-ol; (3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-ol; NCI60_037647; karounidiol; CCRIS 7117; 26-Noroleana-7,9(11)-diene-3,29-diol, 13-methyl-,(3alpha,13alpha,14beta,20alpha)-; 3-epi-Karounidiol; NSC705536; D:C-Friedooleana-7,9(11)-diene-3.alpha.,29-diol |
C30H48O2 |
440.7 |
CC1(C(CCC2(C1CC=C3C2=CCC4(C3(CCC5(C4CC(CC5)(C)CO)C)C)C)C)O)C |
|
TCMBANKIN037277 |
Oleanolic acid |
Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid |
C30H48O3 |
457 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C(
[H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN037484 |
Ganoderenic acid D |
ganoderenic acid D |
|
512.63 |
|
|
TCMBANKIN037539 |
Yuccagenin |
511-97-7; Yuccagenin; Spirost-5-ene-2,3-diol, (2alpha,3beta,25R)- |
|
430.62 |
|
|
TCMBANKIN037649 |
methyl ganoderate B |
|
C31H46O7 |
531 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C(=O)C([H])([H])[C@]([H])(C(OC([H])([H])[H])=O)C([H])([H])[H])C([H])([
H])C2=O)[C@@]23C([H])([H])[H])=C3[C@@]([H])(O[H])C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN037674 |
Momordic acid |
momordicacid |
|
470.68 |
|
|
TCMBANKIN037685 |
Lucialdehyde B |
480439-84-7; CHEBI:66593; ZINC38562918; CHEMBL463372; lucialdehyde b; (24E)-3,7-dioxolanosta-8,24-dien-26-al; lucialdehyde B |
C30H44O3 |
453 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(\C([H])=O)/C([H])([H])[H])C([H])([H])C2([H]
)[H])[C@@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN037739 |
Helioscopinolide A |
helioscopinolide a |
|
316.4 g/mol |
|
|
TCMBANKIN037761 |
Betulonic acid |
Lup-20(29)-en-28-oic acid, 3-oxo-; betulonicacid; 3-Deoxy-3-oxo-betulinic acid; 4481-62-3; betulonic acid; (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-1-Isopropenyl-5a,5b,8,8,11a-pentamethyl-9-oxo-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid; AIDS-051817; AIDS051817; 3-Oxolup-20(29)-en-28-oic acid |
C30H46O3 |
454.68 |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C(=O)O |
|
TCMBANKIN037811 |
15α-hydroxymansumbinone |
|
|
328.59 |
CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(C(C=C4)O)C)C)C |
|
TCMBANKIN037814 |
(20S,22R,24R)-16,22-epoxy-3beta,14alpha,23beta,25-tetrahydroxyergost-7-en-6-one |
|
C28H44O6 |
477 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@@]([C@@]([H])([C@]([H])(C([H])([H])[H])[C@]([H])([C@@]([H])(O[H])[C@@]([H])(C([H])([H])[H])C(O[H])(C([H])([H])[H])C([H])
([H])[H])O2)[C@]2([H])C3([H])[H])(C([H])([H])[H])[C@@]34O[H])C4=C([H])C5=O)[C@@]5([H])C([H])([H])[C@@]1([H])O[H] |
|
TCMBANKIN037884 |
Pulsatillic acid |
pulsatillicacid; pulsatillic acid; SCHEMBL14554424 |
C30H46O4 |
470.7 g/mol |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)CO)C)C(=O)O |
|
TCMBANKIN037960 |
Wallichilide |
|
|
412.52 |
|
|
TCMBANKIN037993 |
Lucidenic acid B |
lucidenicacid b |
|
474.59 |
|
|
TCMBANKIN038018 |
Phytolaccagenic acid |
phytolaccagenicacid |
|
516.7 g/mol |
|
|
TCMBANKIN038117 |
Methyl lucidenate E2 |
methyl lucidenate e2; NSC726131; NSC-726131 |
|
530.6 g/mol |
|
|
TCMBANKIN038251 |
18alpha-Hydroglycyrrhetic acid |
AC1NSWEK; 18alpha-hydroglycyrrhetic acid; (2R,4aS,6bR,12aS)-2,10,14b-trihydroxy-4a,6a,6b,9,9,12a-hexamethyl-13-oxo-1,3,4,5,6,6a,7,8,8a,10,11,12-dodecahydropicene-2-carboxylic acid |
|
488.73 |
|
|
TCMBANKIN038293 |
progesterone |
Cyclogesterin; Luteovis; Progeffik; (8S,9S,10R,13S,14S,17S)-17-ethanoyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Gesterol 50; Corlutin; Syngestrets; NCGC00090798-02; D4-Pregnene-3,20-dione; Hormoluton; Pranone; Crinone progesterone gel; Gesterol 100; Prometrium; Proluton; Luteodyn; Prestwick0_000477; Progestasert; SPBio_002553; .delta.4-Pregnene-3,20-dione; Pregnenedione; NSC-9704; P3972_SIGMA; Methylpregnone; 4-Pregnene-3,20-dione; Prolutone; U 3672; Lutocylin; Colprosterone; Utrogest; Lutocylol; CHEBI:17026; SMR000058345; Corporin; Lipolutin; NCGC00090798-01; P8783_SIGMA; Synovex S; ACon1_002078; 3,20-Pregnene-4; Prestwick_411; Progesterone, water-soluble; Cyclogest; progesterone ; Luteal hormone; Prolets; AIDS070516; NCI60_042166; (S)-Pregn-4-en-3,20-dione; 6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione; Prolidon; NSC 64377; (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Nalutron; Progesterone [BAN:INN:JAN]; Progesteronum [INN-Latin]; STR; Flavolutan; Percutacrine Luteinique; Prontogest; Lutocyclin M; Akrolutin; Lugesteron; Corlutina; SCHEMBL12237373; ZINC03814383; Gynlutin; Gynoluton; Prestwick3_000477; Lutogyl; Progesterone: 2-hydroxypropyl-beta-cyclodextrin complex; Crinone (TN); Gynolutone; Spectrum5_002053; Gesterol; AIDS-070516; Progestronol; Luteopur; Corpus luteum hormone; Lutoform; Luteol; 6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione; 17alpha-Progesterone; STOCK1N-52522; Progesterona [INN-Spanish]; Hormoflaveine; Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-; Progesterone [Progestins]; Delta(4)-pregnene-3,20-dione; Progesterone: HBC complex; Delta4-Pregnene-3,20-dione; .beta.-Progesterone; Piaponon; Progestrel; Primolut; Gestone; Pregnene-3,20-dione; Syntolutan; NSC64377; MEGxm0_000472; Progesteron; Gelbkoerperhormon; Membrettes; Progestogel; Gestron; EU-0100895; MLS000028517; Prolutin; EINECS 200-350-6; Luteinique; 57-83-0; Progestron; P9776_SIGMA; NCGC00179853-01; Luteol (VAN); Utrogestan; Lutidon; Progesterol; Luteosan; Gestormone; Gestiron; Progesterone; Lutocuclin M; D00066; Endometrin; Lutin; Progestol; Fologenon; C00410; BG01605063; Lucorteum; 8023-13-0; AI3-51682; 8012-32-6; Luteogan; Agolutin; Progesterone (JP15/USP/INN); 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione; MLS000758277; Crinone; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; Luteohormone; S00293; BPBio1_000676; 17.alpha.-Progesterone; Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-; CMC_13406; NSC 9704; NCGC00022185-06; Luteocrin normale; Progestosol; Protormone; (S)-4-Pregnene-3,20-dione; P6149_SIGMA; Luteine; Lutren; P7556_ALDRICH; 257630-50-5; COL-1620; MolPort-001-740-063; SBB012538; delta(sup4)-Pregnene-3,20-dione; NSC9704; component of Cyclogesterin; Syngesterone; FE-999913; Bio-luton; Prestwick1_000477; NCGC00022185-07; nchembio.2007.53-comp14; Pregn-4-ene-3,20-dione; (1S,3BS,9AR,11AS)-1-ACETYL-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-ONE; 753497-20-0; CCRIS 533; Vitarrine; delta(sup 4)-Pregnene-3,20-dione; Progestone; Luteum; Lipo-Lutin; Progestin; Lutociclina; Progesteronum; WLN: L E5 B666 OV MUTJ A1 E1 FV1; Progekan; .delta.(sup4)-Pregnene-3,20-dione; 46665_RIEDEL; AKOS030503393; Projestaject; Lingusorbs; Lucorteum Sol; Lopac0_000895; Lutex; P0130_SIGMA; Prochieve; Corluvite; BSPBio_000614; BRD-A51738545-001-01-0; Prestwick2_000477; Luteostab; Progesterone; 4-Pregnene-3,20-dione; Lutocyclin; Glanducorpin; Prometrium (TN); HSDB 3389; Lutromone; (S)-Progesterone |
C21H30O2 |
314.46 |
CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
|
TCMBANKIN038393 |
vitetrifolin d |
|
C24H38O5 |
406.6 g/mol |
CC1C(C(C2=C(C1(C)CCC(C)(C=C)O)CCCC2(C)C)OC(=O)C)OC(=O)C |
|
TCMBANKIN038477 |
Coflodiol |
Olean-13(18)-ene-3,16-diol, (3b,16b)-; (3S,4aR,6aR,6bS,8S,8aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-3,8-diol; AIDS-224771; AIDS224771; coflodiol ; coflodiol |
C30H50O2 |
442.72 |
CC1(CCC2(C(CC3(C(=C2C1)CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C)O)C)C |
|
TCMBANKIN038555 |
Triptonoterpene methyl ether |
AC1NT19F; triptonoterpene methyl ether; 5-hydroxy-8-methoxy-1,1,4a-trimethyl-7-propan-2-yl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one |
C21H30O3 |
330.5 g/mol |
CC(C)C1=CC(=C2C(=C1OC)CCC3C2(CCC(=O)C3(C)C)C)O |
|
TCMBANKIN038707 |
alpha-amyrin |
α-Amyrin; C08615; Urs-12-en-3-ol; Urs-12-en-3-ol, (3beta)- (9CI); alpha-Amyrine; Urs-12-en-3.beta.-ol; ST5411384; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-eicosahydro-picen-3-ol; (3.beta.)-Urs-12-en-3-ol; 3-epi-α-amyrin; A834570; Urs-12-en-3-ol #; FSLPMRQHCOLESF-UHFFFAOYSA-N; EINECS 211-352-1; MCULE-7089035597; 12-ursen-3beta-ol; .alpha.-Amyrine; α-amyrin; NSC-114787; alpha-Amyrin; AC1L5E7U; Urs-12-en-3beta-ol; alpha-Amyrenol; Viminalol; 638-95-9; AIDS-070313; Epi-alpha-amyrin; 53017_FLUKA; AIDS070313; AC1Q7B25; .alpha.-Amyrin; 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; NSC 114787; NSC114787; alpha-amyrin ; Urs-12-en-3-ol, (3.beta.)-; .alpha.-Amyrenol; LMPR01060011; α- amyrin; SMP2_000308 |
C30H50O |
426.72 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
|
TCMBANKIN038726 |
Niloticin |
CHEMBL460656 |
|
456.7 |
|
|
TCMBANKIN038727 |
melianone |
|
C30H46O4 |
471 |
C([H])([H])([H])C1(C([H])([H])[H])C(=O)C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]2([H])[C@@]4([H]
)[C@]([H])(O[H])O[C@@]([H])([C@@]5([H])OC5(C([H])([H])[H])C([H])([H])[H])C4([H])[H])C3=C([H])C6([H])[H])[C@]16[H] |
|
TCMBANKIN038834 |
Ganoderic acid N |
|
|
512.72 |
|
|
TCMBANKIN039029 |
Ganoderic acid epsilon |
|
C30H44O7 |
517 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(O[H])\C([H])=C(\C(O[H])=O)/C([H])([H])[H])C([H])([H])C2=O)[C
@@]23C([H])([H])[H])=C3[C@@]([H])(O[H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN039034 |
methyl betulinate |
NSC-152532; 2259-06-5; methyl 9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate; NSC 152532; EINECS 218-857-6; Methyl betulinate; Lup-20(29)-en-28-oic acid, 3-hydroxy-, methyl ester, (3beta)-; Methyl 3-hydroxylup-20(29)-en-28-oate #; AIDS014854; AIDS-014854; Lup-20(29)-en-28-oic acid, methyl ester; Methyl betulate; Lup-20(29)-en-28-oic acid, 3-hydroxy-, methyl ester, (3.beta.)-; methylbetulinate; Lup-20(29)-en-28-oic acid, methyl ester, (3.beta.)-; XNZIMRUZBOZIBC-UHFFFAOYSA-N; Lup-20(29)-en-28-oic acid, 3.beta.-hydroxy-, methyl ester; NSC152532; 28-O-Methylbetulinic Acid; AC1L9NI6 |
C31H50O3 |
470.7 g/mol |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)OC |
|
TCMBANKIN039081 |
Methyl 8beta,9alpha-dihydroganoderate J |
|
C31H46O7 |
531 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(C([H])([H])C(=O)C([H])([H])[C@]([H])(C(OC([H])([H])[H])=O)C([H])([H])[H])C([H])([H])[H
])C([H])([H])[C@]2([H])O[H])[C@@]23C([H])([H])[H])[C@@]3([H])C(=O)C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN039128 |
Isofucosterol |
C08812; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methylhex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; C08821; AIDS113090; 481-14-1; isofucosterol; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methyl-hex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; AIDS-113090; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 18472-36-1; delta5-Avenasterol |
C29H48O |
412.69 |
CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN039145 |
ilekudinol C |
ilekudinol c |
C30H52O3 |
460.7 g/mol |
CC(C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(CCC(C5(C)C)O)CO)C)CO |
|
TCMBANKIN039177 |
Trametenolic acid |
trametenolicacid |
|
456.7 |
|
|
TCMBANKIN039180 |
Shinjudilactone |
shinjudilactone |
C20H24O7 |
376.4 |
CC1C2CC(=O)OC3C24COC(=O)C1(C4C5(C(C3)C(=CC(=O)C5O)C)C)O |
|
TCMBANKIN039211 |
Haginin E |
|
|
240.25 g/mol |
|
|
TCMBANKIN039284 |
Polyporusterone E |
polyporusterone e |
|
460.65 |
|
|
TCMBANKIN039349 |
Ganoderic acid E |
ganodericacid e |
|
512.63 |
|
|
TCMBANKIN039469 |
gweicurculactone |
(8R)-1,5,8-trimethyl-7,8-dihydro-6H-azuleno[7,6-d]furan-2-one; Azuleno(6,5-b)furan-2(5H)-one, 6,7-dihydro-3,5,8-trimethyl-, (R)-; 123914-43-2 |
C15H16O2 |
228.286 |
C1([H])=C2C(=C(C([H])([H])[H])C(=O)O2)C([H])=C3C(C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[H])=C1C([H])([H])[H] |
|
TCMBANKIN039516 |
(22E,24R)-ergosta-7,22-dien-3-one |
|
C28H44O |
397 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])\C([H])=C([H])\[C@]([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H
])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])C3=C([H])C4([H])[H])[C@@]4([H])C([H])([H])C1=O |
|
TCMBANKIN039527 |
lucidenolactone |
|
C28H38O5 |
455 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]2(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)C2([H])[H])C([H])([H])C3=O)[C@@]34C([H])([H])[H])=C4[C@@](
[H])(O[H])C5([H])[H])[C@]5([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN039532 |
ganoderic acid F |
|
C32H42O9 |
570.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4(C3(CCC(=O)C4(C)C)C)C)O)OC(=O)C)C)C |
|
TCMBANKIN039545 |
gypsogenin |
BUOYQGLRFDDTLB-KBIKRTHESA-N; Saponin-gypsophila; Albsapogenin; Gypsogenin; 3-Hydroxy-23-oxo-olean-12-en-28-oic acid, (3-beta,4-alpha)- (9CI); CHEBI:5580; 3beta-hydroxy-23-oxoolean-12-en-28-oic acid; C08950; Olean-12-en-28-oic acid, 3-beta-hydroxy-23-oxo-; Githagenin; CHEMBL261695; (3beta,4alpha)-3-Hydroxy-23-oxoolean-12-en-28-oic acid; 639-14-5; Gypsophilasapogenin; (4aS,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-9-formyl-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; EINECS 211-353-7; Gypsophila paniculata saponin (swiss standard saponin); Gypsophilasaponin; (4aS,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-10-hydroxy-9-methanoyl-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; Astrantiagenin D |
C30H46O4 |
470.7 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C=O)O)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN039550 |
DIHYDROCUCURBITACIN B |
dihydrocucurbitacin b; Cucurbitacin B, dihydro-; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate; NSC106401; [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hexyl] acetate; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-heptan-2-yl] ethanoate; acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hexyl] ester; 13201-14-4; acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohexyl] ester |
C32H48O8 |
560.72 |
CC(=O)OC(C)(C)CCC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(=O)C4(C)C)O)C)C)C)O)O |
|
TCMBANKIN039688 |
Lucidone B |
lucidone b |
|
400.51 |
|
|
TCMBANKIN039776 |
Quillaic acid |
(4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-9-formyl-5,10-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; AC1O3DV5; quillaic acid; quillaicacid |
|
486.68 |
|
|
TCMBANKIN039808 |
Periplogenin |
3-beta,5,14-Trihydroxy-5-beta-card-20(22)-enolide; periplogenin; 5-beta-Hydroxydigitoxigenin; Desoxostrophanthidin; 4-[(3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 514-39-6; ZINC04023037; STOCK1N-00120; Card-20(22)-enolide, 3,5,14-trihydroxy-, (3-beta,5-beta)- (9CI); 5-beta-CARD-20(22)-ENOLIDE, 3-beta,5,14-TRIHYDROXY- |
|
390.51 |
|
|
TCMBANKIN039963 |
Alisol B |
CHEMBL421220; SMR001397336; alisol b; NCGC00247506-01; alisol B; MLS002473249; HMS2205K03 |
C30H48O4 |
472.7 g/mol |
CC(CC(C1C(O1)(C)C)O)C2=C3CC(C4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)O |
|
TCMBANKIN040065 |
methyl ganoderate D |
|
C31H44O7 |
529 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C(=O)C([H])([H])[C@]([H])(C(OC([H])([H])[H])=O)C([H])([H])[H])C([H])([
H])C2=O)[C@@]23C([H])([H])[H])=C3[C@@]([H])(O[H])C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN040077 |
lucidenic acid G |
lucidenicacid g |
C27H40O7 |
476.6 |
CC(CCC(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)CO)C)O)C)C)O |
|
TCMBANKIN040126 |
myrianthic acid |
myrianthicacid; myrianthic acid |
C30H48O6 |
504.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN040230 |
Ganoderic acid DM |
ganoderic acid dm |
C30H44O4 |
468.67 |
CC(CCC=C(C)C(=O)O)C1CCC2(C1(CCC3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C |
|
TCMBANKIN040287 |
madasiatic acid |
AC1NSXQ6; (1S,4aS,6bR,8R,10R,12aR,14bS)-8,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; madasiaticacid |
C30H48O5 |
488.7 |
CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)C)O)O)C)O)C)C2C1C)C)C(=O)O |
|
TCMBANKIN040506 |
Arjunic acid |
arjunicacid |
|
488.7 |
|
|
TCMBANKIN040584 |
Methyl lucidenate P |
methyl lucidenate p |
|
532.67 |
|
|
TCMBANKIN040610 |
isokarounidiol |
|
C30H48O2 |
440.7 g/mol |
CC1(C(CCC2(C1C=CC3=C2CCC4(C3(CCC5(C4CC(CC5)(C)CO)C)C)C)C)O)C |
|
TCMBANKIN040756 |
poricoic acid B |
AK554030; NSC715081; poricoicacid b; ZINC6040345; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methylhept-5-enoic acid; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methyl-hept-5-enoic acid; (R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-Carboxy-ethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-2,3,3a,4,6,7,8,9b-octahydro-1H-benz[e]inden-3-yl]-6-methyl-hept-5-enoic acid; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-1,2,3,4,7,8-hexahydrocyclopenta[a]naphthalen-3-yl]-6-methyl-hept-5-enoic acid; poricoic acid b; 137551-39-4; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[a]naphthalen-3-yl]-6-methylhept-5-enoic acid; AIDS113409; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-7-isopropenyl-3a,6,9b-trimethyl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methyl-hept-5-enoic acid; 16.alpha.-Hydroxy-3,7,9(11),24-tetraene-3,21-dioic acid; AKOS030530141; CHEMBL456872; 16.alpha.-Hydroxy-3,4-seco-24-methyllanosta-4(28),7,9(11),24-tetraene-3,21-dioic acid; AIDS-113409; (2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[h]naphthalen-3-yl]-6-methylhept-5-enoic acid; NSC-715081; AC1NV7TT; PoricoicacidB |
C30H44O5 |
485 |
C(=C([H])[H])(C([H])([H])[H])[C@]1([H])C([H])([H])C([H])=C2C(=C([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C(O[H])=O)C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])[C@](
[H])(O[H])C3([H])[H])[C@]23C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C([H])([H])C(O[H])=O |
|
TCMBANKIN040791 |
ganoderic acid H |
ganoderic acid h |
C32H44O9 |
572.69 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)OC(=O)C)C)C |
|
TCMBANKIN040836 |
lappadilactone |
CHEMBL502902 |
C30H38O6 |
494.6 g/mol |
CC1(CCC(=O)C2(C1C3C(CC2)C(=C)C(=O)O3)C)CC4(C5CCC(=C)C6CCC(=C)C6C5OC4=O)O |
|
TCMBANKIN040888 |
p-menth-5-en-1,2-diol |
|
|
170.28 |
|
|
TCMBANKIN040934 |
Barbinervic acid |
Urs-12-en-28-oic acid, 3,19,23-trihydroxy-, (3alpha,4beta)-; (1R,2R,4aS,6aR,6aS,6bR,8aR,9S,10R,12aR,14bS)-1,10-dihydroxy-1,2,6a,6b,9,12a-hexamethyl-9-methylol-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; 64199-78-6; barbinervic acid; (1R,2R,4aS,6aR,6aS,6bR,8aR,9S,10R,12aR,14bS)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
|
488.7 |
|
|
TCMBANKIN041007 |
Rosenonolactone |
|
|
316.43 |
|
|
TCMBANKIN041014 |
methyl Ganoderic acid TR |
|
C31H46O4 |
483 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=C([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(\C(OC([H])([H])[H])=O)/C([H])([H])[H])C([H])([H
])[C@]2([H])O[H])[C@@]23C([H])([H])[H])C3=C([H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN041245 |
ganoderic acid B |
ganoderic acid b |
C30H44O7 |
516.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C |
|
TCMBANKIN041285 |
Bryonolic acid |
bryonolicacid; bryonolate; D:C-friedoolean-8-en-3beta-ol-29-oic acid; (2R,4aS,6aS,8aR,10S,12aS,14aS,14bR)-10-Hydroxy-2,4a,6a,9,9,12a,14a-heptamethyl-1,2,3,4,4a,5,6,6a,7,8,8a,9,10,11,12,12a,13,14,14a,14b-eicosahydro-picene-2-carboxylic acid; AIDS-075058; 24480-44-2; bryonolic acid; AIDS075058; (2R,4aS,6aS,8aR,10S,12aS,14aS,14bR)-10-hydroxy-2,4a,6a,9,9,12a,14a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-2-carboxylic acid |
C30H48O3 |
457 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])(C([H])([H])[C@@](C(O[H])=O)(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])[H])C([H])([H])C3
([H])[H])[C@]34C([H])([H])[H])=C4C([H])([H])C5([H])[H])[C@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1(O[H])[H] |
|
TCMBANKIN041415 |
Ganoderic acid C6 |
|
C30H42O8 |
531 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)[C@@]([H])(O[H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C(=O)C([H])([H])[C@]([H])(C(O[H])=O)C([H])([H])[H])C([H])([H])C2=
O)[C@@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN041519 |
Polyporusterone D |
polyporusterone d |
|
460.65 |
|
|
TCMBANKIN041627 |
isomaistemonine |
|
C23H29NO6 |
415.48 |
CC1CC(OC1=O)C2CCC34N2CCCCC3=C(C(=O)C45C(=C(C(=O)O5)C)OC)C |
|
TCMBANKIN041660 |
Tingenone |
(6aR,6bR,8aS,11R,12aR,14aR)-3-hydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione; CHEBI:9602; C08638; (6aR,6bR,8aS,11R,12aR,14aR)-3-hydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-quinone; tingenone; ZINC4097726; AC1L9BH1; 50802-21-6 |
C28H36O3 |
420.58 |
CC1CC2C(CCC3(C2(CCC4(C3=CC=C5C4=CC(=O)C(=C5C)O)C)C)C)(CC1=O)C |
|
TCMBANKIN041860 |
hecogenin |
hecogenin; EINECS 207-392-4; BSPBio_000660; ST5309385; 5alpha-Spirostan-12-one, 3beta-hydroxy-, (25R)- (8CI); Prestwick3_000730; 3-beta-Hydroxy-5-alpha-spirostan-12-one; 467-55-0; NSC 115921; BPBio1_000726; C08902; (22R,25R)-3beta-Hydroxy-5alpha-spirostan-12-one; Spirostan-12-one, 3-hydroxy-, (3beta,5alpha,25R)- (9CI) |
C27H42O4 |
431 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C(=O)[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])[C@@]2(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C([H])([H])O2)O3)
[C@]3([H])C4([H])[H])[C@@]45[H])[C@@]5([H])C([H])([H])C6([H])[H])[C@]6([H])C([H])([H])[C@@]1([H])O[H] |
|
TCMBANKIN042009 |
Abridin |
|
|
368.55 |
|
|
TCMBANKIN042114 |
Ganosporelactone A |
ganosporelactone a |
C30H40O7 |
512.63 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)[C@@]([H])(O[H])[C@](C([H])([H])[H])([C@]2([H])[C@@]([H])([C@@]3(C([H])([H])[C@@]([H])(C([H])([H])[H])C(=O)O3)C([H])([H])[C@@]2([H])C([H])([H])[H])C4
=O)[C@@]45C([H])([H])[H])=C5[C@@]([H])(O[H])C6([H])[H])[C@]6([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN042123 |
isorhamnetin-3-O-beta-D-rutinoside |
Isorhamnetin 3-O-alpha-L-rhamnopyranosyl-(1-6)-bata-D-glucopyranoside; isorhamnetin-3-O-β-D-rutinoside |
C28H32O16 |
625 |
c1([H])c(OC(c2c([H])c(OC([H])([H])[H])c(O[H])c([H])c2[H])=C(O[C@]3([H])O[C@]([H])(C([H])([H])O[C@]4([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(O[H])[C@]([
H])(O[H])[C@@]3([H])O[H])C5=O)c5c(O[H])c([H])c1O[H] |
|
TCMBANKIN042139 |
hancopregnane |
|
C21H28O7 |
392 |
[C@]1([H])(O[H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])C(=C([H])O4)[C@@](O[H])([C@]4(C([H])([H])[H])OC5([H])[H])[C@]5([H])OC3=O)C([H])([H])[C@@]
1([H])O[H] |
|
TCMBANKIN042151 |
ergosterol peroxide |
ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C56H86O2 |
791 |
O([C@]1([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C
([H])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])C3=C4[H])C([H])([H])C1([H])[H])=C4[H])O[C@]5([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([
H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C6([H])[H])[C@]67[H])C7=C8[H])C([H])([H])C5([H])[H])=C8[H] |
|
TCMBANKIN042196 |
dihydroniloticin |
|
C30H50O3 |
458.72 |
CC(CC(C1C(O1)(C)C)O)C2CCC3(C2(CCC4C3=CCC5C4(CCC(C5(C)C)O)C)C)C |
|
TCMBANKIN042273 |
Ganodermic acid R |
ganodermicacid r; (Z,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (Z,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid; (Z,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid; (Z,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid |
C30H42O8 |
530.65 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)OC(=O)C |
|
TCMBANKIN042399 |
Sophoradiol |
|
|
442.72 |
|
|
TCMBANKIN042621 |
lucidenic acid D1 |
lucidenicacid d1 |
C27H34O7 |
470.55 |
CC(CCC(=O)O)C1CC(=O)C2(C1(C(=O)C(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C |
|
TCMBANKIN042639 |
8beta,9alpha-Dihydroganoderic acid J |
8β,9α-dihydroganodericacid j |
C30H44O7 |
516.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN042698 |
Arjunolic acid |
Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2.alpha.,3.beta.,4.alpha.)-; arjunolic acid; arjunolicacid; 2,3,23-Trihydroxyolean-12-en-28-oic acid; AIDS046611; 465-00-9; (4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-methylol-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-; AIDS-046611; (4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
C30H48O5 |
488.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN042711 |
ganoderiol D |
ganoderiol d; AC1NSVQG; 4,4,10,13,14-pentamethyl-17-[(5R,6R)-5,6,7-trihydroxy-6-methylheptan-2-yl]-2,5,6,11,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,7-dione |
C30H48O5 |
488.7 |
CC(CCC(C(C)(CO)O)O)C1CCC2(C1(CCC3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C |
|
TCMBANKIN042744 |
bruceine I |
bruceine I |
C22H28O10 |
452 |
C1(=O)C([H])([H])[C@](C([H])([H])[H])([C@]2([H])[C@]3([C@@]([C@@](OC3([H])[H])(C(OC([H])([H])C([H])([H])[H])=O)[C@@]([H])(O[H])[C@]2([H])O[H])(O[H])C([H])([H])C(=O)O4)[C@@]4([H])C5([H])[H])[C@]5([H])C
(C([H])([H])[H])=C1O[H] |
|
TCMBANKIN042911 |
Lucialdehyde C |
lucialdehyde c |
C30H46O3 |
454.68 |
CC(CCC=C(C)C=O)C1CCC2(C1(CCC3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN043054 |
Ganoderic acid G |
|
C30H44O8 |
533 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)[C@@]([H])(O[H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C(=O)C([H])([H])[C@]([H])(C(O[H])=O)C([H])([H])[H])C([H])([H])C2=
O)[C@@]23C([H])([H])[H])=C3[C@@]([H])(O[H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN043071 |
ganoderenic acid H |
ganoderenicacid h |
C30H40O7 |
512.63 |
CC(CC(=O)C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C)C(=O)O |
|
TCMBANKIN043240 |
(20S)-3β-Acetoxy-12β,16β,25-tetrahydroxydammar-23-ene |
|
|
502.86 |
|
|
TCMBANKIN043273 |
methly lucidenate L |
|
|
488.68 |
|
|
TCMBANKIN043285 |
Echinocystic acid |
echinocysticacid; aster saponin D_qt; aster saponin F_qt; echinocystic acid |
|
473 |
|
|
TCMBANKIN043317 |
Ganolucidic acid B |
ganolucidicacid b |
|
502.68 |
|
|
TCMBANKIN043645 |
Lucidone A |
(3S,5R,7S,10S,13R,17S)-17-acetyl-3,7-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthrene-11,15-dione; lucidone a; AC1L44B5 |
|
402.52 |
|
|
TCMBANKIN043692 |
Ganolucidic acid A |
ganolucidicacid a; Lanost-8-en-26-oic acid, 15-hydroxy-3,11,23-trioxo-, (15.alpha.,25R)-; (2R,6R)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid; AIDS085921; (2R,6R)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-3,11-diketo-4,4,10,13,14-pentamethyl-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-keto-2-methyl-enanthic acid; 98665-21-5; Lanost-8-en-26-oic acid, 15-hydroxy-3,11,23-trioxo-, (15alpha,25R)-; AIDS-085921; (2R,6R)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid |
C30H44O6 |
500.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN043783 |
curzerene |
Curzerene; BG01211968; 4,5,6,7-Tetrahydro-5-isopropenyl-3,6beta-dimethyl-6alpha-vinylbenzofuran; AC1NSU11; Y0061; (6S)-6-ethenyl-3,6-dimethyl-5-prop-1-en-2-yl-5,7-dihydro-4H-1-benzofuran; 17910-09-7 |
C15H20O |
216.319 |
C([H])([H])=C([H])[C@@]1(C([H])([H])[H])C([H])([H])c(oc([H])c2C([H])([H])[H])c2C([H])([H])[C@]1([H])C(C([H])([H])[H])=C([H])[H] |
|
TCMBANKIN043856 |
23-hydroxyursolic acid |
23- hydroxyursolicacid; 23-hydroxy ursolicacid; 23-hydroxyursolicacid |
C30H48O4 |
473 |
C(O[H])(=O)[C@]1([C@@](C(=C([H])C([H])([H])[C@]([H])([C@](C([H])([H])[H])([C@@]2([H])[C@](C([H])([H])[H])(C([H])([H])O[H])[C@@]3([H])O[H])C([H])([H])C3([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C2([H])
[H])[C@]45C([H])([H])[H])([H])[C@@]([H])(C([H])([H])[H])[C@]([H])(C([H])([H])[H])C([H])([H])C1([H])[H])C([H])([H])C5([H])[H] |
|
TCMBANKIN044018 |
Previtexilactone |
previtexilactone |
|
379 |
|
|
TCMBANKIN044172 |
melianol |
|
C30H48O4 |
472.7 g/mol |
CC1(C(CCC2(C1CC=C3C2CCC4(C3(CCC4C5CC(OC5O)C6C(O6)(C)C)C)C)C)O)C |
|
TCMBANKIN044284 |
ganosporelactone B |
ganosporelactone b |
C30H42O7 |
514.65 |
CC1CC2(CC(C(=O)O2)C)C3C1C4(C(C(=O)C5=C(C4(C3=O)C)C(CC6C5(CCC(C6(C)C)O)C)O)O)C |
|
TCMBANKIN044549 |
Vitetrifolin E |
|
|
365 |
|
|
TCMBANKIN044857 |
maistemonine |
maistemonine |
C23H29NO6 |
415 |
O1C(=O)C(C([H])([H])[H])=C(OC([H])([H])[H])[C@@]12C(=O)C(C([H])([H])[H])=C3[C@]24N([C@]([H])([C@]5([H])C([H])([H])[C@]([H])(C([H])([H])[H])C(=O)O5)C([H])([H])C4([H])[H])C([H])([H])C([H])([H])C([H])([H
])C3([H])[H] |
|
TCMBANKIN044879 |
Kulolactone |
|
C30H46O3 |
454.7 g/mol |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]2([H])[C@@]([H])(OC(=O)[C@@]2([H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H]
)C3([H])[H])[C@]34C([H])([H])[H])C4=C([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H] |
|
TCMBANKIN045036 |
Stigmast-4-ene-3,6-dione |
(8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethylhexyl]-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6-dione; (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6-dione; (8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6-dione; 23671-20-7; 23670-94-2; stigmast-4-ene-3,6-dione; stigmast-4- ene-3,6- dione; (8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6-quinone; (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6-dione |
C29H46O2 |
426.67 |
CCC(CCC(C)C1CCC2C1(CCC3C2CC(=O)C4=CC(=O)CCC34C)C)C(C)C |
|
TCMBANKIN045051 |
Lucialdehyde A |
lucialdehyde a |
C30H46O2 |
438.68 |
CC(CCC=C(C)C=O)C1CCC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN045166 |
Lucidenic acid H |
lucidenicacid h |
|
476.6 |
|
|
TCMBANKIN045231 |
Phytolaccagenin |
|
|
532.71 |
|
|
TCMBANKIN045292 |
Leosibiricin |
|
|
404.45 |
|
|
TCMBANKIN045466 |
butyl ganoderate A |
|
C34H52O7 |
572.8 g/mol |
CCCCOC(=O)C(C)CC(=O)CC(C)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
|
TCMBANKIN045705 |
polyporusterone G |
polyporusterone g |
C28H44O5 |
460.65 |
CC(C)C(=C)CC(C(C)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O |
|
TCMBANKIN045713 |
7alpha-Hydroxyconessine |
7α-hydroxyconessine; 7alpha-hydroxyconessine |
C26H43NO |
385.7 |
CC1CC2C3C(CCC24C1C(N(C4)C)C)C5(CCC(CC5=CC3O)C(C)C)C |
|
TCMBANKIN045792 |
Obtusifoliol |
(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; 16910-32-0; 4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol; obtusifoliol; (3S,4S,5S,10S,13R,14R,17R)-17-[(1R)-4-isopropyl-1-methyl-pent-4-enyl]-4,10,13,14-tetramethyl-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; Ergosta-8,24(28)-dien-3-ol, 4,14-dimethyl-, (3beta,4alpha,5alpha)-; (3S,4S,5S,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-4,10,13,14-tetramethyl-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; 4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol; LMST01030101; 4alpha,14alpha-dimethyl-24-methylene-cholest-8-en-3beta-ol; (3S,4S,5S,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylenehexyl]-4,10,13,14-tetramethyl-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; (3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; C01943; 22332-15-6 |
|
426.72 |
|
|
TCMBANKIN045938 |
lucidenic acid I |
lucidenicacid i |
C27H38O7 |
474.59 |
CC(CCC(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)CO)O)C)C)C |
|
TCMBANKIN045962 |
Lucidenic acid L |
lucidenicacid l |
|
474.59 |
|
|
TCMBANKIN046023 |
7alpha,21S,25-Trihydroxy-3beta-acetoxy-21S,23R-epoxy-9(11)-en-dammarane |
[(3S,8S,10S)-7-hydroxy-17-[(2S,5R)-2-hydroxy-5-(2-hydroxy-2-methylpropyl)oxolan-3-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,12,13,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; AC1NT14F; 7α,21s,25-trihydroxy-3β-acetoxy-21s,23r-epoxy-9(11)-en-dammarane; 7alpha,21s,25-trihydroxy-3beta-acetoxy-21s,23r-epoxy-9(11)-en-dammarane |
C32H52O6 |
532.84 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=C([H])C([H])([H])[C@]([H])([C@@]([H])([C@]2([H])[C@@]([H])(O[H])O[C@@]([H])(C([H])([H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C2([H])[H])C([H])([H])C3([H]
)[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])[C@]([H])(O[H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])OC(=O)C([H])([H])[H] |
|
TCMBANKIN046146 |
Lucidenic acid E1 |
lucidenicacid e1 |
|
474.59 |
|
|
TCMBANKIN046311 |
lucidenic acid D2 |
(4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetoxy-3,7,11,15-tetraketo-4,4,10,13,14-pentamethyl-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid; 98665-16-8; NSC733508; (4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; (4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; lucidenicacid d2; Chol-8-en-24-oic acid, 12-(acetyloxy)-4,4,14-trimethyl-3,7,11,15-tetraoxo-, (5.alpha.,12.beta.) |
C29H38O8 |
515 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)[C@@]([H])(OC(C([H])([H])[H])=O)[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])[H])C([H])([H])C2=O)[C@@]23C([H
])([H])[H])=C3C(=O)C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN046347 |
poricoic acid DM |
poricoic acid dm; poricoicacid dm |
C32H48O6 |
529 |
C(=C([H])[H])(C([H])([H])[H])[C@]1([H])C([H])([H])C([H])=C2C(=C([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C(O[H])=O)C([H])([H])C([H])([H])C(=C([H])[H])C(O[H])(C([H])([H])[H])C([H])([H])
[H])[C@]([H])(O[H])C3([H])[H])[C@]23C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C([H])([H])C(OC([H])([H])[H])=O |
|
TCMBANKIN046535 |
Lucidenic acid K |
lucidenicacid k |
|
472.57 |
|
|
TCMBANKIN046768 |
wilforlide B |
Wilforlide B; wilforlide b |
C30H44O3 |
453 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@]([H])(C([H])([H])[C@@](C(=O)O2)(C([H])([H])[H])C([H])([H])[C@]23[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@]45C([
H])([H])[H])[C@@]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN046865 |
ganolucidic acid D |
|
C30H44O6 |
500.67 |
CC(CC(C=C(C)C(=O)O)O)C1CC(C2(C1(CC(=O)C3=C2CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN046920 |
tumulosic acid |
Tumulosic acid; tumulosicacid |
C31H50O4 |
487 |
C([H])([H])([H])C([H])(C(C([H])([H])C([H])([H])[C@@]([H])(C(O[H])=O)[C@]1([H])[C@@](C([H])([H])[H])(C([H])([H])C([H])([H])C2=C3C([H])([H])C([H])([H])[C@]4([H])[C@]2(C([H])([H])[H])C([H])([H])C([H])([H
])[C@]([H])(O[H])C4(C([H])([H])[H])C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])[C@@]1([H])O[H])=C([H])[H])C([H])([H])[H] |
|
TCMBANKIN047098 |
alisol C |
CHEBI:81105; alisol c; C17461 |
C30H46O5 |
486.68 |
CC(CC(C1C(O1)(C)C)O)C2=C3CC(C4C5(CCC(=O)C(C5CCC4(C3(CC2=O)C)C)(C)C)C)O |
|
TCMBANKIN047240 |
Ganoderenic acid A |
|
C30H42O7 |
515 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(\C(\C([H])([H])[H])=C([H])/C(C([H])([H])[C@@]([H])(C(O[H])=O)C([H])([H])[H])=O)C([H])([H])[C@]2([H])O[H])[
C@@]23C([H])([H])[H])=C3[C@@]([H])(O[H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN047284 |
Fastigilin B |
C09451; [(1S,3aS,4R,5S,5aS,8aR,9S,9aS)-4-hydroxy-1,5,8a-trimethyl-2,8-dioxo-3a,4,5,5a,9,9a-hexahydro-1H-azuleno[6,5-b]furan-9-yl] 3-methylbut-2-enoate; 6995-11-5; NSC176503; FASTIGILIIN B; 6995/11/5; fastigilin b; DTXSID30331778; CHEMBL1213003; CHEBI:4982; AC1L9CH2; 3-methylbut-2-enoic acid [(1S,3aS,4R,5S,5aS,8aR,9S,9aS)-4-hydroxy-2,8-diketo-1,5,8a-trimethyl-3a,4,5,5a,9,9a-hexahydro-1H-azuleno[5,6-d]furan-9-yl] ester; 3-methylbut-2-enoic acid [(1S,3aS,4R,5S,5aS,8aR,9S,9aS)-4-hydroxy-1,5,8a-trimethyl-2,8-dioxo-3a,4,5,5a,9,9a-hexahydro-1H-azuleno[6,5-b]furan-9-yl] ester |
C20H26O6 |
362.4 g/mol |
[C@]12([H])[C@@](C([H])([H])[H])(C(=O)C([H])=C1[H])[C@](OC(=O)\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])([H])[C@@]3([H])[C@]([H])(OC(=O)[C@@]3([H])C([H])([H])[H])[C@]([H])(O[H])[C@@]2([H])C([H])([H])[
H] |
|
TCMBANKIN047294 |
raddeanin C |
raddeanin c |
C24H34O7 |
434.52 |
|
|
TCMBANKIN047347 |
lucidone C |
lucidone c |
C24H36O5 |
404.54 |
CC(=O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O |
|
TCMBANKIN047384 |
diayangambin |
CTK4E6827; DTXSID10175733; SCHEMBL17385618; AC1L4ZYE; (1r,3ar,4r,6ar)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1h,3h-furo[3,4-c]furan; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-,(1R,3aR,4R,6aR)-; Diayangambin; (+)-Diayangambin; AC1Q70YI; (3R,3aR,6R,6aR)-3,6-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-(1R)-1alpha,3abeta,4alpha,6abeta-1H,3H-furo(3,4-c)furan; 21453-68-9; ZINC31477287 |
C24H30O8 |
446.49 |
COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC |
|
TCMBANKIN047390 |
Hispidone |
hispidone |
C30H48O4 |
472.7 |
CC1(C2CC=C3C(C2(CCC1=O)C)CCC4(C3(CCC4C5CC(C(C(OC5)(C)C)O)O)C)C)C |
|
TCMBANKIN047394 |
isoglaucanone |
|
C27H44O |
385 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@](C([H])([H])[H])(C([H])([H])C([H])([H])C2=O)[C@]2([H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([
H])([H])[H])C([H])([H])C5([H])[H])[C@]5([H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
|
TCMBANKIN047492 |
Ilekudinol A |
ilekudinol a |
|
454.6 g/mol |
|
|
TCMBANKIN047602 |
Ganoderic acid TR |
|
C30H44O4 |
468.7 g/mol |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN047772 |
isopropylidenkirenol |
|
C23H38O4 |
379 |
[C@@]1([H])(O[H])C([H])([H])[C@@](C([H])([H])[H])([C@@]2([H])C(=C([H])[C@@](C([H])([H])[H])([C@@]3([H])OC(C([H])([H])[H])(C([H])([H])[H])OC3([H])[H])C([H])([H])C2([H])[H])C([H])([H])C4([H])[H])[C@@]4(
[H])[C@@](C([H])([H])O[H])(C([H])([H])[H])C1([H])[H] |
|
TCMBANKIN047925 |
Helioscopinolide C |
helioscopinolide c |
|
330.42 |
|
|
TCMBANKIN047970 |
14-deoxyandrographolide |
14-deoxyandrographolide-19-β-D-glucoside_qt; 14-deoxy-andrographolide |
C20H30O4 |
334.45 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])C2=C([H])C([H])([H])OC2=O)C(=C([H])[H])C([H])([H])C3([H])[H])[C@@]3([H])[C@](C([H])([H])[H])(C([H])([H])O[H])[C@]1([H])O[H] |
|
TCMBANKIN048022 |
Sapogenin ST-1 |
sapogenin st-1 |
C30H50O3 |
458.8 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[C@]2([H])O[H])[C@@]2(C([H])([H])O[H])C([H])([H])C3([H])[H])
[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN048171 |
bruceaketolic acid |
|
C22H28O12 |
484.45 |
|
|
TCMBANKIN048248 |
lanosta-7,9(11),24-trien-3α,15α-diacetoxy-23-oxo-26-oic acid |
lanosta-7,9(11),24-trien-3α,15α-diacetoxy-23-oxo-26-oicacid |
C34H48O7 |
568.82 |
|
|
TCMBANKIN048450 |
xysmalogenin |
|
C23H32O4 |
372.5 |
CC12CCC(CC1=CCC3C2CCC4(C3(CCC4C5=CC(=O)OC5)O)C)O |
|
TCMBANKIN048520 |
Lucidenic acid E2 |
lucidenicacid e2 |
|
516.62 |
|
|
TCMBANKIN048700 |
melianodiol |
|
C30H48O5 |
489 |
C([H])([H])([H])C1(C([H])([H])[H])C(=O)C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])[C@@]4([H])
[C@@]([H])(O[H])O[C@@]([H])([C@@]([H])(O[H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C4([H])[H])C3=C([H])C5([H])[H])[C@]15[H] |
|
TCMBANKIN048855 |
Ganoderic acid AM1 |
ganodericacid am1 |
C30H42O7 |
514.65 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN049206 |
Tamarixone |
tamarixone |
C30H48O2 |
440.7 |
CC1C(C(=C)CC2(C1C3CCC4C(C3CC2)(CCC5C4(CCC(=O)C5(C)C)C)C)CO)C |
|
TCMBANKIN049267 |
ganoderic acid C2 |
ganoderic acid c2 |
C30H46O7 |
518.68 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O |
|
TCMBANKIN049268 |
faradiol |
(3S,6aR,6aR,8aS,14bR)-4,4,6a,6b,8a,11,14b-heptamethyl-2,3,4a,5,6,6a,7,8,9,12,12a,13,14,14a-tetradecahydro-1H-picene-3,13-diol; AC1NSVEA; Faradiol |
C30H50O2 |
442.7 g/mol |
CC1C2C3CCC4C5(CCC(C(C5CCC4(C3(CC(C2(CC=C1C)C)O)C)C)(C)C)O)C |
|
TCMBANKIN049380 |
(20S)-3β,12β,16β,25-Pentahydroxydammar-23-ene |
(20s)-3β,12β,16β,25-pentahydroxydammar-23-ene |
|
428.82 |
|
|
TCMBANKIN049442 |
lucidenic acid M |
lucidenicacid m |
C27H42O6 |
462.62 |
CC(CCC(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O |
|
TCMBANKIN049506 |
ganoderenic acid I |
ganoderenicacid i |
C30H42O7 |
514.65 |
|
|
TCMBANKIN049540 |
Helioscopinolide B |
helioscopinolide b |
|
316.43 |
|
|
TCMBANKIN049586 |
Ajugamarin |
|
|
548.62 |
|
|
TCMBANKIN049843 |
Lucidenic acid J |
lucidenicacid j |
|
490.59 |
|
|
TCMBANKIN049945 |
Picropolygamain |
|
|
352.34 |
|
|
TCMBANKIN050016 |
rubiatriol |
A'-Neo-26,28-dinorgammacer-9(11)-ene-3,7,19-triol, 13,17-dimethyl-, (3beta,7alpha,8alpha,13alpha,14beta,17alpha,18beta,19alpha)-; 107694-02-0; (1R,3R,3aR,5aR,5bR,7aR,9S,11aS,13aS,13bR)-3a,5a,8,8,11a,13a-hexamethyl-3-propan-2-yl-1,2,3,4,5,5b,6,7,7a,9,10,11,13,13b-tetradecahydrocyclopenta[a]chrysene-1,9-diol; D:C-Friedo-B':A'-neogammacer-9(11)-ene-3,7,19-triol, (3beta,7alpha,19alpha)-; Rubiatriol; AC1L4DRZ |
C30H50O3 |
458.72 |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(C5(C)C)O)C)O)C)C)C)O |
|
TCMBANKIN050197 |
Sanguisorbin E |
sanguisorbin E |
|
792.99 |
|
|
TCMBANKIN050236 |
Asatone |
asatone |
C24H32O8 |
448.51 |
COC1=CC2(C(C3C(=CC2(C(=O)C3(OC)OC)OC)CC=C)C(C1=O)(OC)OC)CC=C |
|
TCMBANKIN050318 |
butyl lucidenate N |
|
C31H48O6 |
517 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(OC([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=O)C([H]
)([H])C2=O)[C@@]23C([H])([H])[H])=C3[C@@]([H])(O[H])C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
|
TCMBANKIN050411 |
Alisol A |
alisol a; CHEBI:81103; 19885-10-0; alisol A; C17459 |
C30H50O5 |
490.7 g/mol |
CC(CC(C(C(C)(C)O)O)O)C1=C2CC(C3C4(CCC(=O)C(C4CCC3(C2(CC1)C)C)(C)C)C)O |
|
TCMBANKIN057911 |
se |
selenium |
H2Se |
78.97 g/mol |
[Se] |
|
TCMBANKIN057919 |
2(R)-(3,4-dimethoxy-phenyl)-propanel,3-diol-l-O-β-D-glucopyranoside |
formic acid;fatty acids;FMT;saturated fatty acids;formicacid; methanol peroxide; Dioxirane-3-ol;251364_SIAL; 64-18-6; 27001_RIEDEL; HCOOH; Kyselina mravenci [Czech]; methoic acid; 06473_FLUKA; Spirit of formic acid; Formira; CBX; RCRA waste no. U123; Formylic acid; Methanoic acid; 09676_FLUKA; Formic acid (natural); C1 acid; CCRIS 6039; 49897_FLUKA; 7056-83-9; Kwas metaniowy [Polish]; Bilorin; Myrmicyl; RCRA waste number U123; Ameisensaeure [German]; F0507_SIAL; Collo-didax; EINECS 200-579-1; UN1779; C00058; Add-F; InChI=1/CH2O2/c2-1-3/h1H,(H,2,3; 33015_RIEDEL; 82069-14-5; H-COOH; Collo-bueglatt; LMFA01010040; 94318_FLUKA; AI3-24237; Wonderbond Hardener M 600L; HSDB 1646; Mierenzuur [Dutch]; formic acid; 06450_FLUKA; Sybest; Formic acid solution; FEMA No. 2487; Formisoton; CHEBI:30751; Ameisensaeure; 399388_SIAL; ST5214364; 8006-93-7; Ameisensaure; Formate standard for IC; CARBOXY GROUP; LS-1540; Methanoic acid monomer; Formic acid [UN1779] [Corrosive]; W248703_ALDRICH; Acide formique [French]; Aminic acid; Acido formico [Italian]; 06460_FLUKA; 15907-03-6; Hydrogen carboxylic acid; EPA Pesticide Chemical Code 214900; 56302_FLUKA |
HCOOH or CH2O2 |
46.025 g/mol;46.03 |
C(=O)O |
|
TCMBANKIN058205 |
trans-resveratrol |
(E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene |
C14H12O3 |
228.24 g/mol |
C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O |
|
TCMBANKIN058215 |
kaempferol-3-o-beta-d-glucoside |
kaempferol-3-O-β-D-glucopyranoside;Kaempferol-3-glucoside;astragalin;Kaempferol-3-o- glucoside;kaempferol 3-glucoside;Kaempferol 3-O-glucoside;kaempferol-3-o-glucoside;5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside; Kaempferol-3-O-.beta.-D-glucopyranoside; Kaempferol-3-beta-glucopyranoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; NCGC00163580-01; 4H-1-Benzopyran-4-one, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; Astragaline; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Kaempferol-3-D-glucoside; 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; MEGxp0_000168; Kaempferol-3-beta-monoglucoside; Kaempferol-3-O-glucoside; 3,4',5,7-Tetrahydroxyflavone-3-glucoside; 480-10-4; ACon1_001224; SCHEMBL23898; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; AIDS-051935; AIDS051935; CHEBI:30200; LMPK12111725; Kaempferol 3-O-beta-D-glucopyranoside; C12249; Astragalin; Kaempferol 3-O-glucoside; Kaempferol 3-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; Kaempferol 3-O-beta-D-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone;kaempferol-3-β-D-glucopyranoside;Kaempferol-3-O-β-D- glucopyranoside; kaempferol-3-o-beta-d-glucopyranoside;kaempferol-3-O-β-D-glucoside; Kaempferol-3-o-β-D- glucoside; Kaempferol- 3-O-β-D-glucoside |
C21H20O11 |
448.38 |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O |
|
TCMBANKIN058519 |
(-)-epigallocatechin-3-gallate; (-)-epigallocatechin 3-o-gallate;epigallocatechin gallate; galloyl-l-epigallocatechol; epigallocatechin 3-gallate; (-)-epigallocatechin gallate; |
KBio2_000796; SpecPlus_000277; 50299_FLUKA; Spectrum3_000244; KBioGR_002002; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] ester; MLS000758300; DivK1c_006373; (−)-Epigallocatechin gallate; EGCG; SPBio_000035; (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; KBioSS_000796; Epigallocatechin gallate; Spectrum4_001541; (-)-epigallocatechin 3-gallate; Tea catechin; AIDS000674; KBio2_005932; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-chromanyl] ester; KBio1_001317; 989-51-5; AIDS-000674; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); KBio2_003364; Galloyl-L-epigallocatechol; SDCCGMLS-0066550.P001; (-)-Epigallocatechol gallate; ACon1_001054; Spectrum5_000102; Green tea extract; MEGxp0_001166; C09731; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; (-)-Epigallocatechin gallate; CCRIS 3729; Teavigo; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Spectrum2_000168; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxy-flavane-3-gallate; CHEBI:4806; (-)-epigallocatechin-3-gallate ; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; SPECTRUM210239; E4143_SIAL; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; Spectrum_000316; (-)-EGCG; KBio3_001128; BSPBio_001628; Epigallocatechol, 3-gallate, (-)-; Epigallocatechin-3-gallate; E4268_SIAL; epigallocatechin gallate ; epigallocatechin-3-gallate; (-)epigallocatechin-3-gallate ; EGCG; 989E515; [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate; HMS2051K21; CS-1258; AC1L22IG; AK165605; Green tea polyphenols, Anagen; (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard; AKOS015918182; CAS-989-51-5; Epigallocatechin gallate, primary pharmaceutical reference standard; W-5069; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate; (-)-Epigallocatechin gallate, analytical standard; Q-100914; DSSTox_RID_78830; AN-15867; DSSTox_GSID_29889; (-)-Epigallocatechol gallate; FT-0604392; NCGC00164319-04; Green tea extract; MEGxp0_001166; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; N1874; CHEBI:4806; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; BG00814299; HMS3649E08; D0E9DB; Epigallocatechol, 3-gallate, (-)-; (-)-EpigallocatechinGallateHydrate; Epigallocatechin-3-gallate; AB0014381; BQM438CTEL; NC00078; ST51055716; Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material; SpecPlus_000277; Spectrum3_000244; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate; MLS000758300; (-)-Epigallocatechin gallate (EGCG); CCG-38378; Gallic acid, 3-ester with epigallocatechol, (-)-; SR-01000946601-1; NCGC00164319-01; (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate; NCGC00164319-06; DSSTox_CID_567; MCULE-3341525983; Epigallocatechin monogallate, B; Tox21_303457; SAM001247031; 4awm; K791; 989-51-5; SR-01000946601; MFCD00075940; EGCG analogs; Galloyl-L-epigallocatechol; NCGC00164319-03; (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea; Spectrum5_000102; CPD000449288; (-)-Epigallocatechin gallate; LMPK12030005; E0694; Teavigo; Epigallocatechin gallate analogs, Anagen; Epigallocatechin-3-monogallate; ACN-035233; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Sunphenon; Epigallocatechin gallate(EGCG); s2250; PF-EGCg 90; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate; 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; MLS001424000; (-)-EGCG; ZINC3870412; KBio2_000796; EGCG cpd; KBioGR_002002; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; EGCG, Anagen; NCGC00257243-01; Tox21_201468; L-Epigallocatechin gallate; cid_65064; SPBio_000035; BG01747388; Epigallocatechin gallate; KBioSS_000796; Spectrum4_001541; (-)-epigallocatechin 3-gallate; DB12116; EPIGALOCATECHIN GALLATE; ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE; KBio2_005932; I14-7747; D0U2BH; MCULE-7760530136; 2kdh; Epigallocatechin gallate, Anagen; AOB2839; SDCCGMLS-0066550.P001; 863-65-0; FR-109; ST097428; ACon1_001054; LS-2197; CCRIS 3729; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Epigallocate; GTPL7002; BDBM50070942; C22H18O11; GTPs,Anagen; SCHEMBL35258; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate; MolPort-001-741-358; DivK1c_006373; KB-206444; SR-01000759328; Teavigo;; EGCG; (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT); HY-13653; (-)-Epigallocatechin gallate, >=95%; NCGC00259019-01; Tea catechin; DS-9030; SR-01000759328-6; SR-01000759328-5; KDH; AC1Q5X0Z; KBio1_001317; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); NVP-XAA 723; KBio2_003364; EBD2138593; FT-0082796; NCGC00164319-02; C09731; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; UNII-BQM438CTEL; DTXSID1029889; WMBWREPUVVBILR-WIYYLYMNSA-N; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; (-)-Epigallocatehin gallate; Spectrum2_000168; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; (-)-Epigallocatechin gallat; SPECTRUM210239; Epigallocic acid; Epigallocatcchin Gallate; KS-0000132O; BP-30205; CHEMBL297453; SC-47284; Spectrum_000316; 3oob; (-)-Epigallocatechin gallate, >=97.0% (HPLC); KBio3_001128; BSPBio_001628; epigallo-catechin gallate |
C22H18O11 |
458.4g/mol |
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
|
TCMBANKIN058701 |
alphitotic acid |
Alphitolic acid; alphitolic acid; 2α,3β-dihydroxyl-lup-20(29)-en-28(19)-lactone; 2α,3α-dihydroxylup-20(29)-en-28-oicacid; alphitolicacid; NCGC00169506-02_C30H48O4_(2alpha,3beta,5xi,9xi,13xi,18xi)-2,3-Dihydroxylup-20(29)-en-28-oic acid |
C30H48O4 |
472.7 |
CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(CC(C(C5(C)C)O)O)C)C)C(=O)O |
|
TCMBANKIN058703 |
Betulonic acid |
Lup-20(29)-en-28-oic acid, 3-oxo-; betulonicacid; 3-Deoxy-3-oxo-betulinic acid; 4481-62-3; betulonic acid; (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-1-Isopropenyl-5a,5b,8,8,11a-pentamethyl-9-oxo-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid; AIDS-051817; AIDS051817; 3-Oxolup-20(29)-en-28-oic acid;Liquidambaric acid |
C30H46O3 |
454.68 |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C(=O)O |
|
TCMBANKIN058705 |
23-hydroxy betulinic acid |
Pulchinenoside A_qt;23-hydroxybetulinic acid |
C30H48O3 |
456.7 g/mol |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)O |
|
TCMBANKIN058706 |
betulin |
AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol |
C30H50O2 |
442.7g/mol |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO |
|
TCMBANKIN058710 |
Anemosapogenin |
3alpha,23-Dihydroxylupa-20(29)-ene-28-oic acid; 23-hydroxybetulinicacid; anemosapogenin |
C30H48O4 |
472.7 |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)C(=O)O |
|
TCMBANKIN058854 |
protopanaxtriol |
(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol |
C30H52O4 |
476.73 g/mol |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)O)C |
|
TCMBANKIN058900 |
myrrhanol a |
myrrhanol C; myrrhanol B; Myrrhanol A |
C30H52O3 |
460.7 g/mol |
CC(=CCCC1C2(CCC(C(C2CCC1(C)O)(C)C)O)C)CCC=C(C)CCC=C(C)CO |
|
TCMBANKIN058945 |
Isoramanone |
ramanone isoramanone |
C21H32O4 |
348.48 |
CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)O)C)O |
|
TCMBANKIN058946 |
3-Hydroxynorlupen-2-one |
AIDS113956; AIDS-113956; 1-[(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-Hydroxy-3a,5a,5b,8,8,11a-hexamethylicosahydro-1H-cyclopenta[a]chrysen-1-yl]ethanone;30-nor-lupan-3β-ol-20-one |
C29H48O2 |
428.7 g/mol |
CC(=O)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C |
|
TCMBANKIN058948 |
PLO |
Prestwick_859; Delta5-Pregnen-3beta-ol-20-one; C01953; Pregnenolona [INN-Spanish]; Prestwick3_000546; LMST02030088; BPBio1_000651; P9129_SIGMA; 81630_FLUKA; 3beta-Hydroxy-5-pregnene-20-one; 3beta-hydroxypregn-5-ene-20-one; Prestwick0_000546; Pregn-5-en-20-one, 3beta-hydroxy-; 5-Pregnen-3-beta-ol-20-one; Prestwick1_000546; Pregn-5-en-20-one, 3beta-hydroxy- (8CI); 3beta-Hydroxy-5-pregnen-20-one; Pregnenolone (progesterone precursor); Prestwick2_000546; Pregnenolone (JAN/INN); Spectrum5_002057; 3beta-Hydroxypregn-5-en-20-one; CMC_13393; SPBio_002512; D00143; Pregn-5-en-20-one, 3-hydroxy-, (3-beta)-; Pregnenolonum [INN-Latin]; delta5-Pregnenolone; 3beta-Hydroxy-Delta5-pregnen-20-one; BSPBio_000591; CHEBI:16581; 5-Pregnen-3beta-ol-20-one; ZINC03861150; Pregn-5-en-20-one, 3-beta-hydroxy-; 3-beta-Hydroxypregn-5-en-20-one; Pregn-5-en-3beta-ol-20-one; Delta5-Pregnene-3beta-ol-20-one; PREGNENOLONE; ST5308463; (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE; 5-Pregnenolone; 17beta-[1-Ketoethyl]-Delta5-androsten-3beta-ol; EINECS 205-647-4; 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 145-13-1; NSC 1616; Pregn-5-ene-3beta-ol-20-one; 116907-59-6; Pregn-5-en-20-one, 3-hydroxy-, (3beta)- |
C21H32O2 |
316.5 g/mol |
CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN058971 |
cucurbitacin b |
Cucurbitacin; Cucurbitacine (B); acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; LMST01010104; NSC144154; 19-nor-9.beta.,10.alpha.-Lanosta-5,23-diene-3,11,22-trione, 9-methyl-2.beta.,16.alpha.,20,25-tetrahydroxy-, 25-acetate; C08794; NSC49451; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; Datisca principle B; [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; Cucurbitacin B; Datiscn Principle B; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, [2.beta.,.gamma.,.beta.,10.alpha.,16.alpha.]-; NCI60_004184; 6199-67-3 |
C32H46O8 |
558.7 |
CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(=O)C4(C)C)O)C)C)C)O)O |
|
TCMBANKIN059026 |
3-O-acetyloleanolic acid |
137867-41-5; Olean-12-en-28-oic acid, 3-(acetyloxy)-, (3beta)-; 118122-15-9; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-acetyloxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; 4339-72-4; 3-O-Acetyloleanolic acid; AIDS070322; 87038-54-8; AIDS-070322; Oleanolic acid 3-acetate;Oleanolic acid deriv. |
C32H50O4 |
498.74 |
CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CC=C4C3(CCC5(C4CC(CC5)(C)C)C(=O)O)C)C)C |
|
TCMBANKIN059029 |
3beta-Acetyl-20,25-epoxydammarane-24beta-ol;3beta-Acetyl-20,25-epoxydammarane-24alpha-ol |
3β-acetyl-2,25-epoxydammarane-24β-ol; 3beta-acetyl-20,25-epoxydammarane-24beta-ol; 3β-acetyl-20,25-epoxydammarane-24β-ol;3β-acetyl-2,25-epoxydammarane-24α-ol; 3beta-acetyl-20,25-epoxydammarane-24alpha-ol; 3β-acetyl-20,25-epoxydammarane-24α-ol |
C32H54O4 |
502.86 |
CC(=O)OC1CCC2(C3CCC4C(CCC4(C3(CCC2C1(C)C)C)C)C5(CCC(C(O5)(C)C)O)C)C |
|
TCMBANKIN059120 |
Ostreasterol |
(3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-4-isopropyl-1-methyl-pent-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Ergosta-5,24(28)-dien-3beta-ol (8CI); (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethyl-4-methylenehexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-methylene-cholest-5-en-3beta-ol; Ergosta-5,24(28)-dien-3beta-ol; NSC 232664; 24-Methylenecholesterol; LMST01030099; Ergosta-5,24(28)-dien-3-ol, (3beta)- (9CI); (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 474-63-5; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Chalinasterol |
C28H46O |
398.66 |
CC(C)C(=C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059124 |
pachymic acid |
pachymicacid |
C33H52O5 |
528.76 |
CC(C)C(=C)CCC(C1C(CC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)O)C(=O)O |
|
TCMBANKIN059144 |
ergosta-4,6,8(14),22-tetraen-3-one |
ergosta-4,6,8(14),22,tetraen-3-one; AJ-54768; (22E)-Ergosta-4,6,8(14),22-tetren-3-one; (22e,24r)-ergosta-4,6,8(14),22-tetraen-3-one; MolPort-023-298-990; Ergosta-4,6,8(14),22-tetraen-3-one, (22E)-; Ergosta-4,6,8(14),22-tetraen-3-one; (1R,9AR,9BR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-ONE; CHEBI:69431; BG01104490; 19254-69-4; CHEMBL3588948; UNII-RI51Y55U8P; Ergone; (22E)-Ergosta-4,6,8(14),22-tetraen-3-one; AKOS022184779; SCHEMBL6365010; (9R,10R,13R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; AK104269; AC1O5V9Q; 24-methylcholesta-4,6,8(14),22-tetraen-3-one; ZINC5761087; W2324; RI51Y55U8P; 27625-48-5; ergone; (9R,10R,13R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; (9R,10R,13R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; 19254-69-4; Ergosta-4,6,8(14),22-tetraen-3-one, (22E)- |
C28H40O |
392.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2=C3C=CC4=CC(=O)CCC4(C3CCC12C)C |
|
TCMBANKIN059147 |
ergosterin |
ergosterol;24-Methylcholesta-5,7,22-trien-3beta-ol; 24alpha-Methyl-22E-dehydrocholestero; (3beta,22E)-Ergosta-5,7,22-trien-3-ol; (7S,9AR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; 45480_FLUKA; (24R)-Ergosta-5,7,22-trien-3b-ol; MEGxm0_000450; Ergosterin; 24R-Methylcholesta-5,7,22E-trien-3b-ol; 57-87-4; Ergosterol; ergosta-5,7,22E-trien-3beta-ol; (3beta)-Ergosta-5,7,22-trien-3-ol; C01694; 5,7,22-Ergostatrien-3beta-ol; AIDS064232; E6510_SIGMA; Provitamin D2; (22E)-Ergosta-5,7,22-trien-3.beta.-ol; A831651; ergosta-5,7,22-trienol; ergosta-5,7,22-trien-3 beta-ol; 24R-Methylcholesta-5,7,22E-trien-3beta-ol; ACon0_000429; ERG; ST073383; (3S,10R,13R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-Methylcholesta-5,7,22-trien-3b-ol; ACon1_000637; (3beta,2E)-Ergosta-5,7,22-trien-3-ol; Provitamine D2; AIDS-064232; 24a-Methyl-22E-dehydrocholesterol; ergosta-5,7,22-trien-3-ol; 47130U_SUPELCO; LMST01030093; (22E)-ergosta-5,7,22-trien-3beta-ol; ZINC04084618; (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 3beta-Hydroxy-5,7,22-ergostatriene; CHEBI:16933; (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (22E,24S)-24-methylcholesta-5,7,22-trien-3beta-ol |
C28H44O |
396.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059149 |
Ergosterol peroxide |
2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C28H44O3 |
428.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C |
|
TCMBANKIN059150 |
polyporusterone c |
polyporusterone C |
C28H44O6 |
476.6 g/mol |
CC(C)C(C)C1C(O1)C(C)(C2CCC3(C2(CCC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)O |
|
TCMBANKIN059171 |
(1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one |
triptonoterpenol;(1R,4aR,10aS)-5-hydroxy-1-(hydroxymethyl)-8-methoxy-1,4a-dimethyl-7-propan-2-yl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one; (1R,4aR,10aS)-5-hydroxy-7-isopropyl-8-methoxy-1,4a-dimethyl-1-methylol-4,9,10,10a-tetrahydro-3H-phenanthren-2-one; 110187-23-0; 2(1H)-Phenanthrenone, 3,4,4a,9,10,10a-hexahydro-5-hydroxy-1-(hydroxymethyl)-8-methoxy-1,4a-dimethyl-7-(1-methylethyl)-, (1R-(1alpha,4aalpha,10abeta))- |
C21H30O4 |
346.46 |
CC(C)C1=CC(=C2C(=C1OC)CCC3C2(CCC(=O)C3(C)CO)C)O |
|
TCMBANKIN059178 |
benzaldehyde,4-(1-methylethyl) |
P-ISOPROPYLBENZALDEHYDE; 4(2-propyl)-benzaldehyde; NSC-4886; 4-(Methylethyl)benzaldehyde; 4-propan-2-ylbenzaldehyde; 4-isopropylbenzaldehyde; NSC4886; WTWBUQJHJGUZCY-UHFFFAOYSA-N; EINECS 204-516-9; (4-isopropyl-phenyl)-methanone; p-Cuminic aldehyde; AJ-24583; KB-39398; AC1Q1P0K; p-(1-methylethyl)benzaldehyde; ZB015528; InChI=1/C10H12O/c1-8(2)10-5-3-9(7-11)4-6-10/h3-8H,1-2H; ACMC-1BVEJ; Cumal; C06577; NSC 4886; cumaldehyde; MCULE-4415970320; RP21225; SBB040237; ST50213395; DTXSID9021974; Cumin aldehyde; BDBM50139366; SCHEMBL87226; P-isopropyl benzaldehyde; 4-Isopropyl-benzaldehyde; NCGC00257518-01; TR-030618; cuminic aldehyde; NCGC00248148-01; FEMA No. 2341; 4-(isopropyl)benzaldehyde; LS-2642; p-Isopropylbenzenecarboxaldehyde; CJ-04641; Cuminaldehyde, 98%; AI3-01853; 122-03-2; UNII-O0893NC35F; ANW-17932; p-Isopropylbenzaldehyde, f; 4-(Propan-2-Yl)Benzaldehyde; bmse000508; FT-0624115; 4(isopropyl)benzaldehyde; AN-13943; RTR-030618; Cuminal p-(1-methylethyl)benzaldehyde; KSC176K3D; Cuminadlehyde; DSSTox_RID_76435; ST2418438; MolPort-000-871-215; Cuminaldehyde, analytical standard; p-iso-Propylbenzaldehyde; AC1L18ZP; AS-12957; F2190-0632; EC 204-516-9; ZINC968248; 4-iPr-Benzaldehyde; DSSTox_CID_1974; p-cumic aldehyde; DB-041645; I0168; cuminaldehyde; CHEBI:28671; W-108440; CTK0H6531; AC1Q1ONB; AK-44502; 4-isopropyl benzaldehyde; Cuminyl aldehyde; 4isopropylbenzaldehyde; Benzaldehyde, 4-(1-methylethyl)-; 4-Isopropylphenylcarboxaldehyde; p-isopropyl-benzaldehyde; Benzaldehyde, p-isopropyl-; p-isopropyl benzaldehyde; Cuminaldehyde, >=98%, FCC, FG; I01-7253; Cumic aldehyde; O0893NC35F; 4-Isopropylbenzenecarboxylate; 4-07-00-00723 (Beilstein Handbook Reference); CHEMBL161577; AKOS000119738; BRN 0636547; DSSTox_GSID_21974; Tox21_300712; Cuminaldehyd; MFCD00006953; AC-2430; 4-(1-Methylethyl)benzaldehyde; p-isopropyl-Benzaldehyde; cuminal; CAS-122-03-2; WLN: VHR DY1 & 1;FEMA No. 2341; ZB015528; W-108440; CAS-122-03-2; InChI=1/C10H12O/c1-8(2)10-5-3-9(7-11)4-6-10/h3-8H,1-2H; P-ISOPROPYLBENZALDEHYDE; Cumal; C06577; LS-2642; DSSTox_GSID_21974; I01-7253; 4(2-propyl)-benzaldehyde; Cumic aldehyde; TR-030618; EC 204-516-9; Cuminaldehyde, >=98%, FCC, FG; 4-07-00-00723 (Beilstein Handbook Reference); 4(isopropyl)benzaldehyde; DTXSID9021974; CTK0H6531; SCHEMBL87226; KSC176K3D; BRN 0636547; AN-13943; Cumin aldehyde; 122-03-2; P-isopropyl benzaldehyde; MFCD00006953; BDBM50139366; AKOS000119738; p-Isopropylbenzaldehyde, f; AK-44502; p-Isopropylbenzenecarboxaldehyde; AS-12957; EINECS 204-516-9; ZINC968248; Tox21_300712; 4-propan-2-ylbenzaldehyde; cuminic aldehyde; AC1Q1P0K; ST50213395; I0168; CHEMBL161577; NSC-4886; MolPort-000-871-215; p-cumic aldehyde; NCGC00248148-01; 4-iPr-Benzaldehyde; 4-isopropyl benzaldehyde; ACMC-1BVEJ; Cuminaldehyde, 98%; p-(1-methylethyl)benzaldehyde; NSC4886; 4-Isopropyl-benzaldehyde; AJ-24583; Cuminyl aldehyde; 4-isopropylbenzaldehyde; 4-(Methylethyl)benzaldehyde; FT-0624115; MCULE-4415970320; DSSTox_CID_1974; 4-(1-Methylethyl)benzaldehyde; p-isopropyl-Benzaldehyde; Cuminaldehyde, analytical standard; RTR-030618; AC1Q1ONB; F2190-0632; UNII-O0893NC35F; WLN: VHR DY1 & 1; 4-(isopropyl)benzaldehyde; cuminaldehyde; bmse000508; (4-isopropyl-phenyl)-methanone; RP21225; Cuminadlehyde; 4-(Propan-2-Yl)Benzaldehyde; Benzaldehyde, 4-(1-methylethyl)-; ST2418438; WTWBUQJHJGUZCY-UHFFFAOYSA-N; AC-2430; p-iso-Propylbenzaldehyde; Benzaldehyde, p-isopropyl-; 4-Isopropylbenzenecarboxylate; cuminal; NCGC00257518-01; SBB040237; 4-Isopropylphenylcarboxaldehyde; NSC 4886; p-Cuminic aldehyde; KB-39398; AI3-01853; AC1L18ZP; O0893NC35F; Cuminaldehyd; ANW-17932; DSSTox_RID_76435; Cuminal p-(1-methylethyl)benzaldehyde; DB-041645; CHEBI:28671; 4isopropylbenzaldehyde; CJ-04641 |
C10H12O |
148.2 g/mol |
CC(C)C1=CC=C(C=C1)C=O |
|
TCMBANKIN059195 |
(1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane |
(1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane |
C10H16 |
136.23 g/mol |
CC(C)C12CCC(=C)C1C2 |
|
TCMBANKIN059221 |
Hollow cylinder protein complex |
17904-55-1; D:C-Friedo-B':A'-neogammacer-9(11)-ene, 3-methoxy-, (3beta,8beta,13beta,14alpha,17beta,18alpha,21beta)-;AC1NSZHW; (5aR,9S,11aS,13bR)-9-methoxy-3a,5a,8,8,11a,13a-hexamethyl-3-propan-2-yl-1,2,3,4,5,5b,6,7,7a,9,10,11,13,13b-tetradecahydrocyclopenta[a]chrysene |
C31H52O |
440.74 |
CC(C)C1CCC2C1(CCC3(C2(CC=C4C3CCC5C4(CCC(C5(C)C)OC)C)C)C)C |
|
TCMBANKIN059249 |
CLR |
5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N |
C27H46O |
386.65 |
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059272 |
diisobutyl phthalate |
di-isobutyl phthalate;ST5405544; diisobutyl benzene-1,2-dicarboxylate; benzene-1,2-dicarboxylic acid diisobutyl ester; Di-iso-butyl phthalate; 80130_FLUKA; Isobutyl phthalate; bis(2-methylpropyl) benzene-1,2-dicarboxylate; (C4-C13) Branched alkyl alcohols, phthalic anhydride ester; ZINC00388318; EINECS 201-553-2; NSC15316; 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester; Diisobutyl phthalate; 152641_ALDRICH; EINECS 273-157-8; 68951-39-3; C15205; AI3-04278; Phthalic acid, diisobutyl ester; BRN 2054802; NCGC00091360-01; NSC 15316; WLN: 1Y1&1OVR BVO1Y1&1; 4-09-00-03177 (Beilstein Handbook Reference); Diisobutylester kyseliny ftalove [Czech]; Hexaplas M/1B; 1,2-Benzenedicarboxylic acid, C4-13-branched alkyl esters; AI3-04278 (USDA); Kodaflex DIBP; 68955-80-6; Hatcol DIBP; HSDB 5247; CCRIS 6193; di-l-butyl phthalate (DIBP); Di(i-butyl)phthalate; SMR000112470; MLS000516002; 84-69-5; Palatinol IC |
C16H22O4- C6H4[CO2CH2CH(CH3)2]2 |
278.34 g/mol |
CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C |
|
TCMBANKIN059284 |
delta 5-Pregnenetriol |
(3S,8R,9S,10R,13S,14S,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol; 903-67-3; 5-Pregnene-3beta,17alpha,20alpha-triol; Pregn-5-ene-3,17,20-triol, (3beta,20S)-; Pregn-5-ene-3beta,17alpha,20alpha-triol; 5-pregnene-3β,17α,20α-triol |
C21H34O3 |
334.49 |
CC(C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O)O |
|
TCMBANKIN059308 |
12-Deacetylganoderic acid H |
12-deacetylganoderic acid h;Ganoderic acid C6 |
C30H42O8 |
530.72g/mol |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)O)C)C |
|
TCMBANKIN059309 |
ganoderic acid G |
ganode-8-en-ricacid g |
C30H44O8 |
532.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)O)C)C |
|
TCMBANKIN059310 |
ganodericacid c1 |
ganodericacid c; ganoderic acid D; ganode-8-en-ricacid c1 |
C30H42O7 |
514.6 g/mol |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C |
|
TCMBANKIN059311 |
ganoderic acid B |
ganode-8-en-ricacid b; ganoderic acid b |
C30H44O7 |
516.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C |
|
TCMBANKIN059312 |
ganoderic acid AP |
ganoderic acid a; ganoderic acid A; ganode-8-en-ricacid a |
C30H44O7 |
516.67 |
CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
|
TCMBANKIN059313 |
methyl-7-epiganoderate |
methyl 6-[(10S,13R,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate; AC1NSYD7;methyl ganoderate a;methyl ganoderate A |
C31H46O7 |
530.7 g/mol |
CC(CC(=O)CC(C)C(=O)OC)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
|
TCMBANKIN059316 |
SMR000232320 |
(5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methyl-heptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; MLS000563510; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(1S,3R,4S)-3,4,5-trihydroxy-1,5-dimethylhexyl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(1S,3R,4S)-3,4,5-trihydroxy-1,5-dimethyl-hexyl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one;piscidinol a |
C30H50O4 |
474.7 g/mol |
CC(CC(C(C(C)(C)O)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C |
|
TCMBANKIN059317 |
Alisol A monoacetate |
alisol a 24-acetate;alisol e 24-acetate;alisol a monoacetate |
C32H52O6 |
532.8 g/mol |
CC(CC(C(C(C)(C)O)OC(=O)C)O)C1=C2CC(C3C4(CCC(=O)C(C4CCC3(C2(CC1)C)C)(C)C)C)O |
|
TCMBANKIN059321 |
Ganoderic acid theta |
ganodericacid θ |
C30H42O8 |
530.65 |
CC(CC(C=C(C)C(=O)O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)O)C)C |
|
TCMBANKIN059322 |
Ganoderic acid zeta |
ganodericacid ζ;ganoderic acid Z;Ganoderic acid XL;ganodericacidz |
C30H42O7 |
514.6 g/mol;456.7 |
CC(CC(C=C(C)C(=O)O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN059323 |
Ganoderic acid delta |
ganodericacid δ |
C30H44O7 |
516.7 g/mol |
CC(CC(C=C(C)C(=O)O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
|
TCMBANKIN059325 |
alisol C monoacetate |
alisol cmonoacetate;alisol c 23-acetate |
C32H48O6 |
528.7 g/mol |
CC(CC(C1C(O1)(C)C)OC(=O)C)C2=C3CC(C4C5(CCC(=O)C(C5CCC4(C3(CC2=O)C)C)(C)C)C)O |
|
TCMBANKIN059337 |
CHD;cholalic acid;cholicacid |
5beta-Cholanic acid, 3alpha,7alpha,12alpha-trihydroxy- (7CI); cholic acid; 3alpha,7alpha,12alpha-Trihydroxycholanic acid; 81-25-4 (FREE ACID); CHOLATE; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanoic acid; (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-beta-cholanic acid; (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; Colalin; C9377_SIGMA; SMR000112165; 3.alpha.,7.alpha.,12.alpha.-Trihydroxy-5.beta.-cholanic acid; AIDS017669; 5.beta.-Cholan-24-oic acid, 3.alpha.,7.alpha.,12.alpha.-trihydroxy-; MLS001066422; Cholan-24-oic acid, 3,7,12-trihydroxy-, (3alpha,5beta,7alpha,12alpha)- (9CI); AIDS-017669; Cholic acid (8CI); Cholalic acid; Cholan-24-oic acid, 3,7,12-trihydroxy-, (3-alpha,5-beta,7-alpha,12-alpha)-; Cholsaeure; C1129_SIGMA; ST024722; Spectrum5_002005; 5beta-Cholanic acid-3alpha,7alpha,12alpha-triol 5beta-Cholic acid; Cholalin; 17beta-[1-Methyl-3-carboxypropyl]etiocholane-3alpha,7alpha,12alpha-triol; 73163-53-8 (NA SALT); NSC-6135; 81-25-4; 3-&alpha,7-&alpha,12-&alpha-trihydroxy-5-&beta-cholanate; (3.alpha.,5.beta.,7.alpha.,12.alpha.)-3,7,12-Trihydroxycholan-24-oic acid sodium salt; (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid; NSC6135; CHEBI:16359; C00695; LMST04010001;cholic acid;cholic acid |
C24H40O5 |
408.57;408.6 g/mol |
CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C |
|
TCMBANKIN059345 |
ganoderic acid TQ |
ganodericacid t-q |
C32H46O5 |
510.7 g/mol |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)OC(=O)C |
|
TCMBANKIN059346 |
Ganoderic acid X |
3β-hydroxy-16α-acetoxy-lanosta-7,9(11),24-trien-21-oicacid |
C32H48O5 |
512.72 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)O)C)C)C)OC(=O)C |
|
TCMBANKIN059352 |
lanosterol |
LAN; (3beta)-lanosta-8,24-dien-3-ol; L5768_SIGMA; ZINC03870056; ST5309405; CHEBI:16521; Lanosta-8,24-dienol; 79-63-0; LMST01010017; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; lanosta-8,24-dien-3beta-ol; (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol; Botalan base 138; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.)-; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol; 8,24-Lanostadien-3beta-ol; L1504_SIGMA; Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-; Lanster; C01724; NSC60677; LANOSTEROL; Lanosterin; 3beta-Hydroxy-8,24-lanostadiene; Lanosta-8,24-dien-3.beta.-ol |
C30H50O |
426.72 g/mol |
CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN059358 |
AIDS070764 |
(5R,10S,13R,14R,15S,17R)-15-hydroxy-17-[(2R)-7-hydroxy-6-(hydroxymethyl)hept-5-en-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; (5R,10S,13R,14R,15S,17R)-15-hydroxy-17-[(1R)-6-hydroxy-5-(hydroxymethyl)-1-methyl-hex-4-enyl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; AIDS-070764; (5R,10S,13R,14R,15S,17R)-15-hydroxy-17-[(1R)-6-hydroxy-1-methyl-5-methylol-hex-4-enyl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; (5R,10S,13R,14R,15S,17R)-15-hydroxy-17-[(1R)-6-hydroxy-5-(hydroxymethyl)-1-methylhex-4-enyl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
C30H46O4 |
470.68 |
CC(CCC=C(CO)CO)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN059391 |
Lantadene A |
(4R,4aS,6aR,6aS,6bR,8aR,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-4-[(Z)-2-methylbut-2-enoyl]oxy-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid; LANTADENE A; lantadene a; Olean-12-en-28-oic acid, 22-((2-methyl-1-oxo-2-butenyl)oxy)-3-oxo-, (22beta(Z))-; CHEMBL510691; ZINC42835006; LS-98303; 22-((2-Methyl-1-oxo-2-butenyl)oxy)-3-oxo-olean-12-en-28-oic acid, (22beta); Olean-12-en-28-oic acid, 22-beta-hydroxy-3-oxo-, 2-methylcrotonate, (Z)-; HSDB 3503; MolPort-039-052-678; BG01189754; 22-beta-Angeloyloxyoleanolic acid; 9SK62WCU1W; 467-81-2; AC1O5M0E; (4R,4AS,6AS,6BR,8AR,12AR,12BR,14BS)-2,2,6A,6B,9,9,12A-HEPTAMETHYL-4-{[(2Z)-2-METHYLBUT-2-ENOYL]OXY}-10-OXO-3,4,5,6,7,8,8A,11,12,12B,13,14B-DODECAHYDRO-1H-PICENE-4A-CARBOXYLIC ACID; 22-((2-Methyl-1-oxo-2-butenyl)oxy)-3-oxo-olean-12-en-28-oic acid, 22-beta(Z)-; Olean-12-en-28-oic acid, 22beta-hydroxy-3-oxo-, 2-methylcrotonate, (Z)-; Rehmannic acid; UNII-9SK62WCU1W; rehmannin |
C35H52O5 |
552.78 |
CC=C(C)C(=O)OC1CC(CC2C1(CCC3(C2=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C)C(=O)O)(C)C |
|
TCMBANKIN059402 |
Sitosterol alpha1 |
|
C30H50O |
426.72 |
CC=C(CCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4C)O)C)C)C(C)C |
|
TCMBANKIN059403 |
Fucosterol |
|
C29H48O |
412.7 g/mol |
CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN059404 |
Guggulsterone |
|
C21H28O2 |
312.45 |
CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
|
TCMBANKIN059464 |
7-oxodihydro karounidiol |
|
C30H48O3 |
456.7 g/mol |
CC1(C(CCC2(C1CC(=O)C3=C2CCC4(C3(CCC5(C4CC(CC5)(C)CO)C)C)C)C)O)C |
|
TCMBANKIN059509 |
rabdosinatol |
|
C20H30O4 |
334.45 |
CC1(C2CC(C34C(C2(CCC1=O)C)CCC(C3O)C(=C)C4O)O)C |
|
TCMBANKIN059521 |
B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene |
|
C10H16 |
136.23 g/mol |
CC1(C2CCC(=C)C1C2)C |
|
TCMBANKIN059531 |
eucalyptol |
|
C10H18O |
154.25 g/mol |
CC1(C2CCC(O1)(CC2)C)C |
|
TCMBANKIN059532 |
(1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one |
|
C10H16O |
152.23 g/mol |
CC1(C2CCC1(C(=O)C2)C)C |
|
TCMBANKIN059538 |
11-deoxyglycyrrhetic acid |
|
C30H48O3 |
456.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN059539 |
abrusgenicacid |
|
C30H48O4 |
472.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN059540 |
WILFORLIDE A |
|
C30H46O3 |
454.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C |
|
TCMBANKIN059547 |
16-oxodiepiserratenediol |
|
C30H48O3 |
456.7 g/mol |
CC1(C2CCC3(CC4=CC(=O)C5C(C(CCC5(C4CCC3C2(CCC1O)C)C)O)(C)C)C)C |
|
TCMBANKIN059565 |
leonuridine |
|
C15H24O9 |
348.34 g/mol |
CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O |
|
TCMBANKIN059573 |
soyasponinⅢ |
|
C42H68O14 |
797 g/mol |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(C1)O)C)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C |
|
TCMBANKIN059575 |
Sapogenol C |
|
C30H48O2 |
440.7 g/mol |
CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C=C1)C)C)C)(C)CO)O)C)C |
|
TCMBANKIN059596 |
Caulophyllogenin |
|
C30H48O5 |
488.7 |
CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)O)C)C(=O)O)C |
|
TCMBANKIN059605 |
2α-hydroxyoleanolic acid;crategolicacid;2beta-hydroxyoleanolic acid;bredemolic acid;2a- hydroxy oleanolic acid;2α,3α-dihydroxyolean-12-en-28-oic acid;masilinic acid;(2β,3β)-maslinicacid;3-epimaslinic acid ;2α,3β-dihydroxyolean-12-en-28-oicacid;augustic acid ;Maslinic acid |
|
C30H48O4 |
472.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN059606 |
arjunic acid |
|
C30H48O5 |
488.7 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1O)C)C(=O)O)C |
|
TCMBANKIN059612 |
3-oxo-olean-12-en-28-oicacid |
|
C30H46O3 |
454.7 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN059614 |
Amyrin |
|
C30H50O |
426.72 |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C)C |
|
TCMBANKIN059642 |
Kirenol |
|
C20H34O4 |
338.48 |
CC1(CCC2C(=C1)CCC3C2(CC(CC3(C)CO)O)C)C(CO)O |
|
TCMBANKIN059643 |
sandaracopimaric acid |
|
C20H30O2 |
302.5 g/mol |
CC1(CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)C=C |
|
TCMBANKIN059645 |
isopimaric acid |
|
C20H30O2 |
302.5 g/mol |
CC1(CCC2C(=CCC3C2(CCCC3(C)C(=O)O)C)C1)C=C |
|
TCMBANKIN059651 |
NSC 308879 |
|
C30H52O3 |
460.73 |
CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)O)C)C)O)C)C |
|
TCMBANKIN059663 |
22-hydroxyhopane |
|
C30H52O |
428.7 g/mol |
CC1(CCCC2(C1CCC3(C2CCC4C3(CCC5C4(CCC5C(C)(C)O)C)C)C)C)C |
|
TCMBANKIN059664 |
NCI60_035895 |
|
C20H26O4 |
330.42 |
CC1(CCCC2(C1CCC34C2C=C5C(=C(C(=O)O5)CO)C3O4)C)C |
|
TCMBANKIN059688 |
tripterygone |
|
C29H42O4 |
454.6 g/mol |
CC1=C(C(=O)C=C2C1(CCC3C2CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O |
|
TCMBANKIN059689 |
tripterine |
|
C29H38O4 |
450.61 |
CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O |
|
TCMBANKIN059703 |
Zeaxanthin |
|
C40H56O2 |
568.87 |
CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)O)C)C)C |
|
TCMBANKIN059758 |
triptinin a |
|
C21H28O3 |
328.45 g/mol |
CC1=C(CCC2(C1CCC3=C2C=CC(=C3OC)C(C)C)C)C(=O)O |
|
TCMBANKIN059842 |
o-Acetyl-p-cresol |
|
C9H10O2 |
150.17 g/mol |
CC1=CC(=C(C=C1)O)C(=O)C |
|
TCMBANKIN059901 |
p-xylene |
|
C8H10 |
106.17 |
CC1=CC=C(C=C1)C |
|
TCMBANKIN059916 |
2,6,6-trimethyl-2,4-cycloheptadien-1-one |
|
C10H14O |
150.22 |
CC1=CC=CC(CC1=O)(C)C |
|
TCMBANKIN059920 |
o-methylacetophenone |
|
C9H10O |
134.17 g/mol |
CC1=CC=CC=C1C(=O)C |
|
TCMBANKIN059967 |
germacrone |
|
C15H22O |
218.33 |
CC1=CCC(=C(C)C)C(=O)CC(=CCC1)C |
|
TCMBANKIN059982 |
d-limonene |
|
C10H16 |
136.23 g/mol |
CC1=CCC(CC1)C(=C)C |
|
TCMBANKIN060079 |
14-deoxy-11-oxoandrographolide |
|
C20H28O5 |
348.4 g/mol |
CC12CCC(C(C1CCC(=C)C2C(=O)CC3=CC(=O)OC3)(C)CO)O |
|
TCMBANKIN060083 |
wistariasapogenol A |
|
C30H48O4 |
472.7 |
CC12CCC(C(C1CCC3(C2CC=C4C3(CCC5(C4CC(CC5=O)(C)CO)C)C)C)(C)CO)O |
|
TCMBANKIN060093 |
gamabufotalin |
|
C24H34O5 |
402.5 g/mol |
CC12CCC(CC1CCC3C2C(CC4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O |
|
TCMBANKIN060095 |
Gitoxigenin |
|
C23H34O5 |
390.51 |
CC12CCC(CC1CCC3C2CCC4(C3(CC(C4C5=CC(=O)OC5)O)O)C)O |
|
TCMBANKIN060104 |
paristerone |
|
C27H44O7 |
480.6 g/mol |
CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O |
|
TCMBANKIN060106 |
Cynotoxin |
|
C23H32O6 |
404.5g/mol |
CC12CCC3C(C1(CCC2C4=CC(=O)OC4)O)CCC5(C3(CCC(C5)O)C=O)O |
|
TCMBANKIN060132 |
Hypodiolide A |
|
C20H30O3 |
318.45 |
CC12CCCC3(C1CCC45C3CCC(C4)C(C5)(C)O)COC2=O |
|
TCMBANKIN060140 |
friedelan-3-one |
|
C30H50O |
426.7 g/mol |
CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C |
|
TCMBANKIN060181 |
azukisaponin v |
|
C48H78O18 |
943.1 g/mol |
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4CCC5(C(C4(C)CO)CCC6(C5CC=C7C6(CCC8(C7CC(CC8O)(C)C)C)C)C)C)C(=O)O)O)O)CO)O)O)O)O)O |
|
TCMBANKIN060183 |
ginsenoside- Re |
|
C48H82O18 |
947.15 |
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O |
|
TCMBANKIN060247 |
Saikosaponin D |
|
C42H68O13 |
780.98g/mol |
CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C=CC56C4(CC(C7(C5CC(CC7)(C)C)CO6)O)C)C)C)O)OC8C(C(C(C(O8)CO)O)O)O)O |
|
TCMBANKIN060311 |
gramisterol |
|
C29H48O |
412.69 g/mol |
CC1C(CCC2(C1CC=C3C2CCC4(C3CCC4C(C)CCC(=C)C(C)C)C)C)O |
|
TCMBANKIN060313 |
epifriedelinol |
|
C30H52O |
428.73 g/mol |
CC1C(CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C)O |
|
TCMBANKIN060314 |
epifriedelinol acetate |
|
C32H54O2 |
1128.21 |
CC1C(CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C)OC(=O)C |
|
TCMBANKIN060372 |
dl-Thujone |
|
C10H16O |
152.23 |
CC1C2CC2(CC1=O)C(C)C |
|
TCMBANKIN060394 |
Amarolide 11-acetate |
|
C22H30O7 |
406.5 g/mol |
CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)OC(=O)C)C)C)O |
|
TCMBANKIN060401 |
acetic acid [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(5-oxo-2H-furan-3-yl)ethyl]-1-decalinyl] ester |
|
C22H34O5 |
378.5g/mol |
CC1CC(C2C(CCCC2(C1(CCC3=CC(=O)OC3)O)C)(C)C)OC(=O)C |
|
TCMBANKIN060428 |
Peimisine |
|
C27H41NO3 |
427.6 g/mol |
CC1CC2C(C(C3(O2)CCC4C5CC(=O)C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 |
|
TCMBANKIN060473 |
dehydroagastol |
|
C21H26O4 |
342.4 g/mol |
CC1CCC2(C(C1=C)CC(=O)C3=C2C(=C(C(=C3O)C(=C)C)OC)O)C |
|
TCMBANKIN060475 |
Pennogenin |
|
C27H42O4 |
430.6 g/mol |
CC1CCC2(C(C3(C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)O)C)OC1 |
|
TCMBANKIN060491 |
EINECS 213-897-0 |
|
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
|
TCMBANKIN060507 |
gitogenin |
|
C27H44O4 |
432.64 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CC(C(C6)O)O)C)C)C)OC1 |
|
TCMBANKIN060512 |
smilagenin |
|
C27H44O3 |
416.6 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN060524 |
madecassicacid |
|
C30H48O6 |
504.7 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)O |
|
TCMBANKIN060529 |
Tormentic acid |
|
C30H48O5 |
488.7 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN060532 |
corosolic acid |
|
C30H48O4 |
472.7 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)O |
|
TCMBANKIN060533 |
Methyl 2alpha-hydroxyursolate |
|
C31H50O4 |
486.81 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)OC |
|
TCMBANKIN060534 |
23-hydroxytormentic acid |
|
C30H48O6 |
504.7 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN060536 |
asiatic acid |
|
C30H48O5 |
488.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)O |
|
TCMBANKIN060537 |
Euscaphic acid 3,4-monoacetonide |
|
C30H48O5 |
488.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC6C(C5(C)C)OC(O6)(C)C)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN060538 |
3-oxo-19α-hydroxyurs-12-en-28-oic acid |
|
C30H46O4 |
634.54 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1(C)O)C)C(=O)O |
|
TCMBANKIN060540 |
Boswellic acid;β一 boswellic acid;β-boswellicacid |
|
C30H48O3 |
456.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C |
|
TCMBANKIN060543 |
Chinova acid;quinovic acid |
|
C30H46O5 |
486.68 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C(=O)O)C(=O)O |
|
TCMBANKIN060544 |
alpha-amyrin |
|
C30H50O |
426.72 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
|
TCMBANKIN060547 |
ursolic aldehyde |
|
C30H48O2 |
440.7 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C=O |
|
TCMBANKIN060548 |
NSC 159627 |
|
C30H50O2 |
442.72 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)CO |
|
TCMBANKIN060558 |
17020-04-1 |
|
C32H52O2 |
468.75 |
CC1CCC2(CCC3(C4=CCC5C(C(CCC5(C4CCC3(C2C1C)C)C)OC(=O)C)(C)C)C)C |
|
TCMBANKIN060578 |
Solanidine |
|
C27H43NO |
397.6 g/mol |
CC1CCC2C(C3C(N2C1)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C |
|
TCMBANKIN060674 |
Δ7-stigmasterol |
|
C29H48O |
412.69 |
CCC(C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN060675 |
stigmasta-7, 22-dien-3-one |
|
C29H46O |
410.7 g/mol |
CCC(C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(=O)C4)C)C)C(C)C |
|
TCMBANKIN060686 |
7-oxo-β-sitosterol |
|
C29H48O2 |
428.7 g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2C(=O)C=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN060688 |
stigmastane-3,6-dione |
|
C29H48O2 |
428.69 |
CCC(CCC(C)C1CCC2C1(CCC3C2CC(=O)C4C3(CCC(=O)C4)C)C)C(C)C |
|
TCMBANKIN060691 |
poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol |
|
C29H50O |
414.71 g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN060693 |
Sitogluside |
|
C35H60O6 |
576.85g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
|
TCMBANKIN060785 |
Levistolid A |
|
C24H28O4 |
380.48 |
CCCC=C1C2=C(C3C(CC2)C4CCC35C(=C4)C(=O)OC5=CCCC)C(=O)O1 |
|
TCMBANKIN060811 |
Di(2-ethylhexyl)phthalate;Ethylhexyl phthalate;phthalic acid bis-(2-ethyl-hexyl)ester;bis(2-ethyl-hexyl)-phthalate;Octoil |
|
C24H38O4 |
390.6 g/mol |
CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC |
|
TCMBANKIN060958 |
oleic acid;cis-oleic acid;oleinic acid |
|
C18H34O2 |
282.46 |
CCCCCCCCC=CCCCCCCCC(=O)O |
|
TCMBANKIN061011 |
1-tridecene; Tridecylene; tridecene |
|
C13H26 |
182.35 |
CCCCCCCCCCCC=C |
|
TCMBANKIN061038 |
Gaidic acid |
|
C16H30O2 |
254.41 g/mol |
CCCCCCCCCCCCCC=CC(=O)O |
|
TCMBANKIN061091 |
stearic acid |
|
CH3(CH2)16COOH |
284.5 g/mol |
CCCCCCCCCCCCCCCCCC(=O)O |
|
TCMBANKIN061139 |
n-nonacosane |
|
C29H60 |
408.79 g/mol |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCC |
|
TCMBANKIN061153 |
Octacosanol;octacosanol-1;1-octacosanol |
|
C28H58O |
410.8 g/mol |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCO |
|
TCMBANKIN061220 |
TBP |
|
C12H27O4P |
266.31 |
CCCCOP(=O)(OCCCC)OCCCC |
|
TCMBANKIN061571 |
curcumin ii |
demethoxycurrcumin;24939-17-1; D03EDF; AC1NV635; SCHEMBL2553051; Demethoxycurcumin; CHEBI:65737; X1121; 33171-16-3; (1E,6E)-1-(4-Hydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; (1E,6E)-1-(4-HYDROXY-3-METHOXY-PHENYL)-7-(4-HYDROXYPHENYL)HEPTA-1,6-DIENE-3,5-DIONE; AK198734; 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; monodemethoxycurcumin; (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-hepta-1,6-diene-3,5-dione; (2E)-Demethoxy Curcumin; BHCFM; feruloyl-p-coumaroylmethane; CS-3738; (1E,4Z,6E)-5-Hydroxy-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,4,6-trien-3-one; Demethoxycurcumin, >=98% (HPLC); 1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione; Feruloyl-P-hydroxycinnnamoylmethane; cid_5324476; NSC-687841; 9331AF; W2F8059T80; p-hydroxycinnamoylferuloylmethane; demethoxy-curcumin; 4-hydroxycinnamoyl(feruloyl)methane; AKOS015903509; 1-(4-Hydroxy-3-methoxyphenyl)-7-(p-hydroxyphenyl)-1,6-heptadiene-3,5-dione; 22608-11-3; 1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 9CI; p-Hydroxycinnamoylferuloylmethane; ZINC5115722; UNII-W2F8059T80; BDBM50163744; (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione; N1720; MolPort-016-638-373; 4-Hydroxycinnamoyl(feroyl)methane; 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)- (VAN); 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E,6E)-; HY-N0006; BG01626458; Q-100287; I14-18646; curcuminII; MolPort-044-724-513; 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-; NSC687841; 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one; 1281950-91-1; Ambap22608-11-3; 85801-93-0; (E,E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione; 1-(4-Hydroxystyryl)-3-(3-methoxy-4-hydroxystyryl)propanedial; SCHEMBL431246; Demethoxycurcumin, analytical standard; (1E,6E)-1-(4-Hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,6-diene-3,5-dione; demethoxycurrcumin; AK544533; MFCD03427310; SCHEMBL13521973;24939-17-1; D03EDF; AC1NV635; SCHEMBL2553051; Demethoxycurcumin; CHEBI:65737; X1121; 33171-16-3; (1E,6E)-1-(4-Hydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; (1E,6E)-1-(4-HYDROXY-3-METHOXY-PHENYL)-7-(4-HYDROXYPHENYL)HEPTA-1,6-DIENE-3,5-DIONE; AK198734; demethoxy curcumin; 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; monodemethoxycurcumin; (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-hepta-1,6-diene-3,5-dione; (2E)-Demethoxy Curcumin; BHCFM; feruloyl-p-coumaroylmethane; CS-3738; (1E,4Z,6E)-5-Hydroxy-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,4,6-trien-3-one; Demethoxycurcumin, >=98% (HPLC); 1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione; Feruloyl-P-hydroxycinnnamoylmethane; cid_5324476; NSC-687841; 9331AF; W2F8059T80; AIDS110025; demethoxy-curcumin; (1E,6E)-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; 4-hydroxycinnamoyl(feruloyl)methane; AKOS015903509; 1-(4-Hydroxy-3-methoxyphenyl)-7-(p-hydroxyphenyl)-1,6-heptadiene-3,5-dione; 22608-11-3; 1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 9CI; p-Hydroxycinnamoylferuloylmethane; ZINC5115722; UNII-W2F8059T80; 1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; BDBM50163744; (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione; N1720; MolPort-016-638-373; 4-Hydroxycinnamoyl(feroyl)methane; 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)- (VAN); 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E,6E)-; HY-N0006; BG01626458; Q-100287; I14-18646; curcuminII; MolPort-044-724-513; 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-; NSC687841; 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one; 1281950-91-1; Ambap22608-11-3; 85801-93-0; (E,E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione; 1-(4-Hydroxystyryl)-3-(3-methoxy-4-hydroxystyryl)propanedial; SCHEMBL431246; Demethoxycurcumin, analytical standard; (1E,6E)-1-(4-Hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,6-diene-3,5-dione; AIDS-110025; AK544533; MFCD03427310; SCHEMBL13521973;demethoxycurcumin |
C20H18O5 |
338.35 |
COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O |
|
TCMBANKIN061784 |
lirioresinol b dimethyl ether |
1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-, (1S,3aR,4S,6aR)-; C24H30O8; ( )-O,O-Dimethyllirioresinol B; 1H,3H-Furo(3,4-c)furan, 3aalpha,4,6,6aalpha-tetrahydro-1alpha,4alpha-bis(3,4,5-trimethoxyphenyl)-; ( )-Yangabin; Yangabin; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5)-trimethoxyphenyl)-, 1alpha,3aalpha,4alpha,6aalpha)-; CCRIS 8944; Lirioresinol B dimethyl ether; O,O-Dimethyllirioresinol B; lirioresinol b dimethyl-ether; Lirioresinol B, dimethyl-; LS-70759; (1S-(1alpha,3aalpha,4alpha,6aalpha))-isomer of epiyangambin; Lirioresinol B, O,O-dimethyl-; (- )-lirioresinol B; ACon1_001856; (1R,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; MEGxp0_001363; CTK4E6827; DTXSID10175733; SCHEMBL17385618; AC1L4ZYE; (1r,3ar,4r,6ar)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1h,3h-furo[3,4-c]furan; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-,(1R,3aR,4R,6aR)-; Diayangambin; (+)-Diayangambin; AC1Q70YI; (3R,3aR,6R,6aR)-3,6-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-(1R)-1alpha,3abeta,4alpha,6abeta-1H,3H-furo(3,4-c)furan; 21453-68-9; ZINC31477287; yangambin; C10894; ZINC04098936; (1S,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; 13060-14-5; Yangambin; diayangambin |
C24H30O8 |
446.5 g/mol |
COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC |
|
TCMBANKIN061806 |
aristolochicacid iva |
aristolochic acid Ⅳa; aristolochic acid D;Aristoloside_qt |
C17H11NO8 |
357.27g/mol |
COC1=CC(=CC2=C3C(=C(C=C12)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O)O |
|
TCMBANKIN061873 |
aristolochicacid |
8-Methoxy-3,4-methylendioxxy-10-nitro-1-phenanthrencarbonsaeure; NCGC00095981-03; aristolochic acid; API0000398; TNP00273; MolPort-001-797-985; Bio1_000907; DivK1c_006544; Aristolochind; 8-METHOXY-6-NITROPHENANTHROL(3,4-D)-1,3-DIOXIDE-5-; IDI1_033910; Aristolochin; NCIMech_000812; C-20352; 8-methoxy-6-nitro-2H-phenanthro[3,4-d]1,3-dioxolene-5-carboxylic acid; aris-tolochic acid; Phenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-; NCGC00017334-04; HMS1791H22; CTK4G6973; CC-24181; KBio2_004204; KBio2_006772; SC-14173; NSC 11926; KBioGR_002387; DTXSID0040969; Aristolochic acid I, powder; SR-05000002369-3; CHEBI:2825; 8-Methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylic acid; Spectrum2_000822; KBioSS_001636; KBio3_002068; CCG-36162; 8-METHOXY-6-NITROPHENANTHROL(3,4-D)-1,3-DIOXIDE-5-CARBOXYLIC ACID; CCRIS 1544; NCGC00095981-04; 61117-05-3; NCGC00095981-02; 313A677; SPBio_000743; 8-Methoxy-6-Nitrophenanthol-(3,4-d)-1,3-Dioxole-5-Carboxylic Acid; I07-0211; ZINC52; Q-100394; C17H11NO7; AB0028965; NCI60_000460; C08469; Aristolochic acid 1; Spectrum5_000729; KBio2_002728; TR 1736; 8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid; MLS002695974; Aristolochid; ST50307164; SCHEMBL166284; 313-67-7; KBioGR_000160; Phenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-; Bio2_000640; Ambotz313-67-7; Aristolochic acid I, European Pharmacopoeia (EP) Reference Standard; Tardolyt; AC1L1D86; NSC 50413; KBio2_005296; 8-Methoxy-6-nitro-phenanthro[3,4-d][1,3]dioxole-5-carboxylic acid; 8-methoxy-6-nitro-2H-phenanthro[4,3-d]1,3-dioxolene-5-carboxylic acid; NSC50413; 94218WFP5T; BSPBio_001440; SR-05000002369-2; CHEMBL93353; 3,4-Methylenedioxy-8-methoxy-10-nitro-1-phenanthrenecarboxylic acid; HMS1361H22; N2032; FT-0602867; NCGC00017334-01; LS-21656; Aristolochic acid I; ST057179; Bio1_001396; HMS3402H22; Aristolochiazaeure; KBio3_000319; 8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid; NCGC00095981-01; AKOS015896751; Aristolochia yellod; HSDB 7179; NCGC00017334-07; NSC11926; Descresepd; BBFQZRXNYIEMAW-UHFFFAOYSA-N; Aristolochic-acid-A; Spectrum_001156; MFCD00004996; AN-319; KBio3_000320; NSC-50413; NCGC00017334-06; ARISTOLOCHINE; UNII-94218WFP5T; MLS002702976; X1086; NSC-11926; Aristolochic acid-I; 8-Methoxy-6-nitrophenanthol (3,4-d) 1,3-dioxole-5-carboxylic acid; EINECS 206-238-3; KBio2_000160; SPECTRUM1502233; NCGC00017334-03; Bio1_000418; TR-013344; 8-methoxy-6-nitro-naphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid; NCGC00095981-05; SR-05000002369; Phenanthro[3,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-; BSPBio_002848; HMS1989H22; BDBM50306855; Aristinic acid; Bio2_000160; NCGC00017334-05; 8-Methoxy-3,4-methylenedioxy-10-nitrophenanthrene-1-carboxylic acid; Aristolochia, European Pharmacopoeia (EP) Reference Standard; SpecPlus_000448; Aristolochic acid A; Birthwort; Spectrum3_001114; KBioSS_000160; CCG-35796; Phenanthro[3,4-d]-1,3-dioxole-5-carbocylic acid, 8-methoxy-6-nitro-; MCULE-3861334509; NCGC00017334-02; KBio1_001488; Aristolochic acid; 8-Methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylic acid #; 12770-90-0; KBio2_001636; Spectrum4_001952; BRN 0345159; A000071790; Tardolyd; SMR001562128;aristolochic acid A;aristolochic acid a |
C17H11NO7 |
341.27 g/mol |
COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O |
|
TCMBANKIN061904 |
methyl 6-o-galloy-beta-d-glucopyranoside |
methyl-6-O-galloyl-β-D-glucopyranoside;methyl-6-o-galloyl-β-d-glucopyranoside |
C14H18O10 |
346.32 |
COC1C(C(C(C(O1)COC(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O |
滇IICP备16009434号-1 |
Dai SX Lab